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CRISPR system provides adaptive immunity against foreign DNA in microbes. CRISPR nucleases in 
complex with a guide-RNA targets complementary DNA (protospacer) if they are next to protospacer 
adjacent motif (PAM), by the virtue of RNA-DNA base pairing, resulting in unwinding of DNA strands 
in protospacer. CRISPR has been re-purposed for wide-ranging biological applications. But lack of 
mechanistic understanding and specificity of both binding and cleavage continue to be challenges for 
CRISPR based applications. I employed single molecule fluorescence and biochemical assays to 
investigate the molecular mechanism of widely used CRISPR-enzymes (Cas9, its engineered derivatives 
(EngCas9) and Cpf1 orthologs). Following observations were made: 
 
• CRISPR-enzymes bind DNA in 2 modes. In mode I, enzymes samples DNA non-specifically for 
transient PAM-detection. Upon successful PAM-recognition, binding shifts to mode II involving 
RNA-DNA duplex/DNA unwinding. Mode-II is longer lived, whose lifetime depends on number 
and location of on/off-target base-pairs (bp) (PAM-proximal off-targets bp; deleterious PAM-
distal ones; tolerable). 
 
• Cas9s require only 9-10 bp for stable binding and ~16 bp for cleavage. Cpf1s are significantly 
more specific, requiring ~17 bp for both.  
 
• Release of cleaved-DNA products for genome-editing machinery is likely crucial. Cas9s do not 
release any, where Cpf1s releases one end. 
 
• Cas9s cleavage happens from maximally unwound DNA state. PAM-distal off-target bp reduce 
extent and lifetime of unwinding thus delaying cleavage. EngCas9s mutations destabilize 
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unwound state and have a much lower intrinsic cleavage rate, which are the basis of their 
improved specificity. 
 
• Significant effect of pH and reducing conditions on Cpf1 activity can explain higher performance 
variance (compared to Cas9) in different organisms. These can also be used as switches for Cpf1 
activation/inactivation. 
 
The work presented in this dissertation has already resulted in 3 first-author manuscripts and a review. 
The work has been further extended into other fluorescent geometries and onto newer CRISPR enzymes. I 
am also applying the biophysical information from my PhD work to re-engineer CRISPR-Cas9 for 
precise control of its DNA binding and cleavage activity. These efforts have resulted in useful data and 
will likely lead to more manuscripts. Continued improvement in our understanding of CRISPR 
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Chapter 1.  


















*Some contents of this chapter is under review at: 
Singh, D., Ha, T. Understanding the molecular mechanisms of CRISPR toolbox using single molecule 




The adaptive immunity against foreign genetic elements conferred by CRISPR systems in microbial 
species has been repurposed as a revolutionary technology for wide-ranging biological applications, 
chiefly genome engineering. Biochemical, structural, genetic and genomics studies have revealed 
important insights into their function and mechanisms, but most ensemble studies cannot observe 
structural changes of these molecules during their function and are often blind to key reaction 
intermediates. Here I discuss how single molecule technologies can help us understand the molecular 
mechanism of CRISPR tool box. 
 
1.2 INTRODUCTION to CRISPR 
In certain bacteria and archaea, CRISPR (clustered regularly interspaced short palindromic repeats)–Cas 
systems form an adaptive defense against attacks by foreign genetic elements such as viruses1. The 
system functions by storing memory of attacks by acquiring sequences of the foreign genetic elements 
into host genome in regions known as CRISPR loci2. Short RNA transcripts (Guide-RNA) from CRISPR 
loci forms a complex with the CRISPR proteins (CRISPR-RNA)3. During future invasions, the CRISPR-
RNA is directed by the guide-RNA to target foreign genetic elements for its nucleolytic impairment, 
chiefly by the virtue of base-pairing between the guide-RNA and DNA sequences (DNA target) in foreign 
genetic elements4,5. Region in DNA target spanning the canonical base-pairing between the guide-RNA 
and DNA target is called the protospacer. The single most important requirement of such DNA targeting 
is that the protospacer be followed by a special motif called PAM (protospacer adjacent motif)5,6. 
Sequences in protospacer closest to PAM are referred to as being PAM-proximal whereas those farthest 
away from PAM are PAM-distal. Throughout this dissertation, the base pairs in the protospacer that are 
complementary to the guide-RNA of CRISPR-RNA are referred to as matches whereas the others are 
called mismatches. nPD (the number of PAM-distal mismatches) and nPP (the number of PAM-proximal 
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mismatches) are used to denote the location and extent of mismatches. 
 
Abilities to program a nuclease to induce a cut at a desired genomic site and to program a nucleolytically 
dead CRISPR fused with a marker or an effector to bind any genomic site has revolutionized biology7,8. 
Minimalistic versions of CRISPR systems are employed for such applications because they provide the 
modularity and ease of programming. Class II of CRISPR is one example as it uses a single CRISPR 
endonuclease in complex with guide-RNA to target DNA9. The most commonly used type is SpCas9 
(Cas9 from Streptococcus Pyogenes), followed by SaCas9 from Staphylococcus Aureus10, and Cpf1 
variants; AsCpf1 from Acidaminococcus sp and  LbCpf1 from Lachnospiraceae bacterium11.  In many 
other CRISPR systems, multiple CRISPR proteins form a Cascade complex with the guide-RNA  to 
target DNA and then recruit Cas3 for DNA degradation9,12,13. The protospacer length of Cas9 and Cpf1 
ranges from 20-24 base-pair (bp) and the PAM is 3-6 nucleotides (nt) long. Cascades have ~33 bp 
protospacer and 2-3 nt PAM. Cas9 from Streptococcus Pyogenes is the most widely used Cas9 and is thus 








(a) Complexation of Cas9 with guide-RNA results in Cas9-RNA whichs binds and cleaves DNA 
complementary to the sequence in guide-RNA (shown by red; protospacer) provided that the protospacer 
is adjacent to a protospacer adjacent motif (PAM). (b) Differences between Cpf1 and Cas9. 
1.3 FLUORESCENCE and FORSTER RESONANCE ENERGY TRANSFER. 
Energy in a molecule can be stored as potential energy or kinetic energy, in a variety of ways including 
and some of these can be due to: Rotational energy associated with rotational tumbling motion of 
molecules, vibration energy associated with oscillations of atoms within the molecule. Electronic energy, 
resulting from the potential energy of electrons in different electronic configurations/levels. These listed 
energies are quantized, meaning that they can only occupy discrete values/levels (Figure 1.2a) and 
investigation of transitions between these levels is called Spectroscopy and can be used to obtain useful 
information about the nature and environment of any molecule of interest. 
 
One of the most commonly used techniques in spectroscopy is called Fluorescence which primarily 
involves the investigation of transitions between different electronic levels of a molecule. The 
fundamental principle of fluorescence is best described in a diagram known as the  
Jablonski diagram (Figure 1.2b). A molecule in a ground state electronic configuration, can be irradiated 
with a flash of energy (for example, laser). And if the photons from the energy source has energy of 
quanta equal to difference between ground state (S0) and a first excited electronic state (S1), the molecule 
can absorb these photons and jump to a higher energy excited electronic state (S1). The absorbance occurs 
on the order of 10-15 seconds. As shown before in Figure 1.2b, the electronic energy levels are 
interspersed with the vibrational energy levels. One of the most common ways for the molecule to return 
to the ground state is to dissipate part of its absorbed energy via relaxation to the lowest vibrational 
energy level around S1. From there, the molecule can relax back to S0, while emitting a photon 
corresponding to the energy difference between these two levels. This process takes place on the order of 
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(10-9-10-7 seconds) and is called as Fluorescence. Following this, the molecule can dissipate more of its 
energy to vibrational energy levels around S0 and finally relax to the lowest energy state of the S0 state.  
The transitions to lower vibrational energy levels is non-radiative i.e. no photons are emitted and energy 
is released in form of heat. This process is known as the relaxation and loss of part of energy originally 
obtained from the absorption of photon, results in photon emitted in fluorescence to have lower energy 
and thus higher wave-length. This shift in the higher value of wavelength is known as the Stokes shift.  
 
There are many other pathways by which the molecule can relax back to the lowest energy state of the 
ground state (S0). Some of which are : 
 
1. Collisional Quenching: Molecule in the excited state (S1) may collide with another molecule and 
transfer the energy in a non-radiative way. 
 
2.Electron in the excited state (S1) of the molecule may undergo a spin transition and lead to conversion 
from singlet excited state S1 state to an excited triplet state (T1). Once in T1, the molecule may then relax 
back to levels around S0, in a radiative way emitting photons in the process, which is known as 
Phosphorescence. 
 
3. Molecules have a net dipole. And dipole of fluorescent molecule (termed 
Donor) in excited energy state may get coupled in an interaction with the dipole of another fluorescent 
molecule (termed acceptor). This coupling results in a non-radiative 
energy transfer from donor to acceptor. The transferred energy in the acceptor (now in its excited energy 
state) relaxes back to its own ground state in a radiative way i.e. by emitting photons. This process of 
energy transfer is known as Förster (or Fluorescence) Resonance Energy Transfer (FRET). 
 
The efficiency of energy transfer, also known as FRET efficiency (E), depends on: 
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(1) Physical distance between the donor and the acceptor (r). 
(2) Spectral overlap between the donor emission and acceptor absorption (𝐽𝐽). 
(3) Relative orientation of the dipoles of donor and acceptor molecules (κ). 
(4) Quantum efficiency of the donor molecule (𝑄𝑄𝑑𝑑). 
(5) Refractive index of the medium (𝑛𝑛). 
And they are related by the following equations: 
𝑬𝑬 =
𝟏𝟏









𝒏𝒏𝟒𝟒  𝑱𝑱 
Equation 1.2 
Where 𝑅𝑅𝑂𝑂 is the distance at which the FRET efficiency is 50% (0.5), and 𝑁𝑁𝐴𝐴 is Avogadro’s number. 






Where 𝑰𝑰𝑨𝑨 is the intensity of the fluorescence from the acceptor  (obtained via FRET) and 𝑰𝑰𝑫𝑫 is the 
intensity of the fluorescence from the donor (fluorescence remaining after a fraction of it is FRET 





Figure 1.2 Molecular energy levels and transitions between them for fluorescence and FRET 
spectroscopy. 
(a) Quantized energy levels of a molecule owing to rotational and vibrational motion plus electronic 
states. (b) Transitions between different energy levels, giving rise to phenomenon of absorbance, 
fluorescence, phosphorescence and FRET. 
1.4 INTRODUCTION to SINGLE-MOLECULE TECHNOLOGIES. 
As the name suggests, single-molecule techniques are those that enable investigation of properties of 
individual molecules as opposed to bulk techniques where readouts/measurements result from averaging 
of properties of multiple molecules. For the longest time, the biggest hurdle for single-molecule 
techniques was the ability to detect signal from a desired single molecule i.e. the signal was too weak, 
especially in a biological system. But since late 90s, advent of powerful cameras, new microscopy 
techniques, development and characterization of extremely bright dyes (fluorophores) have enabled 




1. Capture heterogeneity of a biological system: 
Biological systems are extremely complex involving interaction between many components for e.g. 
DNA/RNA, proteins and metabolites. And even the weakest interactions can have critical outcomes. 
Therefore, to understand the system as a whole, it is imperative that we take all different interactions into 
account.  Bulk measurements can only report on average of these interactions thus masking their intrinsic 
heterogeneity. Single-molecule measurements allow us to investigate each interaction separately thus 
helping us to unmask the intrinsic heterogeneity of a system. 
 
2. Analyze molecular mechanism of important processes: 
Biological processes are a combination of many stochastic events i.e. there is no synchronization between 
behaviors of multiple DNA/RNA or protein molecules (biomolecules) that make up the biological 
process. This makes investigating the process and its steps very difficult via bulk measurements, because 
they only report on the averaging of the multiple stochastic events. For e.g. if we relied solely on score 
lines to judge tennis players, we could make a fairly good assessment that Roger Federer is a great tennis 
player. But only the score lines obscure many critical aspects of his greatness, like his technique, foot 
work etc. which are critical information because they not only serve entertainment aspect of tennis, but is 
also used as a model for upcoming players and overall development of the sport. In a way, the scoreline 
can be thought of as a read of a bulk measurement i.e. average of multiple different shots (events) that 
Federer hit, with no information about quality and nature of the shots. 
 
If we can watch single molecule(s) of that entire process or a system, we can understand how various 
parts of the system work individually and combinatorically.  But capturing single biomolecules directly in 
action is almost impossible because their sizes are extremely small and are thus beyond fundamental 
optical limits of most microscopes. So single molecule detection for biological systems is typically 
achieved by attaching an extremely bright fluorescent dye on the biomolecule of interest which makes it 
'fluorescently visualizable' as it emits light of a certain wavelength when illuminated with a light source 
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(laser) of particular wavelength (color). Apart from just being able to localize and track motion of the 
biomolecule via the fluorescent dye attached to it, there are many photophysical properties of these dyes 
that can be utilized to serve variety of purposes. One such example is FRET, which involves transfer of 
fluorescent 'energy' from one dye (donor) molecule to other (acceptor) molecule. So if a donor dye 
molecule is being illuminated with a bright laser for its fluorescent visualization via its emission of a 
certain wavelength or color. A part of its 'energy' can end up being donated to an acceptor dye molecule 
in its vicinity, which would emit the 'donated energy' via its emission of a different wavelength or color. 
The transfer of energy is dependent on distance between the dye molecules, so intensity and wavelength 
of the emission from these two dye molecules can act as a reporter of distance between them. 
Implementation of FRET technique in a single-molecule setup is commonly referred to as single-
molecule FRET (smFRET), which can be adapted to investigate any biological processes and its steps. 
 
For e.g. if Federer had been extremely small like a protein molecule. Then we could watch the internal 
shape changes of the protein/Federer as it does its job/play tennis by attaching a donor and an acceptor 
molecule to specific locations (for e.g. hands of Federer) and illuminate them with a laser light of certain 
wavelength. The real-time output emission from the protein/Federer (donor + acceptor emission) will 
report on real-time changes in distance between two specific points in protein/ hands of Federer. This 
information will help you understand and analyze the molecular mechanism of the protein/Federer. 
 
3. Localization of single molecules for super resolution imaging: 
Biological structures (cells, tissue etc.) are made up of thousands of constituent biomolecules (protein, 
DNA, RNA etc.). Visualization and localization of each of the constituent biomolecules, in singulo, can 
be used to build up the entire biological structure giving us a high quality resolution image of it. Design 




4. Adaptation of single molecule technique in sequencing and other applications: 
If multiple single molecules can be detected simultaneously, then multiple reactions can be performed 
simultaneously and investigated separately. This idea has been most successfully implemented in DNA 
sequencing applications. Previous methods of DNA sequencing relied on series of individual experiments 
that had to be painstakingly performed separately for each specific region in genome to be sequenced. 
Data was then collected from multiple such individual experiments for final analysis.  But the ability to 
detect readout from single (or few) DNA molecule sequencing experiments, performed in parallel but 
analyzed in separate, has revolutionized biology. The point I want to emphasize here is that the ability of 
massively parallel single-molecule detection can be repurposed to separately analyze large number of 
reactions performed in parallel. 
 
1.5 SINGLE MOLECULE FRET (smFRET) and ITS IMPLEMENTATION 
One of the most commonly employed optical method of single molecule fluorescent detection is the Total 
internal reflection (TIR) microscopy. In it, an incident light is irradiated at the cover slip/slide and 
solution interface at an angle that would cause the phenomenon of total internal reflection instead of 
reflection. The total internal reflection creates a strong evanescent field, whose depth is limited to <100 
nm into the solution. Thus only a small subset of molecules which lie within this evanescent volume will 
absorb incident photons and emit fluorescence or FRET depending on the presence and location of donors 
and acceptors. This strategy drastically improves the signal to noise as fluorescence from molecules 
outside the plane of interest is abolished since only molecules within 100 nm distance get excited. 
One of the most common practices is to immobilize the biomolecules of interest (labeled with donor 
and/or acceptor) on the surface of the cover slip or the slide using Avidin-Biotin linkage which is one of 
the tightest non-covalent linkages). The most common optical strategies of  achieving TIR and capturing 




Figure 1.3 | Common strategies for single molecule fluorescence. 
13 
 
(a-d) Biomolecules of interest, immobilized a cover slip is irradiated with a green laser (that can excite a 
particular donor molecule). The angle of incidence is managed by modulating the angles at which the 
laser beam enters the objective and hits the coverslip. Upon reaching the critical angle, the laser beam 
undergoes a total internal reflection and creates a strong but limited evanescent field. The molecules 
within the evanescent field get excited by the energy of the evanescent field and undergo fluorescence or 
FRET depending on the geometry of donor and acceptor molecules within the biomolecules or 
biomolecular complexes. The emission from all the molecules with in the evanescent field is captured by 
the objective. The total emission is then spectrally split into donor fluorescence and acceptor fluorescence 
(via FRET) and projected as two separate images (channels) of the same set of molecules at any given 
time point. The single fluorescent spots ideally represent the fluorescence from single biomolecules or 
biomolecular complex. The intensity as a function of time of any spot in donor channel (ID (t)) and 
acceptor channel (IA (t)) can be used to evaluate the changing FRET efficiency (E) of the given single 
biomolecule as a function of time via Equation 1.3 we discussed before. Different values of E can report 
on different conformational states of a biomolecule or interaction between two biomolecules, depending 
on the labeling geometry of donor and acceptor. (a) and (b) are two primary strategies of achieving TIR. 
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Binding specificity of Cas9-guide RNA complexes to DNA is important for genome engineering 
applications, but how mismatches influence target recognition/rejection kinetics is not well-
understood.  We used single-molecule FRET to probe real-time interactions between Cas9-RNA and 
DNA targets. Bimolecular association rate is only weakly dependent on sequence, but the dissociation 
rate greatly increases from < 0.006 s-1 to > 2 s-1 upon introduction of mismatches proximal to protospacer 
adjacent motif (PAM), demonstrating that mismatches encountered early during heteroduplex formation 
induce rapid rejection of off-target DNA. In contrast, PAM-distal mismatches up to 11 base pairs in 
length, which prevent DNA cleavage, still allow formation of a stable complex (dissociation rate < 0.006 
s-1), suggesting that extremely slow rejection could sequester Cas9-RNA, increasing Cas9 expression 
level necessary for genome-editing thereby aggravating off-target effects. We also observed at least two 
different bound FRET states that may represent distinct steps in target-search and proofreading.  
 
2.2 INTRODUCTION 
CRISPR (clustered regularly interspaced short palindromic repeats)–Cas systems provide adaptive 
immunity against foreign genetic elements in bacteria and archaea14. In type II CRISPR-Cas systems, the 
Cas9 endonuclease functions together with a dual-guide RNA comprising CRISPR RNA (crRNA) and 
trans-activating crRNA (tracrRNA) to target 20 base pair (bp) DNA sequences (cognate sequence) for 
double-stranded cleavage15. Efficient targeting requires RNA-DNA complementarity as well as a specific 
motif flanking the target sequence called the PAM (protospacer adjacent motif, 5’-NGG-3’ for S. 
pyogenes Cas9)15-17. Cas9-RNA complexes have proven to be extremely versatile tools for genome 
engineering applications18, and minimizing off-target effects19,20 remains an active area of study.  
 
Numerous studies have assessed off-target DNA binding and cleavage by the Cas9 RNA complex, both in 
vitro and in vivo 15,17,21-56.While subtly different conclusions have been reached depending on the exact 
16 
 
method of analysis, these studies agreed about specificity being heavily influenced by the presence of a 
PAM, a 7-12 bp long seed sequence proximal to the PAM, and the concentration of Cas9 and guide-RNA. 
Most of previous studies lacked dynamic information on DNA targeting, yet in order to improve the 
efficacy of processing only the correct targets, we need such information on targeting dynamics. Single 
molecule methods are ideal for this task because they can detect wide-ranging interactions (transient to 
long-lived) and identify multiple states in real time57. Moreover, they can be used to obtain the dynamic 
information on short and specific DNA sequences, thus enabling the sequence specific estimation of 
various kinetic parameters58-60. Several single molecule studies have examined sequence specificity in 
CRISPR targeting53-56,61,62. Here, we report a systematic investigation of the binding and dissociation 
kinetics of Cas9-RNA as a function of sequence mismatches to determine how quickly cognate sequence 
is recognized and how quickly partially matching sequences are rejected. 
 
2.3 RESULTS 
2.3.1 Real-time single molecule assay for DNA interrogation by Cas9-RNA 
We used single-molecule fluorescence resonance energy transfer63,64 (smFRET) to directly observe 
individual Cas9-RNA complexes binding to DNA targets in real time. Donor (Cy3) and acceptor (Cy5) 
fluorophores were conjugated to modified nucleotides in the DNA target and crRNA, respectively, so that 
FRET between them would report on Cas9-RNA binding to the DNA (Figure 2.1a and Figure 2.2). 
Fluorescence labeling did not compromise target cleavage (Figure 2.3). After introducing 20 nM Cas9-
RNA complexes to cognate DNA target molecules immobilized on passivated microscope slides, two 
distinct populations were observed centered at FRET = 0.92 and 0, respectively (Figure 2.1b, c). The 
labeling sites are separated by 30 Å65 (Figure 2.2), consistent with the observation of the high FRET value 
upon Cas9-RNA binding. In control experiments using a non-cognate (fully mismatched) DNA target 
with PAM (Table 2.1), or guide-RNA without Cas9, the 0.92 FRET state was not observed (Figure 2.1c). 
Therefore, we assigned the 0.92 FRET state to a stably formed Cas9-RNA-DNA complex. The high 
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FRET state was long-lived, with a lifetime (>3 min) limited only by fluorophore photobleaching (Figure 
2.4d). A catalytically dead Cas9 mutant (dCas9; D10A/H840A mutations15,16) showed signal 
indistinguishable from active Cas9 (Figure 2.4), indicating that DNA products remain tightly bound after 
cleavage as was observed previously17 (Figure 2.3). To capture the moment of binding, we added Cas9-
RNA into the flow cell during data acquisition. FRET efficiency increased from 0 to 0.92 in a single step 
(Figure 2.1d), suggesting that any intermediates on-path to target binding, if present, cannot be resolved at 
the time resolution of our measurements (0.1 s). 
 
2.3.2 Effect of DNA target mismatches on Cas9-RNA binding 
We next examined how DNA targets with imperfect RNA-DNA complementarity are discriminated 
against and rejected by Cas9-RNA. We prepared a series of donor-labeled, fully duplexed DNA 
containing mismatches relative to the guide-RNA (Table 2.1 and Figure 2.5a). The mismatches were 
introduced either from the PAM proximal side or from the PAM distal side, and are denoted using the 
naming convention x-ymm where xth through yth base pairs are mismatched. The fraction of DNA bound by 
Cas9-RNA (ratio between counts with FRET > 0.75 and total counts in FRET histograms) remained 
identical to the cognate DNA up to 12 PAM-distal mismatches (17-20mm, 13-20mm, 12-20mm, 11-20mm, 10-
20mm, 9-20mm) (Figure 2.5b, d). The bound state remained stable, with the observed lifetimes limited only 
by fluorophore photobleaching (Figure 2.4d).  A large decrease in the bound fraction occurred only when 
the number of mismatches from the distal end exceeded 13 bp (7-20mm, 6-20mm, 5-20mm), corresponding to 
less than 7 matched bp from the PAM-proximal end.  In contrast, even 2 bp mismatches from the PAM-
proximal end (1-2mm) were deleterious for Cas9-RNA binding and binding to 4 bp PAM-proximal 
mismatches (1-4mm) was indistinguishable from binding to fully mismatched (1-20mm), underscoring the 




Figure 2.1 | Cas9-RNA binding to a cognate sequence. 
(a) Schematic of single-molecule FRET assay. High FRET signal resulted when Cas9 in complex with an 
acceptor (Cy5)-labeled guide RNA (Cas9-RNA) bound a surface-immobilized, donor (Cy3)-labeled target 
DNA that contains the cognate sequence (red DNA segment) and PAM (yellow segment). (b) A 
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representative smFRET time trajectory of a stably bound Cas9-RNA in the presence of 20 nM Cas9-RNA 
in solution.  (c) FRET histograms obtained with cognate DNA (top) and negative controls with a non-
cognate DNA (middle) and with RNA only (without Cas9) (bottom). The number of molecules included 
ranged from 568 to 1,314.  Corresponding images of donor and acceptor channels are shown. (d) A 
representative smFRET time trajectory of real-time binding of Cas9-RNA in a single step after 20 nM 





Figure 2.2 | FRET probe labeling locations in the Cas9-RNA-DNA complex. 
(a) Cy3 and Cy5 labeling locations shown in the crystal structure of Cas9-RNA bound to a cognate DNA 
target (PDB ID: 4UN3)65. The strand hybridized with the guide RNA to form the RNA-DNA 
heteroduplex is referred to as the target strand while the other strand, containing the PAM (5’-NGG-3’), is 
the non-target strand. (b) Schematic of a bound Cas9-RNA-DNA complex showing the base pairing 
between different components. The sequences shown in red denote the cognate sequence of the DNA 
target and the complementary guide sequence of the crRNA. The DNA sequence highlighted in light gray 






Figure 2.3 | Target cleavage activity is not impaired by fluorescent labeling of guide RNA or DNA 
target. 
(a) DNA cleavage assays using fluorescently labeled components, analyzed by denaturing PAGE. TS, 
target strand; NTS, non-target strand. Note that Cy3-DNA exhibits retarded gel mobility compared to 
unlabeled DNA, giving rise to two cleavage product bands and two substrate bands due to incomplete 
labeling. (b) Single-molecule assay to monitor DNA cleavage of the cognate DNA target. Because Cas9-
RNA retains high-affinity binding to DNA cleavage products, 7 M urea was required to release Cas9-
RNA and the DNA product containing Cy317. (c-d) Disappearance of Cy3 spots resulted from Cas9-RNA 
mediated DNA cleavage, as shown by (c) fluorescence images and (d) quantification of Cy3 spot counts. 
About 20% of spots remained after Cas9-RNA reaction followed by urea wash compared to more than 50 










Figure 2.4 | Comparison between Cas9 and dCas9, and high stability of Cas9-RNA-DNA for certain 
DNA targets. 
(a)  Cas9 or dCas9 were assembled with acceptor-labeled guide RNA to monitor binding to a donor-
labeled cognate DNA target. (b-c) Cas9 and dCas9 were indistinguishable in our binding assay, as shown 
by the similarity of (b) FRET histograms at 20 nM Cas9-RNA/dCas9-RNA and (c) lifetimes of the high 
FRET state at 10 nM Cas9-RNA/dCas9-RNA, fit with a single exponential decay. The number of 
molecules used for the FRET histograms was 346 (Cas9-RNA) and 297 (dCas9-RNA). (d) DNA targets 
with contiguous complementarity larger than 8 bps in the PAM-proximal end of the protospacer showed 
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long-lived binding as shown in (c). To confirm that the slow decay was caused by photobleaching instead 
of Cas9-RNA dissociation, we monitored the loss of signal at different laser intensities.  As expected, the 
apparent lifetime of the high FRET state increased with decreasing laser intensity, reaching 3.3 min for 





Figure 2.5 | Cas9-RNA binding to DNA with proximal or distal mismatches. 
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(a) A series of fully-duplexed DNA targets with a varying number of mismatches (blue segments) relative 
to the guide RNA.  An x-ymm target has a contiguous mismatch running from position x to y relative to 
PAM. (b, c) FRET histograms of Cas9-RNA binding to DNA constructs carrying PAM-distal (b) and 
PAM-proximal (c) mismatches.  The number of molecules for each histogram ranged from 568 to 3,053. 
[Cas9-RNA] = 20 nM. (d) The fraction of Cas9-RNA bound DNA molecules for different DNA targets. 
All the data shown in the figure are from independent experiments and error bars represent s.d. for n = 3 
(n = 2 for few sets). 
 
2.3.3 Different DNA binding modes of Cas9-RNA 
For DNA targets to which Cas9-RNA binds weakly, we observed a second bound state with a mid FRET 
peak at ~0.42, in addition to the 0.92 high FRET state. Single-molecule time trajectories (Figure 2.6a) and 
transition density plots reporting on the relative transition frequencies after hidden Markov modeling 
analysis66 (Figure 2.6b, Figure 2.7, Figure 2.8, and Figure 2.9) revealed reversible transitions between the 
unbound (FRET<0.2) state and both mid and high FRET=2 bound states, and lifetime analysis as a 
function of Cas9-RNA concentration confirmed that transitions are due to Cas9-RNA 
association/dissociation events (Figure 2.10 and Figure 2.11). The mid FRET was more frequently 
observed as the number of mismatches increased (Figure 2.6b and Figure 2.7), and were also observed for 
DNA targets without PAM or without matching sequence, indicating that it does not require either 
(Figure 2.12 and Figure 2.13). The high FRET state was rarely observed without PAM (Figure 2.14). We 
propose that the Cas9-RNA has two binding modes (Figure 2.17). The mid FRET state (sampling mode) 
likely does not involve RNA-DNA heteroduplex formation and may represent a mode of PAM 
surveillance. It is possible that local diffusion may give rise to the time-averaged FRET value of the mid 
FRET state. Sequence-independent sampling of DNA target for PAM can occur at multiple locations in 
the DNA target, and the mid-FRET state, representative of this sampling, expectedly had a broad FRET 
distribution (Figure 2.7, Figure 2.8, and Figure 2.9). If PAM is recognized during transient biding in the 
sampling mode, RNA-DNA heteroduplex formation follows, resulting in the high FRET state.  
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Multimodal binding kinetics were also observed for Cascade in Type I CRISPR systems, but its shorter-
lived binding mode plays a priming function which is absent for Cas955. 
 
2.3.4 Effect of DNA target mismatches on Cas9-RNA binding and dissociation kinetics 
Survival probability distributions of dwell times in the bound state (FRET>0.2) before transitioning to the 
unbound state were best described by a double-exponential decay (Figure 2.14). The amplitude-weighted 
lifetime of the bound state (τavg) decreased precipitously even with just 2 bp PAM-proximal mismatches, 
likely because the R-loop failed to extend beyond the mismatches. In contrast, 12 bp mismatches were 
necessary from the distal end for any detectable decrease in τavg (Figure 2.6c). Similar pattern was also 
observed for lifetime of transitions from high to zero FRET state whereas the lifetimes of the mid to zero 
FRET state remained short for all DNA targets tested, on average ~0.1 s (Figure 2.6c), supporting our 
proposal that the mid FRET state is a sampling mode that does not require sequence recognition. 
In contrast to the bound state lifetimes, the lifetimes of the unbound state were only weakly dependent on 
sequence (Figure 2.6c and Figure 2.12), yielding the bimolecular association rate constant (kon) of ~ 6 x 
106 M-1 s-1 with some reduction for DNA targets without PAM. Overall, our kinetic analysis showed that 
mismatches affect Cas9-RNA binding mainly through changes in the dissociation rate. Complete kinetic 
model along with rates of transitions between different states for some DNA targets are in Figure 2.17 and 
Figure 2.15. 
 
The relative importance of PAM-proximal base pairs over the PAM-distal base pairs (Figure 2.5d and 
Figure 2.6c) supports the model of unidirectional extension of the RNA-DNA heteroduplex starting from 
the PAM-proximal end 17,61. For 5-20mm that has a maximum of 4 bp heteroduplex extension from PAM, 
the bound state lifetime was about 0.5 s, i.e. such potential targets are rapidly rejected. The bound state 
lifetime increased to about 8 s for 8-20mm with 7 bp heteroduplex, and to about 16 s for 9-20mm with 8 bp 
heteroduplex. For 9 bp or more heteroduplexes, the measured lifetime was limited by photobleaching 
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lifetime of about 3 min (Figure 2.4). Therefore, DNA sequences with 9 or more matching bp from the 
PAM proximal end have extremely long times, and Cas9-RNA would be unable to reject such sequences 
rapidly. A prediction of this model is that inserting a roadblock of mismatches near this boundary would 
prematurely terminate heteroduplex extension such that dissociation kinetics would be independent of the 
presence of a matched sequence beyond the block. To test this prediction, we created two “roadblock” 
targets, 9-12mm and 5-8mm. Indeed, the binding fraction and the lifetime of the bound state (Figure 2.16 
and Figure 2.6d) for 9-12mm and 5-8mm were similar to those of 9-20mm and 5-20mm, respectively, 
confirming our prediction. 
 
 
Figure 2.6 | Cas9-RNA bound state lifetimes for different DNA targets. 
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(a) smFRET time trajectory (donor and acceptor intensities, top, and idealized FRET via HMM analysis, 
bottom) for 9-20mm DNA target in the presence of 20 nM Cas9-RNA. Reversible Cas9-RNA association 
to high and mid FRET states and disassociation to zero FRET state are shown. (b) Transition density 
plots show relative transition frequencies between different FRET states for 9-20mm and 5-20mm DNA 
targets. [Cas9-RNA] =20 nM.  (c) The amplitude-weighted lifetime, τavg, of the putative bound state, 
lifetime of high to zero and mid to zero FRET state transitions and biomolecular rate association constants 
for different DNA targets. Based on our model, the mid and high FRET states correspond to sampling and 
RNA-DNA heteroduplex modes respectively. (d) Lifetime comparison of DNA targets with the 
respective DNA targets containing mismatches after the roadblock. All the data shown in the figure are 





Figure 2.7 | Hidden Markov model analysis and transition density plots reveal transitions between 
three different FRET states.  
(a-b) Representative single-molecule fluorescence time trajectories and their idealized FRET time 
trajectories, obtained using hidden Markov modeling66, for (a) the 9-20mm DNA target and (b) the 1-2mm 
DNA target. [Cas9-RNA] = 20 nM. (c-d) Transition density plots (TDP) reveal the relative frequencies of 
transitions between the initial FRET value and the final FRET value, as identified by hidden Markov 
modeling. The heat maps are separately scaled for each DNA target.  A small proportion of rapid FRET 
fluctuations between high and mid FRET states were also observed. The relative population of transitions 
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to/from the mid FRET state increased with increasing mismatches at both (c) PAM-distal and (d) PAM-
proximal ends. The actual number of transitions from high to zero FRET state and mid to zero FRET state 











Figure 2.8 | Transition density plots for 5-20mm DNA target at two different frame rates of image 
acquisition. 
In order to test if the short-lived mid FRET state observed at 100 ms time resolution was affected by time 
resolution, we performed additional measurements at 30.2 ms time resolution and compared the results 
for 5-20mm and found no appreciable difference. (a)  A representative single-molecule fluorescence time 
trajectory showing Cas9-RNA binding at 100 ms/frame (top) and the associated transition density plot 
(bottom). [Cas9-RNA] = 20 nM.  (b)  A representative single-molecule fluorescence time trajectory 
showing Cas9-RNA binding at 30.2 ms/frame (top) and the associated transition density plot (bottom). 




Figure 2.9 | Transition density plots for 9-20mm, 5-20mm and 1-2mm DNA targets with different inputs 
for hidden Markov modeling. 
3 hidden Markov states were sufficient to capture the different FRET states of Cas9 targeting as any 





Figure 2.10 | Determination of dwell times in the unbound state. 
(a) A representative smFRET time trajectory shows Cas9-RNA binding the cognate DNA target in real 
time. A 20 nM Cas9-RNA solution was added at the indicated time point and the dwell time in the zero 
FRET unbound state until the appearance of FRET was recorded. (b) A representative smFRET time 
trajectory for a DNA target with full sequence complementarity to guide RNA but without a PAM motif, 
obtained by imaging under steady state conditions with 20 nM Cas9-RNA in solution. Dwell times in the 
zero FRET unbound state between upward spikes in FRET due to transient binding events were recorded. 





Figure 2.11 | Determination of the rates of FRET appearance and disappearance. 
(a) Survival probability of dwell times of zero FRET state for 9-12mm DNA target (colored dots) fit with a 
single exponential decay (black line), to determine the observed binding rate, kbinding at three different 
Cas9-RNA concentrations. (b, c) kbinding vs. [Cas9-RNA] for different DNA constructs as noted.  Linear 
fits were used to estimate the bimolecular association constant (kon). (d) koff vs. [Cas9-RNA]. Error bars 





Figure 2.12 | The binding rates. 
(a) Rate of Cas9-RNA DNA binding for a panel of DNA targets. For these calculations of the binding 
rate, kbinding, both the mid and high FRET state were taken together as a single state. A straight line fit to 
the observed binding rates was used to estimate the binding constant (kon) of Cas9-RNA averaged over all 




Figure 2.13 | Binding dynamics for ‘PAM-less’ cognate DNA target and non-cognate target with 
PAM. 
Representative single-molecule fluorescence time trajectories (top) and associated transition density plots 
(bottom) of DNA target with full sequence complementarity (cognate) to guide-RNA but lacking a PAM 
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motif (a, 0-0mmNo-PAM) and with no matches and no PAM (b, 1-20mmNo-PAM). [Cas9-RNA] = 20 nM. 
The number of transitions from high to zero FRET states and mid to zero FRET states are indicated 







Figure 2.14 | Fitting survival probability of Cas9-RNA bound states vs. time. 
(a) The survival probability vs. time for different DNA targets (colored circles) of the putative bound 
states (FRET>0.2) (double exponential fit in black). (b) The parameters, of the double exponential fit 
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which results in two characteristic bound state lifetimes i.e. long lived and transient binding with their 





Figure 2.15 | Kinetic model describing the transitions between various states of Cas9-RNA DNA 
targeting. 
(a) The kinetic model of Cas9-RNA and DNA interaction. Cas9-RNA has two binding modes i.e. the 
sampling mode for PAM surveillance and the RNA-DNA heteroduplex mode which are referred to as s 
and r. Unbound DNA state is u. (b) Rates of transitions from RNA-DNA heteroduplex and sampling 
mode to unbound state for certain DNA targets including the ones without PAM. Error bars represent s.d. 




Figure 2.16 | FRET histograms for roadblock constructs and ‘PAM-less’ constructs. 
(a) FRET histograms for DNA targets with and without mismatches beyond 4 bp roadblock starting from 
8th or 5th bp from PAM. (b) FRET histograms for DNA with full sequence complementarity but no PAM 
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(left), and for DNA with no sequence complementarity and no PAM. The number of molecules per 
histogram ranged from 297 to 3,053.  
 
2.4 DISCUSSION 
A previous single-molecule61 study that investigated the Cas9-RNA induced RNA-DNA heteroduplex 
formation via magnetic tweezers observed 11 PAM-proximal matches to be sufficient for stable RNA-
DNA heteroduplex formation for StCas9 (the Cas9 ortholog from Streptococcus thermophilus). In our 
current study using SpCas9 (from Streptococcus pyogenes, simply referred to as Cas9), we found 9-10 
PAM-proximal matches to be sufficient for ultra-stable Cas9-RNA binding. The stability of RNA guided 
CRISPR enzymes and DNA targets depends on energetic contributions of RNA-DNA heteroduplex and 
interactions between the DNA target and amino-acid residues of the CRISPR enzymes. The latter has 
been fine-tuned67,68 through protein engineering to create more specific Cas9 variants and the small 
differences between different Cas9 orthologs may stem from the variations in the interactions 
between the DNA target and protein residues. 
 
A two-step mechanism of Cas9-RNA binding involving PAM surveillance in the sampling mode and 
RNA-DNA heteroduplex formation upon PAM recognition (Figure 2.17) is also supported by structural 
analysis of Cas9 and Cas9-RNA-DNA ternary complexes, in which interactions between PAM-interacting 
amino acid motifs in Cas9 and the PAM of the DNA target precede and guide the further RNA-DNA 
heteroduplex formation32,65,69.  Our observation that the heteroduplex lifetime increases greatly between 6 
and 8 base pairs can be explained by the recently determined Cas9-RNA structure69, in which Watson-
Crick faces of eight PAM-proximal nucleotides are solvent exposed, thus primed for heteroduplex 
formation. Once an RNA-DNA heteroduplex of 8 bp or more is formed, Cas9-RNA establishes a stable 
complex with the DNA, regardless of PAM-distal mismatches. Therefore, Cas9-RNA is unable to rapidly 
reject such off-target DNA, which it cannot cleave, and is sequestered by off-target DNA, limiting the 
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speed of genome editing. This effect would increase the minimal amount of Cas9-RNA required for 
genome editing, and may in turn lead to an increase in off-target cleavage. For applications requiring 
binding only, for example genome decoration or gene regulation, binding specificity will be almost 
entirely determined by the first 8 or 9 bps away from PAM, greatly reducing the ability to target well 
defined sequences in a large genome. For example, we found that 1,126 positions in the human reference 
genome match PAM plus 8 bp in the sequence we used (Table 2.2). For future improvements in Cas9 
proteins, we suggest that one should focus on rapid rejection of such off targets. Our observations may 
also further inform the design of the guide-RNA and the DNA targets with minimal off-target effects70-81. 
 
 
Figure 2.17 | The proposed model of bimodal Cas9-RNA binding along with the kinetics of Cas9-
RNA DNA targeting as a function of mismatches. 
 
2.5 MATERIALS AND METHODS 
2.5.1 Preparation of DNA targets 
All DNA oligonucleotides were purchased from Integrated DNA Technologies (IDT, Coralville, IA 
52241). The Cy3 label in the DNA target is located 3 bp upstream of the protospacer adjacent motif 
(PAM 5’-NGG-3’) and was achieved via conjugation of Cy3 N-hydroxysuccinimido (NHS) to an amino-
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group attached to a modified thymine through a C6 linker (amino-dT). The entire panel of DNA targets 
used in our measurements is available in Table 2.1. A 22 nt long biotinylated adaptor strand was used for 
surface immobilization (Figure 2.2b). DNA targets were prepared by mixing all three component strands 
and heating to 90°C followed by cooling to room temperature over 3 hrs.  
 
2.5.2 Expression and purification of Cas9 and dCas9 
The protein purification protocol was adapted from the methods described previously2,32. A fusion 
construct inserted into a custom pET-based expression vector was used for protein expression. The fusion 
construct consisted of the sequence encoding Cas9 (Cas9 residues 1-1368 from S. pyogenes) and an N-
terminal decahistidine-maltose binding protein (His10-MBP) tag, followed by a peptide sequence 
containing a tobacco etch virus (TEV) protease cleavage site. The fusion protein was expressed in E. coli 
strain BL21 Rosetta 2 (DE3) (EMD Biosciences), grown in 2xYT medium at 18 °C for 16 h following 
induction with 0.5 mM IPTG. The harvested cells were lysed in 50 mM Tris pH 7.5, 500 mM NaCl, 5% 
glycerol, 1 mM TCEP, supplemented with protease inhibitor cocktail (Roche), and then homogenized 
(Avestin). Following ultra-centrifugation, the supernatant clarified cell lysate was separated from the 
cellular debris and bound in batch to Ni-NTA agarose (Qiagen).  The resin was washed extensively with 
50 mM Tris pH 7.5, 500 mM NaCl, 10 mM imidazole, 5% glycerol, 1 mM TCEP and the bound protein 
was eluted in a single-step with 50 mM Tris pH 7.5, 500 mM NaCl, 300 mM imidazole, 5% glycerol, 1 
mM TCEP. TEV protease was added to the elutant and cleavage of the protein fusion was allowed to 
proceed overnight. Cas9 was then dialyzed into Buffer A (20 mM Tris-HCl pH 7.5, 125 mM KCl, 5% 
glycerol, 1 mM TCEP) for 3 h at 4°C, before being applied onto a 5 ml HiTrap SP HP sepharose column 
(GE Healthcare). After washing with Buffer A for three column volumes, Cas9 was eluted using a linear 
gradient from 0-100% Buffer B (20 mM Tris-HCl pH 7.5, 1 M KCl, 5% glycerol, 1 mM TCEP) over 20 
column volumes. The protein was further purified by gel filtration chromatography on a Superdex 200 
16/60 column (GE Healthcare) in Cas9 Storage Buffer (20 mM Tris-HCl pH 7.5, 200 mM KCl, 5% 
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glycerol, 1 mM TCEP). Cas9 was stored at -80°C. Catalytically dead Cas9 (dCas9; D10A/H840A 
mutations) was prepared with the same protocol.  
 
2.5.3 Preparation of guide-RNA and Cas9-RNA 
The guide-RNA consists of CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA). The crRNA 
with an amino-dT was purchased from IDT and was labeled using Cy5-NHS. The tracrRNA was prepared 
using in vitro transcription as described previously17. The guide-RNA was assembled freshly for each 
experiment by mixing equimolar accounts of Cy5-labeled crRNA with tracrRNA, heated to 80°C 
followed by slow cooling to room temperature. The guide-RNA was then complexed with Cas9 (2-3 
times the stoichiometric amount of guide-RNA) to form the Cas9-RNA complex for use in imaging 
experiments. RNA sequences are available in Table 2.1. A detailed schematic of the DNA and the Cas9-
RNA design can be found in the Figure 2.2. The Cas9-RNA activity on the cognate sequence used in this 
study was characterized previously17. Our biochemical assays showed that fluorophore labeling in the 
DNA target or crRNA had not impaired DNA target cleavage. (Figure 2.3). 
 
2.5.4 Single-molecule detection and data analysis 
Cy3-labeled DNA targets were immobilized on the PEG (Polyethylene glycol) passivated surface using 
neutravidin-biotin interaction. The DNA target molecules were then imaged in the presence of Cy5-
labeled Cas9-RNA (referred to as Cas9-RNA for brevity here) using the total internal reflection 
fluorescence microscopy. Imaging was performed at room temperature in a buffer (20 mM Tris-HCl, 100 
mM KCl, 5 mM MgCl2, 5 % (v/v) glycerol, 0.2 mg ml-1 BSA, 1 mg ml-1 glucose oxidase, 0.04 mg ml-1 
catalase, 0.8% dextrose and saturated Trolox (~3 mM)). The time resolution for all the experiments was 
100 ms unless stated otherwise. Detailed methods of single-molecule FRET (smFRET) data acquisition 
and analysis were described previously64. The FRET efficiency of a single molecule was approximated as 
FRET = IA/(ID+IA), where ID and IA are the background and leakage corrected emission intensities of 




2.5.5 FRET histograms and Cas9-RNA bound DNA fraction 
The first five frames (100 ms each) of each of the molecule’s FRET time trajectories were used as data 
points to construct the FRET histograms. The first ten frames were used for the FRET histograms in 
Figure 2.4. The Cas9-RNA bound DNA fraction was calculated as the fraction of data points with FRET 
>0.75 and the total number of data points in the FRET histograms. For each DNA target, the single 
molecule FRET time trajectories from independent experiments were combined together to construct the 
FRET histograms as described. 
 
2.5.6 Lifetime analysis of bound and unbound states via thresholding 
To confirm that the FRET signal indeed reports on Cas9-RNA binding, the lifetimes of the zero FRET 
(FRET < 0.2) and the putative bound state (mid and high FRET states taken as a single state, FRET > 0.2) 
were determined as a function of Cas9-RNA concentration [Cas9-RNA]. Based on this cut-off of 
FRET=0.2, the survival probability of the zero FRET state vs. time could be fit well with a single 
exponential decay, and the decay rate increased linearly with [Cas9-RNA]. In contrast, the survival 
probability vs time for the bound state had to be fit with a double exponential decay and the decay rates 
did not depend on [Cas9-RNA]. (Figure 2.14). Therefore, a bimolecular association/disassociation 
kinetics was used for the analysis of DNA binding by Cas9-RNA.  
 
DNA Target    +    Cas9-RNA     ⇌     Cas9-RNA-DNA 
 
kbinding (s-1)  = kon (M-1s-1 )  × [Cas9-RNA] (M) 
 
Lifetime of the bound state via thresholding. In order to perform unbiased analysis of apparently three-
state FRET fluctuations observed from binding-challenged DNA targets, we employed hidden Markov 





states (high, mid and zero FRET states). To estimate the lifetime of the putative bound states, the survival 
probability of all the bound state events (mid and high FRET states taken as a single state, FRET > 0.2) vs 
time was fit using a double exponential decay profile (A1 exp(-t/τ1)+A2 exp(-t/τ2)) (Figure 2.14). The final 
bound state lifetime (τavg, observed), is an amplitude weighted average of two distinct lifetimes τ1 and τ2 i.e. 
τavg, observed = A1τ1 +A2τ2 (kobserved = 1/τavg, observed).  
 
Association rates. We determined the observed rates of binding kbinding using two independent methods. 
First, the Cas9-RNA binding events were captured in real time by flowing Cas9-RNA into the sample 
chamber with immobilized DNA target molecules (Figure 2.10a). Second, for the binding challenged 
DNA targets that showed reversible association/disassociation, the smFRET time trajectories obtained 
under steady state conditions were used to extract the unbound state duration between adjacent binding 
events (Figure 2.10b). These dwell times in the unbound state were then used to get the rate of association 
by fitting their survival probability distribution to a single exponential decay (Figure 2.11a).  
 
Rates of transitions between different states. Generation of idealized FRET time trajectories using the 
hidden Markov model66 yielded three different FRET states (zero, mid and high) along with the 
probabilities of transitions between the various FRET states. The log of transitions probabilities between 
any two states was used to estimate the mean transition probability between the two given states which 
was then used to estimate the rate as following: 
kA-B (s-1) = Tp (A-B) × Sampling rate of image acquisition 
where kA-B is the rate of transition from state A to B 
Tp (A-B) is the mean probability of transition from A to B. 




Correction factors. Because the high FRET state was very long-lived for certain DNA targets (i.e. 8-20mm, 
9-20mm, 9-12mm, 1-2mm), their dwell times were not accurately captured due to photobleaching-induced 
truncation of smFRET time trajectories. The same is true for the dwell time of the unbound state. We 
made the following correction to obtain the actual rate.  
kactual=    kobserved  - kphotobleach (high/zero FRET state) 
where kobserved is the rate calculated above and kphotobleach (high/zero FRET state) is the rate of photobleaching of the 
high or zero FRET state. Finally, we obtain τavg = 1/ kactual. 
 
2.5.7 Counts of DNA target sequences in human genome. 
The human genome assembly (GRCh38.p6) was analyzed using custom MATLAB scripts to calculate the 
total occurrences of DNA target sequences used in this study, which is referred to as the actual count 
(Table 2.2). The total number of occurrences expected for a sequence, assuming a random distribution of 
A, T, G and C nucleotides, is referred to as the probabilistic count and is calculated as follows: 
Probabilistic Count = (¼)n × Total number of bp in human genome ( 3.2 billion) 
where ¼ is the probability of occurrence of any given nucleotide at a position in the sequence, and n is the 
number of bp in the genome. 
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Table 2.2 | The abundance count of the sequence of the different DNA targets in human genome 
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In microbes, CRISPR-Cas systems provide adaptive immunity against invading genetic elements.  Cas9 
in complex with a guide-RNA targets complementary DNA for cleavage and has been repurposed for 
wide-ranging biological applications. New Cas9s have been engineered (eCas9 and Cas9-HF1) to 
improve specificity, but how they help reduce off-target cleavage is not known. Here, we developed 
single molecule DNA unwinding assay to show that sequence mismatches affect cleavage reactions 
through rebalancing the internal unwinding/rewinding equilibrium. Increasing PAM-distal mismatches 
facilitate rewinding, and the associated cleavage impairment shows that cleavage proceeds from the 
unwound state. Engineered Cas9s depopulate the unwound state more readily upon mismatch detection. 
Intrinsic cleavage rate is much lower for engineered Cas9s, preventing cleavage from transiently 
unwound off-targets. DNA interrogation experiments showed that engineered Cas9s require about one 
additional base pair match for stable binding, freeing them from sites that would otherwise sequester 
them. Therefore, engineered Cas9s achieve their improved specificity (1) by inhibiting stable DNA 
binding to partially matching sequences, (2) by making DNA unwinding more sensitive to mismatches, 
and (3) by slowing down intrinsic cleavage reaction.  
 
3.2 INTRODUCTION 
In bacteria and archaea, CRISPR (clustered regularly interspaced short palindromic repeats)–Cas systems 
impart adaptive defense against phages and plasmid1. In type II CRISPR-Cas systems, the Cas9 
endonuclease in complex with two RNAs, a CRISPR guide-RNA (crRNA) and a trans-activating RNA 
(tracrRNA), targets complementary 20 base pair (bp) sequences (protospacers) in foreign DNA for 
double-stranded cleavage, with a requirement that they be followed by a motif called PAM (protospacer 
adjacent motif, 5’-NGG-3’ for S. pyogenes Cas9)4,16,17. Programmable DNA binding and cleavage by 
Cas9 has revolutionized life sciences, where Cas9 cleavage is used for genome editing and Cas9 binding 
is used for tagging genomic sites with markers or effectors for wide-ranging applications7,8. Minimizing 
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off-target effects of both binding and cleavage20,82 remains an active area of study. In vitro and in vivo 
investigations have shown that Cas9-RNA specificity is most affected by PAM plus an 8-10 PAM-
proximal seed region and concentrations of both Cas9 and RNA82,83. Rationally designed and engineered 
S. Pyogenes Cas9s (EngCas9s), namely enhanced Cas9 (eCas9; K848A/K1003A/R1060A mutations) and 
high fidelity Cas9 (Cas9-HF1; N497A/R661A/Q695A/Q926A mutations), led to remarkable specificity 
improvements in unbiased genome wide CRISPR-Cas9 specificity measurements67,68. 
 
The stability of Cas9-RNA-DNA complex is in part a function of the specific RNA-DNA base-pairing 
and sequence-independent interactions between Cas9 residues and DNA, the latter being a potential 
source of promiscuity. Cas9-RNA uses binding energy to initially melt DNA near PAM, and DNA 
unwinding can continue downstream in the presence of sequence complementary with guide-RNA. The 
motivation behind the mutations in EngCas9s was to destabilize the Cas9-RNA-DNA complex by 
diminishing the favorable sequence-independent interactions between Cas9 residues and the DNA 
backbone (Figure 3.1b). Single molecule FRET measurements showed that Cas9 conformational changes 
that bring a nuclease domain to the cleavage site can be disrupted by fewer mismatches for the EngCas9, 
leading to the proposal that the nuclease movement is the conformational checkpoint against off-target 
cleavage84,85.  Here, we report a comparative analysis of DNA interrogation and rejection, DNA 
unwinding and rewinding dynamics, and cleavage activation among different Cas9s using single molecule 
imaging methods that can detect multiple conformations and transient intermediates57 and have been used 
previously to study CRISPR systems in vitro6,53,54,62,83-88. We found evidence that DNA unwinding is the 
checkpoint that guard against off-target cleavage and could determine the equilibrium between unwinding 
and rewinding that allowed us to estimate the intrinsic cleavage rate from the unwound state. Based on 
our findings, we propose that engineered Cas9s achieve their improved specificity (1) by inhibiting stable 
DNA binding to partially matching sequences, (2) by making DNA unwinding more sensitive to 





3.3.1 Real-time single molecule FRET assay for DNA interrogation 
We employed a single-molecule fluorescence resonance energy transfer (smFRET) assay89 to investigate 
DNA interrogation by EngCas9-RNA. DNA targets (donor-labeled, 82 bp long) were immobilized on 
polyethylene glycol (PEG)-passivated flow chambers and EngCas9 pre-complexed with acceptor-labeled 
guide-RNA (EngCas9-RNA) was added to observe their interactions in real time. Locations of donor 
(Cy3) and acceptor (Cy5) were chosen such that specific interaction between DNA target and EngCas9-
RNA would lead to FRET (Figure 3.1a and Figure 3.2). Labeling at these locations do not affect Cas9 
cleavage activity83. Unless mentioned otherwise, we used catalytically dead versions of all Cas9s (denoted 
with the prefix d) in order to focus on the properties prior to cleavage. Wild-type (WT) Cas9 and dCas9 
showed similar behavior in DNA interrogation experiments83. 
 
We examined different DNA targets containing mismatches relative to the guide-RNA. As the naming 
convention, we used nPD (the number of PAM-distal mismatches) and nPP (the number of PAM-proximal 
mismatches) (Figure 3.1b). The cognate DNA target gave two distinct populations centered at FRET 
efficiency (E) of 0.9 and 0 in the presence of 20 nM EngCas9-RNA. The E=0.9 population was negligible 
if only the labeled RNA was added without Cas9 or if a fully mismatched DNA without PAM was used. 
Therefore, we assigned the E=0.9 species to a sequence-specific EngCas9-RNA-DNA complex (Figure 
3.1c). The E=0 population is a combination of unbound states and bound states with inactive or missing 
acceptor. Cas9-RNA titration gave the apparent dissociation constant (Kd) of 0.50 nM (dCas9), 0.5 nM 
(deCas9) and 2.7 nM (dCas9-HF1) (Figure 3.3). 
 
To quantify the impact of mismatches, we determined the apparent Cas9-RNA bound fraction fbound, 
defined as the normalized fraction of DNA molecules with E > 0.75 (20 nM Cas9-RNA) (Figure 3.1d and 
Figure 3.4). fbound vs. mismatches for EngCas9s was similar to that observed previously with WT Cas983; 
54 
 
(i) fbound remained unchanged when nPD increased from 0 to 10 or 11, but precipitously decreased beyond, 
(ii) even nPP of 2 or 4 caused a >50% or >95% drop in fbound, respectively, (iii) binding is ultra-stable with 
>8-9 PAM-proximal matches as fbound remained high even 1 hour after washing away free Cas9-RNA 
(Figure 3.5). 
 
If there are enough mismatches to preclude stable binding, smFRET time-traces showed repetitive 
transitions between E=0 and E=0.45 states in addition to transitions between E=0 and E=0.9, suggesting 
that there are multiple bound states distinguishable based on E 83 (Figure 3.1c). We used a hidden Markov 
modeling analysis90 to determine τavg as a fraction-weighted average of the high (E=0.9) and mid (E=0.45) 
FRET state lifetimes. τavg was over 1 hour for DNA targets with at least m PAM-proximal matches (m=9 
for WT Cas9 and deCas9, 10 for dCas9-HF1) but decreased to 0.5 – 15 s with fewer than m PAM-
proximal matches or any PAM-proximal mismatches (Figure 3.1e). Dwell times of the unbound state (E 
<0.2) were only weakly dependent on sequence (Figure 3.1f) (Figure 3.6 and Figure 3.7). 
 
We list below qualitative features common between EngCas9s and WT Cas9 as well as quantitative 
differences: 
(1) All Cas9s interrogate and bind DNA in two distinct modes. Sequence-independent sampling of DNA 
target in search of PAM results in transient mid FRET events. The high FRET state results upon PAM 
detection and RNA-DNA heteroduplex formation, and its lifetime increased with increasing base-pairing 
between guide-RNA and DNA target. (2) The binding frequency is independent of sequence. The 
bimolecular association rate constant kon decreased for EngCas9s (2.9×106 M-1 s-1 for deCas9 and 1×106 
M-1 s-1 for dCas9-HF1, compared to 5.4×106 M-1 s-1 for WT Cas9), possibly as a result of alteration in 
electrostatic and polar interaction upon removal of positively charged and polar residues (Figure 3.1f). (3) 
PAM-proximal mismatches are much more deleterious for stable binding compared to PAM-distal 
mismatches, and mismatches in the middle of the protospacer renders PAM-distal matches 
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inconsequential (Figure 3.4) 83, suggesting that all Cas9s extend RNA-DNA heteroduplex unidirectionally 
from PAM-proximal to PAM-distal end. (4) PAM-proximal mismatches are more deleterious for 
EngCas9 binding than WT Cas9, and (5) deCas9 and WT Cas983,91 require 9 PAM-proximal matches for 
ultra-stable binding whereas dCas9-HF1 requires 10 (Figure 3.1e and Figure 3.5). Overall, EngCas9 are 
similar to WT Cas9 in their sequence-dependent binding properties except for the higher ability to reject 
both PAM-proximal and PAM-distal mismatches which may help reduce Cas9-RNA sequestration by 







Figure 3.1 | smFRET assay to study DNA interrogation by engineered Cas9-RNA. 
(a) Schematic of smFRET assay. Cas9 in complex with an acceptor labeled guide-RNA binds a donor-
labeled cognate DNA target. (b) DNA targets with mismatches in the protospacer region against the 
guide-RNA. The number of mismatches PAM-distal (nPD) and PAM-proximal (nPP) are shown in cyan 
and orange, respectively. Also shown are locations of EngCas9 mutations in dCas9-RNA-DNA complex 
(PDB ID: 4UN3).  (c) E histograms (left) at 20 nM EngCas9-RNA or RNA only. Representative single 
molecule intensity time traces of donor (green) and acceptor (red) are shown (middle), along with E 
values idealized (right) by hidden Markov modeling. (d) Normalized fraction (fbound) of DNA molecules 
bound with Cas9-RNA at 20 nM Cas9-RNA. Fractions were normalized relative to the bound fraction of 
cognate DNA target. (e) τavg, obtained from dwell times of E >0.2 states. (f) Unbound state lifetimes at 
[Cas9-RNA] = 20 nM. The mean of τavg over various DNA targets was used to calculate kon. Number of 
PAM-distal (nPD) and PAM-proximal mismatches (nPP) are shown in cyan and orange respectively. Error 






Figure 3.2 | FRET probe locations for DNA interrogation by Cas9-RNA. 
(a) Schematic of Cas9-RNA-DNA complex. The hybridized crRNA and tracrRNA are referred to as 
guide-RNA. Sequences in red denote guide sequence of the guide-RNA and the matching sequence of the 
DNA. The target strand is complementary to the guide-RNA. The non-target strand contains the PAM 
(5’-NGG-3’). A 22 nt biotin-labeled adaptor strand was used for surface immobilization of DNA and is 





Figure 3.3 | Determination of Kd between Cas9-RNA and DNA. 
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(a-c) E histograms for cognate DNA and DNA with nPD=11 for (a) dCas9 (b) deCas9 and (c) dCas9-HF1 
vs [Cas9-RNA] obtained in smFRET DNA interrogation experiments. (d-e) The apparent bound fraction 
vs. [Cas9-RNA] and fits for Kd estimation. The number of PAM-distal mismatches (nPD) and PAM 





Figure 3.4 | E histograms for different DNA targets obtained smFRET DNA interrogation 
experiments at 20 nM Cas9-RNA. 
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(a) deCas9. (b) dCas9-HF1. (c) WT Cas9. The number of PAM-distal mismatches (nPD) and PAM-
proximal mismatches (nPP) are shown in cyan and orange, respectively. 
 
 
Figure 3.5 | Ultrastable binding of EngCas9-RNA to DNA. 
E histograms before and >60 min after washing away free Cas9-RNA in solution obtained from smFRET 
DNA interrogation experiments. Like WT Cas9-RNA6,83, EngCas9-RNA remains near-irreversibly bound 
to the DNA targets if there are >8-9 PAM-proximal matches. (a) deCas9 for cognate DNA and DNA with 
nPD = 11.  (b) dCas9-HF1-RNA for cognate DNA and DNA with nPD = 10. (c-d) Like WT Cas9-RNA6,83, 
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catalytically capable EngCas9s do not release cleaved DNA products. The release of cleaved products 
would have resulted in disappearance of fluorescent/FRET spots. (c) E histograms before and after >60 
minutes after removing free eCas9-RNA and Cas9-HF1-RNA for cognate DNA. (d) Representative 
images showing no reduction in the number of spots. The number of PAM-distal mismatches (nPD) is 





Figure 3.6 | Binding and kinetic parameters of DNA interrogation (20 nM Cas9-RNA). 
(a) Normalized fraction of DNA molecules bound with Cas9-RNA. Fractions were normalized relative to 
the bound fraction of cognate DNA for each Cas9-RNA. (b) Average bound state lifetime obtained from 
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dwell times of E >0.2 states. (c) Average lifetime of high FRET (E>0.6) binding events (τhigh), obtained 
from the dwell times of E>0.6 states. (d) Average lifetime of mid FRET binding events (τmid) obtained 
from dwell times of mid FRET (E>0.2 & E<0.6) states. (e) Fraction of binding events with mid FRET. (f) 
Average unbound state lifetime obtained from the single-exponential fits to the distributions of dwell 
times of E<0.2 state. The number of PAM-distal mismatches (nPD) and PAM-proximal mismatches (nPP) 





Figure 3.7 | Transition density plots for smFRET DNA interrogation experiments. 
(a-b) Transition density plots pictorialize the relative number of transitions between different FRET 
states, as identified by hidden Markov modeling. (a; deCas9 and b; dCas9-HF1) (c-d) A small fraction of 
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binding events showed rapid fluctuations between high and mid FRET states. The source of these 
fluctuations, also observed for WT Cas983, is unknown and dwells in these states were not included in the 
lifetime calculation.  The number of PAM-distal mismatches (nPD) and PAM-proximal mismatches (nPP) 
are shown in cyan and orange, respectively. 
 
3.3.2 Cas9-RNA induced DNA unwinding 
Genome wide characterization of EngCas9 cleavage specificity showed marked improvements over WT 
Cas967,68. Yet, our binding study shows that the EngCas9s still stably bind to DNA with nPD as large as 10. 
We reasoned that EngCas9s may differ from WT Cas9 in their mismatch dependence of DNA unwinding 
which, if promoted by annealing to guide-RNA, may be a determinant of cleavage action93. Therefore, we 
probed the internal unwinding of PAM-distal region of the protospacer by labeling the target and non-
target strands with a donor and an acceptor, respectively, with 9 bp spacing (Figure 3.8). Labeling at these 
locations did not perturb cleavage (Figure 3.9). The DNA by itself showed high FRET (E~0.75) (Figure 
3.10a-b), and upon addition of 100 nM WT dCas9-RNA to cognate DNA, we observed a shift to a stable 
low FRET state (E~0.30), likely because of DNA unwinding (Figure 3.10a-b). A similar FRET change 
was observed when the locations of the donor and acceptor were swapped (Figure 3.8b). A DNA with nPD 
= 1 showed a similarly stable unwinding but with a slightly higher E of ~0.35 and occasional short-lived 
transitions to the high FRET state, likely due to one bp fewer unwinding and increased frequency to 
rewind, respectively. The trend continued upon increasing nPD to 2 and 3; E value for the unwound state 
increased, and the relative population of the rewound state increased. With nPD = 4, the unwound state is 
rarely populated. deCas9 and dCas9-HF1 showed a similar behavior but their unwound state population 
and lifetime were smaller and decreased more quickly with increasing nPD (Figure 3.10b). Therefore, 
EngCas9s are more sensitive to PAM-distal mismatches in their ability to unwind DNA. The rewound 
state must still have at least 8 PAM-proximal bp unwound because we did not see stable binding with 




We observed two distinct E populations even at a higher time resolution (35 ms) (Figure 3.11), indicating 
that Cas9-RNA induces primarily two states, unwound and rewound, without spending appreciable time 
in between. We used the Hidden Markov modeling analysis to segment single molecule time traces into 
two states (Figure 3.12). All Cas9s showed a reduction in the relative population and lifetime of the 
unwound state with increasing nPD (Figure 3.10c-e). Combined with the gradual increase of E values for 
the unwound state (Figure 3.10b), we can conclude that PAM-distal mismatches reduce the time spent in 
the unwound state in addition to reducing the maximal extent of unwinding. For a given nPD, EngCas9s 
showed lower occupancy and shorter lifetime of the unwound state (Figure 3.10c-e), suggesting that the 
mutations indeed destabilize the maximally unwound states. We observed a similar unwinding behavior 
from catalytically active Cas9 but E distribution was broader and state transitions were less frequent 
(Figure 3.13), suggesting a change in unwinding dynamics after cleavage, possibly due to disordered non-
target strand93,94.  
 
In order to capture the initial DNA unwinding event, we added labeled DNA to surface-immobilized 
Cas9-RNA molecules (Figure 3.10f) (Figure 3.14 and Figure 3.15). DNA binding is detected as a sudden 
appearance of fluorescence signal in a high E state, followed by a single step change to a low E (unwound 
state) (Figure 3.10g). Subsequently, we observed unwinding/rewinding dynamics similar to what we 
observed in the steady state (Figure 3.10g) (Figure 3.16 and Figure 3.17). The average dwell time of the 
initial high E state which we attribute to the time it takes to unwind DNA for the first time (τunwinding) 
remained constant (~1 s) for dCas9 when nPD changed from 0 to 2. In contrast, τunwinding increased ~9 folds 
for EngCas9s when nPD changed from 0 to 2 (Figure 3.10h), suggesting that EngCas9s take longer to 




3.3.3 DNA cleavage vs. mismatches 
Next, we probed how mismatches influence target cleavage through modulating DNA 
unwinding/rewinding dynamics. Cleavage was more specific for EngCas9s because they cleaved only up 
to nPD = 3 compared to nPD = 4 for WT Cas9 (Figure 3.18a and Figure 3.9). EngCas9s did not release 
cleavage products under physiological conditions (Figure 3.5), as was the case for WT Cas983. In terms of 
the cleavage reaction, EngCas9s were much slower than WT Cas9 for cognate or PAM-distal mismatched 
DNA (Figure 3.18b-c) but were faster for PAM-proximal mismatched DNA (Figure 3.18a). Overall, we 
observed a clear correlation between the cleavage time scale, τcleavage, and DNA unwinding signatures; 
τcleavage decreased with increasing population (Figure 3.18d) and lifetime (Figure 3.18e) of the unwound 
state. Therefore, cleavage must proceed from the unwound state.   
 
HNH and RuvC nuclease domains cleave target and non-target strand respectively. Additional 3’-5’ 
exonuclease activity of RuvC4,93,95, which normally causes multiple bands of cleaved non-target strand, 
decreased with increasing nPD, and more efficiently so for EngCas9s (Figure 3.9).  
 
Armed with the kinetic information on DNA binding, interrogation, unwinding/rewinding and cleavage, 
we can clarify in which reaction steps sequence mismatches and Cas9 mutations exert their influence. 
Because cleavage likely occurs from the unwound state, we estimated the lower limits of intrinsic rate of 
cleavage (kc,int) from the apparent cleavage time τcleavage and unwound fraction by fitting τcleavage vs 
unwound fraction using τcleavage  = 1/([unwound fraction]*kc,int +C). Because a single value of kc,int was 
able to fit the data for each Cas9, we conclude that changes in τcleavage  caused by mismatches can be 
attributed to changes in the unwound fraction (Figure 3.18d). Therefore, although DNA molecules with 
different nPD values show different extents of unwinding, their unwound states have similar intrinsic 




Inserting two single bp mismatches in the PAM-distal region gave a predominantly rewound state with 
only brief excursions to the unwound state for all Cas9s (Figure 3.19a), indicating that there is no 
difference in unwound fraction among them. Nevertheless, WT Cas9 cleaved the DNA whereas 
EngCas9s did not, further confirming the much higher kc,int for WT Cas9 which in turn allows cleavage 
even from a transiently populated unwound state, likely contributing to higher  off-target cleavage yields 
(Figure 3.19b).  
 
3.3.4 Mechanism of mismatch sensitivity of EngCas9s 
The changing balance between unwinding and rewinding caused by mismatches reflect the energetic 
competition between target strand annealing with RNA vs with non-target strand. Mismatches would 
favor rewinding to recover the parental duplex by disrupting RNA/DNA duplex. We found that mutations 
in EngCas9s further promote rewinding, helping improve cleavage specificity. In order to gain additional 
insights into how EngCas9s more readily rewind in the presence of mismatches, we disrupted the parental 
DNA duplex by pre-unwinding the PAM-distal mismatched portion (Figure 3.19c). Pre-unwinding shifted 
the balance toward unwinding for WT Cas9 and Ca9-HF1 (Figure 3.19d), possibly because the residues 
that sequester the non-target strand, mutated in eCas9, are still intact. The result also explains why pre-
unwinding allows rapid cleavage of mismatched DNA96. In contrast, eCas9 failed to shift E distribution 
toward a low value in the presence of PAM-distal mismatches (Figure 3.19d and Figure 3.20), likely 
because the residues that help sequester the unwound non-template strand are mutated (Figure 3.1b and 
Figure 3.21).  
 
3.3.5 PAM-proximal DNA unwinding 
To investigate if EngCas9-RNA mutations also affect PAM-proximal DNA unwinding we designed a 
DNA construct with a donor and an acceptor at the PAM proximal site separated by 12 bp (Figure 3.19e 
and Figure 3.22). Cas9-RNA binding to cognate DNA shifted E from 0.55 to 0.35 for all Cas9s, 
indicating a stable DNA unwinding at PAM-proximal site. With nPP = 2, the fraction of unwound 
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population decreased to 50% for dCas9, 40% for deCas9 and < 5% for dCas9-HF1 (Figure 3.19f), 
mirroring the decreases in fbound. However, this decrease did not correlate with cleavage efficiency of 
DNA target with nPP = 2, where EngCas9 were more efficient than WT Cas9 (Figure 3.18a). Therefore, 






Figure 3.8 | FRET probe locations for smFRET DNA unwinding experiments. 
(a) Schematic of Cas9-RNA-DNA complex. The hybridized crRNA and tracrRNA are referred to as 
guide-RNA. Sequences in red denote guide sequence of the guide-RNA and the matching sequence of the 
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DNA. The target strand is complementary to the guide-RNA. The non-target strand contains the PAM 
(5’-NGG-3’). A 22 nt biotin-labeled adaptor strand was used for surface immobilization of DNA and is 
highlighted in grey. The donor is attached to the target strand in the 6th position from PAM and the 
acceptor is attached to the non-target strand in the 16th position from PAM. Formation of Cas9-RNA-
DNA complex leads to the unwinding of DNA target, causing a decrease in E. (b) Similar FRET changes 
upon Cas9-RNA induced unwinding was observed when the donor and acceptor positions were swapped. 





Figure 3.9 | Fluorescent labeling for smFRET DNA unwinding experiments does not affect 
cleavage. 
(a) Schematic of cognate DNA target used in smFRET DNA unwinding experiments. Protospacer is 
highlighted in red and PAM in yellow. Also indicated are Cas9-RNA induced cleavage positions. (b) 
Cleavage of the DNA targets analyzed by denaturing polyacrylamide gel electrophoresis and Cy5 
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imaging. Multiple cleaved products for the non-target strand likely arises from 3’-5’ additional 
exonuclease activity of RuvC domain4. [DNA] =5 nM and [Cas9-RNA] =100 nM in 10 µl reaction. DNA 
was incubated with Cas9-RNA for ~75 minutes before being denatured by formamide loading buffer and 
heating at 95 oC for 10 minutes. The denatured sample products were then resolved using 15% 
polyacrylamide denaturing gel electrophoresis and imaged via Cy5 fluorescence. (c) Time courses of 
cognate DNA cleavage by eCas9-RNA with and without fluorescent probes (Cy3 and Cy5 pair) on the 
DNA show that labeling does not affect cleavage kinetics.  Aliquots from a running reaction were taken at 
different time points and analyzed by PAGE. DNA targets were radio-labeled at the 5’ end of the target 
strand with 32-P via a T4 polynucleotide kinase reaction for visualization. (d) Time evolution of multiple 
cleavage products of non-target strand due to additional 3’-5’ exonuclease activity of RuvC. HNH has no 
exonuclease activity and consequently does not result in cleaved products of different sizes. The number 





Figure 3.10 | Internal DNA unwinding/rewinding dynamics modulated by mismatches and Cas9 
mutations. 
(a) Schematic of smFRET assay for Cas9-RNA induced unwinding of surface-tethered DNA. (b) E 
histograms for nPD = 0, 1, 2, 3 and 4 (cyan numbering) and representative time traces. (c-e) Relative 
population of the unwound state, average lifetime of the unwound state and average lifetime of the 
rewound state vs. nPD.  (f) Schematic of smFRET assay for DNA unwinding by surface-tethered Cas9-
RNA. (g) Representative single molecule fluorescence intensity time traces of donor (green) and acceptor 
(red) show abrupt signal increase upon DNA binding followed by FRET changes. (h) Time taken to go 
from initial binding to its first unwound state configuration (τunwinding) as denoted by a dark yellow line (f). 






Figure 3.11 | smFRET DNA unwinding experiments at different Cas9-RNA concentrations and 
different frame rates of image acquisition. 
(a) smFRET assay to investigate the Cas9-RNA induced DNA unwinding as described in Figure 3.10a. 
(b-d) E histograms (left) of DNA targets vs nPD and their representative single molecule time traces of 
donor and acceptor intensities (middle) and E values (right). (b) DNA unwinding smFRET experiments 
performed at 5 nM of dCas9-RNA produce results similar to those observed with 100 nM Cas9-RNA. We 
used 100 nM for all unwinding experiments reported elsewhere in this study. (c-d) Frame rate of image 
acquisition for these experiments = 35 ms (c) and 100 ms (d). Both experiments performed with dCas9-
HF1 show similar E distributions. Although the overall signal was noisier for 35 ms data, fast transitions 





Figure 3.12 | Transition density plots for smFRET DNA unwinding experiments. 
Transition density plots pictorialize the relative number of transitions between different FRET states, as 
identified by hidden Markov modeling90. (a) dCas9 (b) deCas9 (c) dCas9-HF1. Number of PAM-distal 





Figure 3.13 | smFRET DNA unwinding experiments using catalytically active Cas9-RNA. 
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(a) smFRET assay to investigate the Cas9-RNA induced DNA unwinding as described in Figure 3.10a. 
smFRET data of DNA target only are shown. (b-d) E histograms vs nPD (left) and their representative 
time traces of donor and acceptor intensities (middle) and E values (right) for (b) dCas9 (c) deCas9 (d) 
dCas9-HF1. (e) Possible scenario of altered DNA unwinding/rewinding dynamics with cleaved strands in 









The tracrRNA with the indicated 3’ extension for the biotinylated DNA adaptor did not affect Cas9-RNA 
activity as shown by cleavage products analyzed by 15% denaturing polyacrylamide gel electrophoresis 
and Cy5 imaging.  
 
 
Figure 3.15 | DNA unwinding dynamics with surface immobilized Cas9-RNA. 
(a) smFRET DNA unwinding experiments as described in Figure 3.10f but with the Cas9-RNA tethered 
to the surface instead of DNA. (b) Representative images of the donor and acceptor imaging channels 
before and after addition of labeled DNA with nPD=2. (c, d, e) E histograms vs nPD obtained >~10 minutes 
after addition of labeled DNA (left), and the corresponding representative single molecule time traces of 






Figure 3.16 | DNA unwinding dynamics upon initial formation of Cas9-RNA-DNA complex. 
(a) Schematic of experiment to observe the DNA unwinding dynamics during very first moments of 
Cas9-RNA-DNA complex formation. The Cas9-RNA immobilized flow chamber surface was imaged 
during the addition of the FRET pair labeled DNA target to the flow chamber. Results with catalytically 
dead Cas9s are in: (b) dCas9 (c) deCas9 (d) dCas9-HF1. Representative single molecule time traces of 
donor and acceptor intensities (left) and their idealized E values (middle). E density maps (right) show the 
real-time evolution of different FRET states synchronized to the moment of DNA binding to Cas9-RNA. 
Histograms (in border blue bars) show E distribution at the moment of binding (time = 0). (e) Average 
time it takes for catalytically dead Cas9-RNA to go from initial binding (no unwinding) to its first 
unwound state configuration (τunwinding) is described by a dark yellow line in the schematic shown in (a). 
(f) Data obtained using catalytically active WT Cas9. The number of PAM-distal mismatches (nPD) is 





Figure 3.17 | Appearance of unwound state over time (dCas9-HF1-RNA on DNA with nPD=1). 
(a) Schematics of smFRET DNA unwinding experiments as described in Figure 3.10a. E Histogram of 
DNA target only (nPD=1) is shown. (b) E histograms of 1 nPD DNA target before and at different time 
points after adding 100 nM dCas9-HF1-RNA. Rapid appearance of a peak near E=0.5 indicates that Cas9-
RNA induced DNA unwinding occurs as soon as Cas9-RNA-DNA complex forms. The number of PAM-




Figure 3.18 | Cleavage vs mismatches and its relation with DNA unwinding. 
(a) Cas9-RNA induced cleavage pattern analyzed by 15% denaturing polyacrylamide gel electrophoresis 
of target strand 5’- labeled with 32-P. Dashed boxes highlight DNA targets with nPD =4 and nPP =2 that 
show differences between EngCas9s and WT Cas9. (b) Fraction of uncleaved DNA vs time for eCas9 as a 
function of time and single exponential decay fits to obtain cleavage time τcleavage. Inset shows a 
representative gel image. [DNA] = 1 nM. [Cas9-RNA] = 100 nM. (c) τcleavage vs nPD. Data for WT Cas9-
RNA is taken from a previous study96. (d) τcleavage vs unwound fraction as shown in Figure 3.10c. Fits are 
made to determine kc,int (see methods). (e) τcleavage vs. unwound state lifetime as shown in Figure 3.10d. nPD 
and nPP are shown in cyan and orange, respectively. Error bars represent standard deviation (s.d.) from 




Figure 3.19 | Cas9-RNA induced unwinding of various DNA and mechanisms of increased 
specificity by EngCas9s. 
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(a) Unwinding and cleavage of DNA with internal single base mismatches at positions 16th and 18th. E 
histograms were obtained at [Cas9-RNA] =100 nM or in its absence. Idealized E traces show transient 
unwinding observed in a subset of molecules. (b) Gel image of non-target strand shows that WT Cas9, 
but not EngCas9s, cleave the DNA. (c) Schematics of Cas9-RNA induced unwinding of pre-unwound 
DNA. (d) E histograms obtained at [Cas9-RNA] =100 nM or in its absence. Black numbers denote the 
number of base pairs pre-unwound and are mismatched. (e) Schematics of Cas9-RNA induced unwinding 
of PAM-proximal region. (f) E histograms obtained at [Cas9-RNA] =100 nM or in its absence. nPP is 
shown in orange digits. (g) Proposed model of DNA targeting, unwinding, rewinding, and cleavage (top). 






Figure 3.20 | smFRET unwinding experiments using pre-unwound DNA. 
(a) Schematics of smFRET DNA unwinding experiments utilizing pre-unwound DNA targets as 
described in Figure 3.19c. (b-d) E histograms vs nPD (left) and representative single molecule time traces 










Figure 3.22 | Probe locations for smFRET assay to investigate Cas9-RNA induced DNA unwinding 
in PAM-proximal site. 
(a) Schematic of a cognate dsDNA target before and after Cas9-RNA binding. (b) Probe locations 
mapped to the structure of Cas9-RNA-DNA complex (PDB ID: 5F9R93).  
 
3.4 DISCUSSION 
Like WT Cas9, EngCas9s also require only 9-10 PAM-proximal matches for ultra-stable binding and thus 
will likely not confer significant specificity advances for applications utilizing Cas9 binding, for example 
transcription regulation97 or imaging98. EngCas9s, however, do show a modest increase in binding 
specificity. For example, Cas9-HF1 requires one additional basepair match for ultra-stable binding 
compared to WT Cas9. Ultra-stable binding to partially matching sequences can sequester Cas9-RNA, 
limiting the speed of genome editing. To overcome sequestration, one would need higher Cas9-RNA 
concentrations which may in turn lead to an increase in off-target cleavage. One base pair difference 
would mean about four-fold reduction in such off-target sinks for Cas9-HF1, and even such a modest 
improvement in binding specificity may improve cleavage specificity by reducing the total concentration 
of Cas9-RNA required. 
 
Activation and dynamics of proofreading (REC2) and HNH domains in response to PAM-distal 
mismatches and Cas9 mutations has been studied using single molecule FRET 84,85. But what changes in 
the DNA target conformation trigger these movements of Cas9 domains were not known. Cas9’s cleavage 
activity requires many more matches than stable binding4,17 and we found that we found that DNA 
unwinding, instead of DNA binding, is strongly correlated with the cleavage rate when we vary the DNA 
sequence or Cas9 mutations. Unwound DNA configuration is likely verified by REC3 domain and linker 
connecting HNH and RuvC nuclease domains in Cas985,99, guiding HNH nuclease movement for 
cleavage. Here, we show that PAM-distal mismatches impair DNA unwinding, consequently this also 
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results in impairments in REC2 (coupled to REC3) proofreading and HNH movements84,85. In fact, Chen 
et al showed that the cleavage active conformation is more readily depopulated with mismatches for 
EngCas9s compared to WT Cas9, raising the possibility that HNH movement and DNA unwinding are 
concurrent. To test this possibility, we utilized the observation that HNH movement requires divalent 
cations and is inhibited by EDTA84.  We found that DNA unwinding occurs even in the absence of 
divalent cations (Figure 3.23), suggesting that DNA unwinding is upstream of HNH movement and that 
HNH movement does not occur with or because of HNH movement as had been suggested in a simulation 
study99. All these results suggest that DNA unwinding is the critical step that verifies sequence matching, 
which then subsequently triggers a series of steps toward cleavage including HNH movement. 
 
The impact of PAM-distal matches in opposing DNA unwinding is even greater for EngCas9 because 
their mutations destabilize the unwound DNA configuration, and because cleavage likely proceeds from 
the unwound state, the increased sensitivity to mismatches in DNA unwinding is likely to contribute to 
the increased specificity of cleavage by EngCas9s. Any perturbation that destabilizes unwound DNA or 
fully extended R-loop will delay or fully impair the cleavage action and is also likely the reason why Cas9 
with truncated guide-RNAs are more specific in cleavage100.  
 
DNA targets with only a few interspersed single base-pair mismatches at PAM-distal site can prevent 
stably unwound states by all Cas9 but even transiently unwound states appear to allow cleavage by WT 
Cas9, but not by EngCas9s which we showed here to have much lower intrinsic cleavage rate. Therefore, 
the large enhancement in cleavage specificity for EngCas9s may in part be due to the lower intrinsic 
cleavage rate that prevents cleavage from transiently unwound states that are populated in partially 
matching sequences. 
 
Figure 3.19g summarizes our findings on the three possible mechanisms of specificity increase for 
EngCas9 in the form of free energy diagram along the axis of Nunw, the number of bp unwound, leading 
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toward cleavage. Once the initial barrier of PAM detection is overcome, DNA unwinding proceeds in the 
direction from PAM-proximal to PAM-distal. There is a sudden drop in energy at Nunw=9 for WT Cas9 
and eCas9, marking a threshold for stable binding. Because the threshold is shifted to Nunw=10 for Cas9-
HF1, Cas9-HF1 can achieve higher cleavage specificity by reducing the number of off-target sites which 
can otherwise sequester Cas9-RNA (Mechanism 1).  EngCas9s also tilt the energetic balance toward 
rewinding in the PAM-distal region such that PAM-distal mismatches readily depopulate the fully 
unwound state needed for cleavage (Mechanism 2). Finally, EngCas9s have lower intrinsic cleavage rates 
from the unwound state, represented as higher energetic barrier against cleavage, preventing cleavage 
from transiently unwound off-targets (Mechanism 3). 
 
EngCas9s still cleave DNA targets with ~3 PAM-distal mismatches thus there is room for further 
improvement. Cas9-HF1 and eCas9 mutations eliminated some of the favorable sequence-independent 
interactions for target and non-target strands separately and may act in an independent manner and thus, 
their mutations may be combined. EngCas9 mutations may also be combined with truncated RNA to 
improve the specificity even further. But, combining a number of such strategies that destabilize unwound 
state and decrease the intrinsic cleavage rate from the unwound state as we showed here could lead to 
substantially reduced on-target cleavage as well, as has been observed when Cas9-HF1 was used with the 





Figure 3.23 | DNA unwinding occurs in the absence of divalent cations. 
Without divalent cations, the unwound fraction is unchanged for cognate DNA although final E value is 
slightly higher. But unwound fraction is much lower for DNA with nPD=3 with its smFRET traces 
showing rare cases of transient excursions to low FRET state. These results indicate that divalent cations 
are not required for DNA unwinding but may help in unwinding. A fraction of high FRET population 
with nPD=3 could also be due to deleterious binding of Cas9 in absence of divalent cations. 
 
3.5 MATERIALS AND METHODS 
3.5.1 Preparation of DNA targets 
DNA targets used in smFRET assay for DNA interrogation by Cas9-RNA are the same as what were used 
previously for WT Cas9 studies83 and Figure 3.2 shows the overall schematics. The schematic of DNA 
targets used for smFRET assay of Cas9-RNA induced DNA unwinding is shown in Figure 3.8 and Figure 
3.14. All DNA oligonucleotides were purchased from Integrated DNA Technologies (IDT, Coralville, IA 
52241). A thymine modified with an amine group through a C6 linker (amino-dT) was used to label DNA 
with Cy3 or Cy5 N-hydroxysuccinimido (NHS). Non-target strand, target strand and a 22 nt biotinylated 
adaptor strand were assembled by mixing them in buffered solution with 10 mM Tris-HCl, pH 8 and 50 
mM NaCl and heating to 90 °C followed by cooling to room temperature over 3 hrs. For DNA unwinding 
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by surface-tethered Cas9-RNA, the biotin adaptor strand was omitted. Full sequence and modifications of 
DNA targets used in smFRET assays for DNA interrogation and DNA unwinding are shown in Table 3.1 
and respectively. For radio-labeled gel electrophoresis cleavage experiments, the target strand was 
phosphorylated with P32 using T4 polynucleotide kinase reaction and was annealed with the non-target 
strand as described above. Sequences are the same as in Table 3.1 and Table 3.2 but without the 
biotinylated adaptor strand. For fluorescently-labeled gel electrophoresis cleavage experiments, the DNA 
targets used are the same as those used in smFRET assays. 
 
3.5.2 Expression and purification of Cas9 
All Cas9 were expressed and purified as described previously2,32. A pET-based expression vector was 
used for protein expression which consisted of sequence encoding Cas9 (Cas9 residues 1-1368 from S. 
pyogenes) and an N-terminal decahistidine-maltose binding protein (His10-MBP) tag, followed by a 
peptide sequence containing a tobacco etch virus (TEV) protease cleavage site.  
Mutations for cleavage impairment, enhanced mutations (eCas9), HF1 mutations or the desired 
combinations of them were introduced by site-directed mutagenesis (QuickChange Lightning; Agilent 
Technologies, Santa Clara, CA 95050). Proteins were expressed in E. coli strain BL21 Rosetta 2 (DE3) 
(EMD Biosciences), grown in TB (Terrific Broth) or 2YT medium (higher expression obtained for TB) 
at 37 °C for a few hours. When the optical density at 600 nm (OD600) reached 0.6, protein expression 
was induced with 0.5 mM IPTG and the temperature was lowered to 18 °C. The induction was then 
continued for 12-16 h. The medium was then discarded and cells were harvested. The harvested cells 
were lysed in 50 mM Tris pH 7.5, 500 mM NaCl, 5% glycerol, 1 mM TCEP, supplemented with 
protease inhibitor cocktail (Roche) and with/without Lysozyme (Sigma Aldrich), and then homogenized 
in a microfluidizer (Avestin) or homogenized with Fisher Model 500 Sonic Dismembrator (Thermo 
Fisher Scientific) at 30% amplitude in 3 one minute cycles, each consisting of series of 2 s sonicate-2 s 
repetitions. The lysed solution was then ultra-centrifuged at 15,000 g for 30-45 minutes, supernatant of 
lysate was collected and cellular debris was discarded. The supernatant was added to Ni-NTA agarose 
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resin (Qiagen).  The resin was washed extensively with 50 mM Tris pH 7.5, 500 mM NaCl, 10 mM 
imidazole, 5% glycerol, 1 mM TCEP and the bound protein was eluted in a single-step with 50 mM Tris 
pH 7.5, 500 mM NaCl, 300 mM imidazole, 5% glycerol, 1 mM TCEP. Dialysis of Cas9 into Buffer A 
(20 mM Tris-HCl pH 7.5, 125 mM KCl, 5% glycerol, 1 mM TCEP) and cleavage of TEV-protease site 
by TEV protease was simultaneously carried out overnight at 4 °C. Deconstitution of 10-His-MBP-TEV-
Cas9 by TEV protease resulted in 10-His-MBP and Cas9 constituents in the solution. Another round of 
Ni-NTA agarose column was performed to arrest 10-His-MBP out of the solution and obtain free Cas9. 
Cas9 was then further purified by size-exclusion chromatography on a Superdex 200 16/60 column (GE 
Healthcare) in Cas9 Storage Buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 5 % glycerol and 5 mM 
MgCl2) and stored at -80 °C. All the purification steps were performed at 4 °C. In some preparations, 
TEV protease was first added to the elutant and cleavage of the protein fusion was carried out overnight. 
Following TEV protease cleavage, Cas9 was then dialyzed into Buffer A (20 mM Tris-HCl pH 7.5, 125 
mM KCl, 5% glycerol, 1 mM TCEP) for 3 h at 4 °C, before being applied onto a 5 ml HiTrap SP HP 
sepharose column (GE Healthcare). After washing with Buffer A for three column volumes, Cas9 was 
eluted using a linear gradient from 0-100% Buffer B (20 mM Tris-HCl pH 7.5, 1 M KCl, 5% glycerol, 1 
mM TCEP) over 20 column volumes. The protein was further purified by gel filtration chromatography 
on a Superdex 200 16/60 column (GE Healthcare) in Cas9 Storage Buffer (20 mM Tris-HCl pH 7.5, 200 
mM KCl, 5% glycerol, 1 mM TCEP). Cas9 was stored at -80 °C.  
 
3.5.3 Preparation of guide-RNA and Cas9-RNA 
Guide-RNA for Cas9 is a combination of CRISPR RNA (crRNA) and trans-activating crRNA 
(tracrRNA). For smFRET assay for DNA interrogation by Cas9-RNA, crRNA with an amino-dT was 
purchased from IDT and labeled with Cy5-NHS. Location of the Cy5 in the crRNA is shown in Figure 
3.2. The tracrRNA was in vitro transcribed as described previously17. For DNA unwinding smFRET 
assay, both crRNA and tracrRNA were unlabeled and transcribed in vitro. Guide-RNA was assembled by 
mixing crRNA and tracrRNA at 1:1.2 ratio in buffer containing 10 mM Tris HCl (pH 8) and 50 mM 
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NaCl, heated to 90 °C and slowly cooled to room temperature. Cas9-RNA was assembled by mixing 
guide-RNA and Cas9 at a ratio of 1:3 in Cas9-RNA activity buffer (20 mM Tris HCl (pH 8), 100 mM 
KCl, 5 mM MgCl2, 5% v/v glycerol). Cas9-RNA cleavage activity on cognate sequence used for smFRET 
assay for DNA interrogation was characterized previously17. We used a slightly difference sequence for 
optical placement of amino-dTs for DNA unwinding smFRET assay and Cas9-RNA cleavage activity on 
that sequence was also confirmed (Figure 3.9). RNA sequences are available in Table 3.1 and Table 3.2.  
For smFRET assay of DNA unwinding by surface-tethered Cas9-RNA, a biotin adaptor DNA strand was 
annealed to a complementary extension on guide-RNA (Figure 3.14) 
 
3.5.4 Single-molecule fluorescence imaging and data analysis 
DNA targets were immobilized on the polyethylene glycol-passivated flow chamber surface (purchased 
from Johns Hopkins University Microscope Supplies Core or prepared following protocols reported 
previously 89 using neutrAvidin-biotin interaction and imaged in the presence of Cas9-RNA at the stated 
concentration using two-color total internal reflection fluorescence microscopy.  For DNA unwinding by 
surface-tethered Cas9-RNA smFRET assay, 20 nM of biotin-labeled Cas9-RNA was immobilized on 
surface before adding FRET pair labeled DNA targets. All the imaging experiments were done at room 
temperature in a Cas9-RNA activity buffer with oxygen scavenging for extending photostability (20 mM 
Tris-HCl, 100 mM KCl, 5 mM MgCl2, 5% (v/v) glycerol, 0.2 mg ml-1 BSA, 1 mg ml-1 glucose oxidase, 
0.04 mg ml-1 catalase, 0.8% dextrose and saturated Trolox (>5 mM)101. Time resolution was 100 ms 
unless stated otherwise. Detailed methods of single-molecule FRET (smFRET) data acquisition and 
analysis have been described previously89. Video recordings obtained using EMCCD camera (Andor) 
were processed to extract single molecule fluorescence intensities at each frame and custom written 
scripts were used to calculate FRET efficiencies. Data acquisition and analysis software can be 
downloaded from https://cplc.illinois.edu/software/.  FRET efficiency (E) of the detected spot was 
approximated as E = IA/(ID+IA), where ID and IA are background and leakage corrected emission 




3.5.5 FRET histograms, Cas9-RNA bound DNA fraction and unwound fraction 
Unless stated otherwise, first five frames of each molecule’s E value time traces were used as data points 
to construct E histograms. At least 2,500 molecules were included in each histogram. Cas9-RNA bound 
DNA fraction was calculated as a fraction of data points with E > 0.75 and was then normalized relative 
to Cas9-RNA bound DNA fraction for the cognate DNA target, which is not 100% because missing or 
inactive acceptor fluorophore, and is referred to as fbound. To estimate Kd, fbound vs Cas9-RNA 
concentration (c) was fit using  
fbound= M × c / (Kd + c) where M is the maximum observable fbound. M is typically less than 1 because 
inactive or missing acceptors or because not all of the DNA on the surface are capable of binding Cas9-
RNA. 
For DNA unwinding smFRET assay, unwound fraction was calculated as the ratio of data points with 0.2 
<E <0.6 and total number of data points with E>0.2.  
 
3.5.6 Kinetic analysis of DNA interrogation by Cas9-RNA 
A bimolecular association/dissociation kinetics was used for the analysis of DNA binding by Cas9-RNA. 
DNA Target    +    Cas9-RNA     ⇌     Cas9-RNA-DNA 
 
kbinding (s-1)  = kon (M-1s-1 )  × [Cas9-RNA] (M) 
A hidden Markov model analysis of smFRET traces of DNA targets that showed real-time reversible 
association/dissociation of Cas9-RNA yielded three pre-dominant FRET states, of zero, mid and high E 
values. Dwell times of high FRET (E>0.6) states before their transition to zero FRET (E<0.2) states were 
used to calculate lifetime of high FRET (τhigh) (Figure 3.6c) binding events by fitting their distribution 
using a double-exponential decay. Dwell times of mid FRET (0.2 <E <0.6) states before their transition to 
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zero FRET (E<0.2) states were used to calculate lifetime of mid FRET (τmid) (Figure 3.6d) binding events 
by fitting their distribution using a single exponential decay. 
To calculate the total bound state lifetime (τavg) (Figure 3.1d), mid and high FRET states were taken as 
bound states and zero FRET state as the unbound state. The survival probability of all the bound state 
events (mid and high FRET states taken as a single state, FRET > 0.2) vs time was fit using a double 
exponential decay profile (A1 exp(-t/τ1)+A2 exp(-t/τ2)).τavg is an amplitude weighted average of two 
distinct lifetimes τ1 and τ2.  
τavg = A1τ1 +A2τ2.  
A1 values are also used as the fraction of mid FRET state binding events (fmid FRET). Dwell time 
distribution of zero FRET state (E<0.2) was fit to a single exponential decay to calculate lifetime of 
unbound state (τunbound) (Figure 3.1f). Cy5 labeling efficiency of guide-RNA was 88.7% and thus τunbound 
was appropriately corrected to account for it. Inverse of τunbound was used to calculate kbinding and kon. Since 
Cas9-RNA DNA association were sequence independent, a mean of kon for different DNA target was used 
to determine kon for each Cas9 (Figure 3.1f) 
 
3.5.7 Kinetic analysis of Cas9-RNA induced DNA unwinding and rewinding 
Cas9-RNA induced DNA unwinding was modeled as a two-state system (Figure 3.10b): 
 
 
                                       Cas9-RNA-DNA      ⇌    Cas9-RNA-DNA            Cas9-RNA-DNA                                               
                                            (rewound)                       (unwound)                         (cleaved)                                                        
                                          (high FRET)                    (low FRET)   
 
A hidden Markov model analysis segmented single molecule time traces into unwound and rewound 







determine the average lifetime of the high (τhigh) and low FRET (τlow) states respectively (Figure 3.10d-e). 
A small fraction of its smFRET time trajectories had a constant high FRET without any fluctuations, 
likely representing DNA molecules unable to bind Cas9-RNA and were excluded from kinetic analysis. 
Unwinding rate (ku) was calculated as inverse of τhigh and rewinding rate (kr) was calculated as inverse of 
τlow. Intrinsic cleavage rate kc,int was determined by fitting cleavage lifetime vs unwound fraction 
usingτcleavage  = 1/([unwound fraction]*kc,int + C), where C=0 for eCas9 but an extremely small value of C 
had to be used for WT Cas9 and Cas9-HF1. 
In smFRET experiments to capture the initial DNA unwinding event, distribution of dwell times of the 
initial high FRET state before the first transition to the low FRET state was fit with a single exponential 
to obtain τunwinding. 
 
3.5.8 Gel-electrophoresis to investigate Cas9-RNA induced cleavage 
FRET pair labeled DNA targets used in the smFRET DNA unwinding assays were also used in 
fluorescence-based gel electrophoresis experiments. The DNA targets were incubated with Cas9-RNA in 
Cas9-RNA activity buffer (20 mM Tris HCl (pH 8), 100 mM KCl, 5 mM MgCl2, 5% v/v glycerol) at the 
specified concentrations and for specified durations. The reaction samples were then denatured by 
formamide loading buffer (95% formamide, 5 mM EDTA) and resolved via polyacrylamide gel 
electrophoresis (PAGE) using 15% Polyacrylamide TBE Urea pre-cast gels (Bio-rad laboratories) and 
imaged via Cy5/Cy3 excitation (GE Amersham Imager 600). Sequences of DNA targets and guide-RNA 
are shown in Table 3.2. For radio-labeled PAGE experiments, P32 -labeled DNA targets at 1 nM 
concentration were incubated with 100 nM Cas9-RNA in Cas9-RNA activity buffer (20 mM Tris HCl 
(pH 8), 100 mM KCl, 5 mM MgCl2, 5% v/v glycerol) at for 10 minutes. The reaction samples were then 
denatured by formamide loading buffer (95% formamide, 5 mM EDTA), resolved via PAGE and imaged 
via phosphorimaging (GE Healthcare). For the rate of cleavage experiments, aliquots of Cas9-RNA DNA 
running reaction were taken at different time points for the PAGE analysis. Sequences of DNA targets 
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and guide-RNA are the same as in Table 3.2 except that the biotinylated adaptor strand is omitted. τcleavage 
for WT Cas9 is taken from a study96 which used a slightly different protospacer, shown in Table 3.1. In a 
control, the τcleavage for WT Cas9 were similar between the two protospacers and much lower than τcleavage 
for EngCas9.For all experiments reported in the manuscript, error bars represent s.d. from n=2 or 3. n=1 






















Table 3.1 | Guide-RNA and DNA targets used for the smFRET assay for DNA interrogation by 




Table 3.2 | Guide-RNA and DNA targets used for Cas9-RNA induced DNA unwinding smFRET 
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Chapter 4.  
Real-time observation of DNA target interrogation 
and product release by the RNA-guided 
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CRISPR-Cas9, which imparts adaptive immunity against foreign genomic invaders in certain prokaryotes, 
has been repurposed for genome-engineering applications. More recently, another RNA-guided CRISPR 
endonuclease called Cpf1 was identified and is also being repurposed. Little is known about the kinetics 
and mechanism of Cpf1 DNA interaction and how sequence mismatches between the DNA target and 
guide-RNA influence this interaction. We have used single-molecule fluorescence imaging and 
biochemical assays to characterize DNA interrogation, cleavage, and product release by three Cpf1 
orthologues. Like Cas9, Cpf1 initially binds DNA in search of PAM (protospacer-adjacent motif) 
sequences, verifies the target sequence unidirectionally from the PAM-proximal end and rapidly rejects 
any targets that lack a PAM or that are poorly matched with the guide-RNA.  Cpf1 requires ~ 17 bp 
sequence match for both stable binding and cleavage, contrasting it with Cas9 which requires 9 bp for 
stable binding and ~16 bp for cleavage. Unlike Cas9, which does not release the DNA cleavage products, 
Cpf1 rapidly releases the PAM-distal cleavage product, but not the PAM-proximal product. Our findings 
have important implications on Cpf1-based genome engineering and manipulation applications. 
 
4.2 INTRODUCTION 
In prokaryotes, CRISPR (clustered regularly interspaced short palindromic repeats)–Cas (CRISPR-
associated) acts as an adaptive defense system against foreign genetic elements102. The system achieves 
adaptive immunity by storing short sequences of invader DNA into the host genome, which get 
transcribed and processed into small CRISPR RNA (crRNA). These crRNAs form a complex with a 
CRISPR nuclease to guide the nuclease to complementary foreign nucleic acids (protospacers) for 
cleavage. Binding and cleavage also require that the protospacer be adjacent to a protospacer adjacent 
motif (PAM)4,103. CRISPR-Cas9, chiefly the Cas9 from Streptococcus pyogenes (SpCas9), has been 
repurposed to create an RNA-programmable endonuclease for gene knockout and editing7,8,104. Nuclease 
deficient Cas9 has also been used for tagging genomic sites in wide-ranging applications7,8,104. This 
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repurposing has revolutionized biology and sparked a search for other novel CRISPR-Cas enzymes105,106. 
One such search led to the discovery of the Cas protein Cpf1, with some of its orthologues reporting 
highly specific cleavage activities in mammalian cells9,11,107,108.  
 
Compared to Cas9, Cpf1 has an AT rich PAM (5’-YTTN-3’ vs. 5’-NGG-3’ for SpCas9), a longer 
protospacer (24 bp vs. 20 bp for Cas9), creates staggered cuts distal to the PAM vs. blunt cuts proximal to 
the PAM by Cas911, and is an even simpler system than Cas9 because it does not require a trans-activating 
RNA for nuclease activity or guide-RNA maturation109. Off-target effects remain one of the top concerns 
for CRISPR-based applications but Cpf1 is reportedly more specific than Cas9107,108. However, its kinetics 
and mechanism of DNA recognition, rejection, cleavage and product release as a function of mismatches 
between the guide-RNA and target DNA remain unknown. Precise characterization of differences 
amongst different CRISPR enzymes should help in expanding the functionalities of the CRISPR toolbox.  
 
Here, we have used single-molecule imaging and biochemical assays to understand how mismatches 
between the guide-RNA and DNA target modulate the activity of three Cpf1 orthologues from 
Acidaminococcus sp. (AsCpf1), Lachnospiraceae bacterium (LbCpf1) and Francisella novicida 
(FnCpf1)11. Single-molecule methods have been helpful in the study of CRISPR 
mechanisms6,53,62,83,86,88,110-113 because they allow real-time detection of multiple and distinct steps of 
varying time lengths i.e. transient to long-lived57.  
 
4.3 RESULTS 
4.3.1 Real-time DNA interrogation by Cpf1-RNA 
We employed a single-molecule fluorescence resonance energy transfer (smFRET) binding assay63,89. 
DNA targets (donor-labeled, 82 bp long) were immobilized on a polyethylene glycol (PEG) passivated 
surface and Cpf1 pre-complexed with acceptor-labeled guide-RNA (Cpf1-RNA) was added. Cognate 
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DNA and guide-RNA sequences are identical to the Cpf1 orthologue-specific sequences that were 
previously characterized biochemically11 with the exception that we used canonical guide-RNA of 
AsCpf1 for FnCpf1 analysis because guide-RNAs of AsCpf1 and FnCpf1 are interchangeable11 (Figure 
4.1). Locations of donor (Cy3) and acceptor (Cy5) fluorophores were chosen such that FRET would 
report on interaction between the DNA target and Cpf1-RNA114 (Figure 4.2a and Figure 4.1). Fluorescent 
labeling did not affect cleavage activity of Cpf1-RNA (Figure 4.3). We used a series of DNA targets 
containing different degrees of mismatches relative to the guide-RNA referred to here with nPD (the 
number of PAM-distal mismatches) or nPP (the number of PAM-proximal mismatches) (Figure 4.1b). 
Cognate DNA target in the presence of 50 nM Cpf1-RNA gave two distinct populations with FRET 
efficiency E centered at 0.4 and 0. Using instead a non-cognate DNA target (nPD of 24 and without PAM) 
or guide-RNA only without Cpf1 gave a negligible E=0.4 population, allowing us to assign E~0.4 to a 
sequence-specific Cpf1-RNA-DNA complex where the labeling sites are separated by 54 Å114 (Figure 
4.2c and Figure 4.1). The E=0 population is a combination of unbound states and bound states but with an 
inactive or missing acceptor. smFRET time trajectories of the cognate DNA target showed a constant 
E~0.4 value within measurement noise (Figure 4.2c).  
 
Cpf1-RNA titration experiments yielded dissociation constants (Kd) of 0.27 nM (FnCpf1), 0.1 nM 
(AsCpf1), 3.9 nM (LbCpf1) in our standard imaging condition and 0.13 nM (LbCpf1) in a reducing 
condition (Figure 4.4). Binding is much tighter than the 50 nM Kd previously reported for FnCpf1109. We 
performed purification and biochemical experiments in buffer containing dithiothreitol (DTT) as per 
previous protocols11 but did not include DTT for standard imaging condition because of severe 
fluorescence intermittency of Cy5 caused by DTT 115. DTT did not affect FnCpf1 or AsCpf1 DNA 
binding but made binding >20-fold tighter for LbCpf1 (Figure 4.4). Cleavage by AsCpf1 is most effective 





E histograms obtained at 50 nM Cpf1-RNA show the impact of mismatches on DNA binding (Figure 
4.6). The apparent bound fraction fbound, defined as the fraction of DNA molecules with E > 0.2, remained 
unchanged when nPD increased from 0 to 7 (0 to 6 for LbCpf1 in non-reducing conditions) (Figure 4.6 and 
Figure 4.7d). Binding was ultra-stable for nPD ≤ 7 because fbound did not change even 1 hour after washing 
away free Cpf1-RNA (Figure 4.7a). fbound decreased steeply when nPD exceeded 7 for FnCpf1 and LbCpf1 
but the decrease was gradual for AsCpf1 and for LbCpf1 in the reducing condition (Figure 4.6 and Figure 
4.7d). For all Cpf1 orthologues, ultra-stable binding required nPD ≤ 7, corresponding to a 17 bp PAM-
proximal sequence match. This is much larger than the 9 bp PAM-proximal sequence match required for 
ultra-stable binding of Cas983. PAM-proximal mismatches are highly deleterious for Cpf1 binding 
because fbound dropped by more than 95% if nPP ≥ 2 (Figure 4.6 and Figure 4.7d). In comparison, Cas9 
showed a more modest ~50% drop for nPP = 2 83. Overall, Cpf1 is much better than Cas9 in discriminating 
against both PAM-distal and PAM-proximal mismatches for stable binding.  
 
Single molecule time-trajectories of all Cpf1 orthologues for nPD ≤ 7 showed a constant E~0.4 value 
within noise, limited only by photobleaching. For nPD > 7, we observed reversible transitions in E likely 
due to transient binding (Figure 4.8 and Figure 4.9 and Figure 4.10). Dwell time analysis as a function of 
Cpf1-RNA concentration confirmed that E fluctuations are due to binding and dissociation, not 
conformational changes (Figure 4.7b, Figure 4.7c, and Figure 4.4). We used hidden Markov modeling 
analysis90 to segment the time traces to bound and unbound states. Average lifetime of the bound state, 
τavg, was > 1 hour for nPD ≤ 7 but decreased to a few seconds with nPD > 7 or any PAM-proximal 
mismatches (Figure 4.7e). The unbound state lifetime differed between orthologues but was nearly the 
same among most DNA targets, indicating that initial binding has little sequence dependence. The 
bimolecular association rate kon was 2.37 × 106 M-1 s-1 (FnCpf1), 0.87 × 106 M-1 s-1 (LbCpf1) and 1.33 × 
107 M-1 s-1 (LbCpf1 in reducing conditions) (Figure 4.7c and Figure 4.7f). Much longer apparent unbound 
state lifetimes with PAM-proximal mismatches or DNA targets without PAM are likely due to binding 
112 
 
events shorter than the time resolution (0.1 s).  
 
These results show that Cpf1-RNA has dual binding modes. It first binds DNA non-specifically (mode I) 
in search of PAM and upon detection of PAM, RNA-DNA heteroduplex formation ensues (mode II) and 
if it extends ≥ 17 bp, Cpf1-RNA remains ultra-stably bound to the DNA. Some reversible transitions in E 
were observed even for DNA with nPD = 7, indicating that multiple short-lived binding events take place 
before the one resulting in ultra-stable binding (Figure 4.8, Figure 4.9 and Figure 4.10). RNA-DNA 
heteroduplex extension is likely unidirectional from PAM-proximal to PAM-distal end because any 
PAM-proximal mismatch prevented stable binding. Consistent with dual binding modes, survival 
probability distributions of bound and unbound state were best described by a double and single 









Figure 4.1 | Design of DNA targets and guide-RNA along with FRET probes labeling locations in 
the Cpf1-RNA-DNA complex for smFRET assay for DNA interrogation by Cp1-RNA. 
(a) Description of single-stranded DNA oligonucleotides with appropriate modifications for constitution 
of a fully duplexed DNA target for use in the smFRET assay. Oligonucleotides referred to as smFRET 
Cy3 oligo and Biotin oligo provide donor label for the smFRET assay and anchor for surface 
immobilization of the fully duplexed DNA target respectively. These oligonucleotides were same for all 
DNA targets.  Other two strands were unmodified oligonucleotides, and strand that hybridizes with the 
guide-RNA (of Cpf1-RNA) is referred to as target strand and strand complementary to the target strand is 
called non-target strand. Base sequence of the target and non-target strands were changed to create DNA 
targets with mismatches against fixed guide-RNA sequence. These smFRET experiments were done both 
with DNA targets with ‘nick’ close to PAM at the indicated location and with DNA targets where this 
nick was ligated to close it. (b) Illustrated schematic of a complete Cpf1-RNA-DNA (b; As/FnCpf1-
RNA-DNA and LbCpf1-RNA-DNA) complex showing base-pairing between different components. 
Sequences written in red denote cognate sequence in the DNA target and complementary sequence in the 
guide-RNA. (c) Fluorescent (Cy3 and Cy5) labeling locations shown in structure of AsCpf1-RNA bound 
to cognate DNA target (PDB ID: 5B43)114. As mentioned, strand which hybridizes with guide-RNA to 
form RNA-DNA heteroduplex is referred to as the target strand while the other strand, containing the 
PAM (5’-YTN-3’), is the non-target strand. (d) Cy5 labeling location shown in structure of LbCpf1-RNA 
complex (PDB ID: 5ID6)116. (e) Cy5 labeling location shown in structure of FnCpf1-RNA-DNA complex 






Figure 4.2 | smFRET assay to study DNA interrogation by Cpf1-RNA. 
(a) Schematic of single-molecule FRET assay. Cy3-labeled DNA immobilized on a passivated surface is 
targeted by a Cy5-labeled guide-RNA in complex with Cpf1, referred to as Cpf1-RNA. (b) DNA targets 
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with mismatches in the protospacer region against the guide-RNA. The number of mismatches PAM-
distal (nPD) and PAM-proximal (nPP) are shown in cyan and orange, respectively. (c) E histograms (left) at 
50 nM Cpf1-RNA or 50 nM RNA only. Representative single molecule intensity time traces of donor 




Figure 4.3 | FnCpf1-RNA activity is not impaired by fluorescent labeling of guide-RNA and DNA 
target. 
FnCpf1-RNA induced DNA cleavage & binding analyzed by 4% native agarose gel electrophoresis and 
visualization of SYBR Gold II stained nucleic acids. (a) Activity of unmodified RNA and Cy5 labeled 
RNA for FnCpf1-RNA targeting of cognate DNA target without Cy3 or Biotin label. (b) Activity of 
unmodified RNA and Cy5 labeled RNA for FnCpf1-RNA targeting of cognate DNA target labeled with 
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Cy3 and Biotin. It must be noted that the strands used to constitute dsDNA target with and without Cy3 
and Biotin label were mixed with excess of non-target strand to ensure a near 100% hybridization of 










(a) E histograms demonstrating increase in Cpf1-RNA bound state population of cognate DNA targets 
with increasing Cpf1-RNA concentration for different Cpf1 orthologs. (b) Cpf1-RNA bound fraction 
defined as a fraction of population of DNA target molecules with FRET (>0.2 & <0.6) vs. Cpf1-RNA 
concentration. Trend was fit to obtain disassociation constant (Kd) of Cpf1-RNA and DNA interaction. 
(C, D) After a hidden Markov analysis90 on smFRET time-trajectories, bound and unbound states were 
divided based on the FRET values via thresholding at FRET= 0.2. The FRET states > 0.2 were taken as 
putative bounds states. Dwell-times of bound states were used to estimate the overall bound state lifetime, 
inverse of which was taken as FnCpf1-RNA-DNA dissociation rate (koff). The dwell-times of the unbound 
states were used to estimate rate of FnCpf1-RNA and DNA association (kbinding). (c) The rate of binding 
for DNA target with nPD =16 showing a linear increase with the increasing concentration of FnCpf1-RNA. 
(d) The rate of FnCpf1-RNA-DNA dissociation for DNA target with nPD =16 remained largely unchanged 
at different FnCpf1-RNA concentrations. Error bars represent s.d for replicate experiments. Number of 
PAM-distal mismatches (nPD) is shown in cyan. 
 
 
Figure 4.5 | Cleavage activity of AsCpf1 at different pH conditions. 









Figure 4.6 | E histograms during DNA interrogation by Cpf1-RNA. 
(a) FnCpf1. (b) AsCpf1. (c) LbCpf1. (d) LbCpf1 (in reducing conditions of 5 mM DTT). Number of 
PAM-distal (nPD) and PAM-proximal mismatches (nPP) are shown in cyan and orange respectively. [Cpf1-





Figure 4.7 |  Dynamic interaction of Cpf1-RNA with DNA as a function of mismatches. 
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(a) E histograms for various nPD with 50 nM Cpf1-RNA (left) and indicated minutes after free Cpf1-RNA 
was washed out (right) for FnCpf1, LbCpf1, AsCpf1 and LbCpf1 in reducing condition of 5 mM DTT. 
(b) E histograms (left) and representative smFRET time-trajectories (middle) with their idealized E values 
(right) for nPD = 16 at various concentrations of LbCpf1-RNA in reducing condition and AsCpf1-RNA. 
(c) Rate of LbCpf1-RNA and DNA association (kbinding) at different LbCpf1-RNA concentration. E > 0.2 
and E <0.2 states were taken as putative bound and unbound states. Dwell-times of the unbound states 
were used to calculate kbinding. (d) fbound, (e) bound state lifetime, (f) unbound state lifetime for various 
mismatches at 50 nM Cpf1-RNA. Average of rates of binding (τunbound-1) of DNA with nPD = 8-18 were used to 





Figure 4.8 | Representative smFRET time-trajectories from smFRET experiments to study DNA 
interrogation by AsCpf1-RNA. 
These representative smFRET time- trajectories (left) along with their idealized FRET values (right) are 
taken from representative DNA targets with/without nick near the PAM (Figure 4.1) and no differences 
were observed between them. The indicated protein induced fluorescence enhancement (PIFE) on the 
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donor only signal is likely resulting from non-specific interaction of free-excess of Apo AsCpf1 with the 
DNA and was observed for all the DNA targets. Number of PAM-distal (nPD) and PAM-proximal 





Figure 4.9 | Representative smFRET time-trajectories from smFRET experiments to study DNA 
interrogation by FnCpf1-RNA. 
These representative smFRET time- trajectories (left) along with their idealized FRET values (right) are 
taken from representative DNA targets with/without nick near the PAM (Figure 4.1) and no differences 
were observed between them. The indicated protein induced fluorescence enhancement (PIFE) on the 
donor only signal is likely resulting from non-specific interaction of the free-excess of Apo FnCpf1 with 
the DNA and was observed for all the DNA targets. DNA targets with nick (Figure 4.1) exhibit stronger 
anti-correlation between donor and acceptor signal for transient FRET binding events. PIFE upon the 
FnCpf1-RNA binding can influence this anti-correlation and slightly different levels of PIFE on Cy3 in 
DNA target with and without nick i.e. different flexibilities could be causing these variations. 
Photophysics or isomerization of Cy3 resulting PIFE is guided by local DNA flexibility118. Number of 





Figure 4.10 | Representative smFRET time-trajectories from smFRET experiments to study DNA 
interrogation by LbCpf1-RNA. 
These representative smFRET time- trajectories (left) along with their idealized FRET values (right) are 
taken from representative DNA targets with/without nick near the PAM (Figure 4.1) and no differences 
were observed between them. The indicated protein induced fluorescence enhancement (PIFE) on the 
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donor only signal is likely resulting from non-specific interaction of the free-excess of Apo LbCpf1 with 
the DNA and was observed for all the DNA targets. DNA targets with nick (Figure 4.1) exhibit stronger 
anti-correlation between donor and acceptor signal for transient FRET binding events. PIFE upon the 
LbCpf1-RNA binding can influence this anti-correlation and slightly different levels of PIFE on Cy3 in 
DNA target with and without nick i.e. different flexibilities could be causing these variations. 
Photophysics or isomerization of Cy3 resulting PIFE is guided by local DNA flexibility118. Number of 








(a) Survival probability of FRET state (E > 0.2; putative bound states) and zero FRET state (E<0.2; 
unbound states) dwell-times vs. time, fit with double-exponential and single exponential decay to obtain 
lifetime of bound state (τavg) and unbound state (τunbound) respectively. 
(b) Model describing a bimodal binding nature of Cpf1-RNA. (c) Fraction of DNA molecules bound with 
Cpf1-RNA (fbound). (d) Amplitude-weighted lifetime, τavg, of the Cpf1-RNA bound state. (e) Lifetime of 
long-lived binding mode (τ1). (f) Lifetime of transient (τ2) binding mode which was similar for all the 
DNA targets (~ <0.5 s). (f) Amplitude of the transient binding mode only. (g) unbound state lifetime.  
Error bars represent s.d. for replicate experiments. Large error bars were observed due to the under-
sampling (i.e. below detection limit of 0.1s) of extremely transient binding events for certain DNA 
targets, especially with PAM-proximal mismatches or without PAM. This indicates that Cpf1-RNA 
rejected DNA faster if there were PAM-proximal mismatches or in absence of PAM. Number of PAM-
distal (nPD) and PAM-proximal mismatches (nPP) are shown in cyan and orange respectively. 
 
4.3.2 DNA cleavage by Cpf1 as a function of mismatches 
Next, we performed gel-based experiments using the same set of DNA targets to measure cleavage by 
Cpf1. Cleavage was observed at a wide range of temperatures (4-37 °C), required divalent ions (Ca2+ 
could substitute for Mg2+), and showed a pH dependence. AsCpf1 is most active only at slightly acidic to 
neutral pH (6.5-7.0) whereas FnCpf1 has more activity at pH 8.5 than pH 8.0 (Figure 4.12 and Figure 
4.13 and Figure 4.14).  Cleavage required 17 PAM-proximal matches, corresponding to nPD ≤ 7, (Figure 
4.15a, Figure 4.12 and Figure 4.13 ) which is identical to the threshold for stable binding (Figure 4.6 and 
Figure 4.7). This contrasts with Cas9, which requires only 9 PAM-proximal matches for stable binding83 
but 16-18 PAM-proximal matches for cleavage4,6.  
 
We measured the time it takes to cleave DNA, τcleavage (Figure 4.16). τcleavage remained approximately the 
same among DNA with 0 ≤ nPD ≤ 6 for FnCpf1 (30-60 s) but steeply increased upon increasing nPD to 7 
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(Figure 4.15b and Figure 4.15c). AsCpf1 showed a more complex nPD dependence with a minimal τcleavage 
value of 8 minutes for nPD = 6. (Figure 4.15c). τcleavage is much longer than the 1 to 15 seconds it takes 
Cpf1-RNA to bind the DNA at the same Cpf1-RNA concentration, suggesting that Cpf1-RNA-DNA 
undergoes additional rate-limiting steps after DNA binding and before cleavage. These additional steps 
are likely the conformational rearrangement of Cpf1-RNA-DNA complex that position the nuclease 
domains and DNA strands for cleavage, as has been described in structural analysis of Cpf1-RNA-DNA 
complex114,117.  
 
Because of the finite τcleavage we can infer that the ultra-stable binding (lifetime > 1 hr) for nPD ≤ 7 is that 
of Cpf1-RNA binding to the cleaved product, and it is in principle possible that cleavage stabilizes Cpf1-
RNA binding. In order to test this possibility, we purified catalytically dead FnCpf1 (dFnCpf1) and 
performed DNA interrogation experiments. dFnCpf1 binding was ultra-stable for cognate DNA but 
showed a substantial dissociation after 5-10 min for nPD=6 or 7 (Figure 4.17). Therefore, cleavage can 
further stabilize Cpf1-RNA binding to DNA. Cleavage was negligible for DNA targets that showed 
transient binding. Therefore, transient binding and dissociation we observed is not to and from a cleaved 
DNA product. 
 
4.3.3 Fate of cleaved DNA. 
For an efficient addition of a new piece of DNA at a cleaved site, the cleaved site needs to be exposed94. 
To investigate the fate of DNA targets post cleavage, we relocated the Cy3 label to a PAM-distal DNA 
segment that would depart the imaging surface if the Cpf1 releases cleavage product(s) (Figure 4.15d and 
Figure 4.18).  The number of fluorescent spots decreased over time (Figure 4.15e), suggesting the 
cleavage product is released under physiological conditions, which is in stark contrast to Cas9, which 
holds onto the cleaved DNA and does not release except in denaturing condition 6,83. Cpf1 releases only 
the PAM-distal cleavage product, however, because when Cy3 is attached to a site on the PAM-proximal 
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cleavage product, the number of fluorescence spots did not decrease over time (Figure 4.2, Figure 4.6 and 
Figure 4.7). The average time for fluorescence signal disappearance ranged from ~30 s to 30 min 
depending on the PAM-distal mismatches and Cpf1 orthologues. By subtracting the time it takes to bind 
and cleave, we estimated the product release time scale (τrelease) (Figure 4.15f), which showed a 
dependence on nPD. Therefore, PAM-distal mismatches can also affect product release.  
 
 
Figure 4.12 | FnCpf1 activity at different temperatures and divalent cation conditions. 
DNA cleavage and binding by FnCpf1 at (a) different temperature and (b) divalent cation conditions 
analyzed by 4% native agarose gel electrophoresis and SYBR Gold II staining of nucleic acids. (a) DNA 
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targets with nPD ranging from 0 to 7 were stably bound and cleaved by FnCpf1, as seen from depletion of 
uncleaved DNA band for these DNA targets. Binding and cleavage cut-off was observed at nPD = 7 
(substantially reduced cleavage activity), beyond which all the DNA targets remained unbound and 
uncleaved. FnCpf1 remained active across different temperatures but its efficiency was higher at 37 °C 
and lower at 4 °C compared to room temperature. Also, differences in cleavage efficiency nPD = 7 were 
markedly different across different temperature conditions. (b) Divalent cation is crucial for DNA 
targeting and cleavage by FnCpf1 as shown by the fully intact uncleaved DNA target band (bottom) for 
experiments without divalent cation, the binding was also significantly impaired for such cases with a 
faint band corresponding to the FnCpf1-RNA-DNA complex. Both Ca2+ and Mg2+ supported the FnCpf1 
binding and cleavage activity (top, middle). All these experiments were performed with short dsDNA 
targets with only 6 bp flanking the protospacer (4 of which is for PAM). These results also underlie 
FnCpf1’s ability to affect interference on short dsDNA targets. Sequences of DNA targets and guide-
RNA used for these experiments is in Table 4.3 and Table 4.5. Number of PAM-distal (nPD) and PAM-





Figure 4.13 | AsCpf1-RNA activity and effect of divalent cation conditions. 
(a) DNA cleavage & binding by AsCpf1 at room temperature analyzed by 4% (a) native and (b) 
denaturing agarose gel electrophoresis and SYBR Gold II staining of nucleic acids. (a-b) DNA targets 
with nPD ranging from 0 to 7 were stably bound and cleaved by FnCpf1, as seen from depletion of 
uncleaved DNA band for these DNA targets. Binding and cleavage cut-off was observed at nPD = 7 
(substantially reduced cleavage activity), beyond which all the DNA targets remained unbound and 
uncleaved. (c) Divalent cation is crucial for DNA targeting and cleavage by AsCpf1 as shown by the fully 
intact uncleaved DNA target band (bottom) for experiments without divalent cation, the binding was also 
significantly impaired for such cases with a faint band corresponding to the AsCpf1-RNA-DNA complex. 
Both Ca2+ and Mg2+ supported the AsCpf1 binding and cleavage activity (top, middle). All these 
experiments were performed with short dsDNA targets with only 6 bp flanking the protospacer (4 of 
135 
 
which is for PAM). These results also underlie AsCpf1’s ability to affect interference on short dsDNA 
targets. Sequences of DNA targets and guide-RNA used for these experiments is in Table 4.3 and Table 
4.5.All these experiments were performed in pH 8.0 conditions, and it was later discovered (Figure 4.5) 
that AsCpf1 shows strong pH dependence and works efficiently only at pH 6.5-7.0. Therefore, all 
subsequent experiments were performed at pH 7.0. Lower activity of the experiments shown here can be 
attributed to its high pH conditions. Number of PAM-distal (nPD) and PAM-proximal mismatches (nPP) are 





Figure 4.14 | Cpf1-RNA activity at different pH conditions. 
(a) FnCpf1-RNA DNA cleavage and binding reactions incubated for 3 and 5 hr at different pH conditions 
analyzed by 4% native agarose gel electrophoresis and SYBR Gold II staining of nucleic acids. 60 nM of 
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DNA targets was mixed with the ~300 nM of FnCpf1-RNA in reaction buffer volume of 20 μL. 10 μL of 
the reaction was analyzed at 3 hr time point and the remaining 10 μL of the reaction was analyzed at 5 hr 
time point. For the reactions incubated for 3 hr, intensity of the uncleaved DNA target band was taken as 
being inversely proportional to rate of DNA interference by FnCpf1 and was ~37% and ~79% higher 
when pH of the Tris-HCl component used in the reaction buffer was 8.0 and 8.5 respectively as compared 
to 7.5. For the reactions incubated for 5 hr, the rate of cleavage was ~46% and ~59% higher when pH of 
the Tris-HCl component used in the reaction buffer was 8.0 and 8.5 respectively as compared to 7.5. (b) 
Effect of pH on AsCpf1 activity. Sequences of DNA targets and guide-RNA used for these experiments is 
in Table 4.3 and Table 4.5. Number of PAM-distal (nPD) and PAM-proximal mismatches (nPP) are shown 





Figure 4.15 | DNA cleavage and product release. 
(a) Cpf1 induced DNA cleavage at room temperature analyzed by 10% denaturing polyacrylamide gel 
electrophoresis of radio-labeled DNA targets. b) Fraction of DNA cleaved by AsCpf1 vs time for cognate 
and DNA with nPD=6, and single exponential fits. A representative gel image is shown in inset. c) 
Cleavage time (τcleavage) determined from cleavage time courses as shown in (b).  (d) Schematic of single-
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molecule cleavage product release assay. PAM-distal cleavage product release can be detected as 
disappearance of fluorescence signal from Cy3 attached to the PAM-distal product. (e) Average fraction 
of Cy3 spots remaining vs time for FnCpf1-RNA (50 nM). Inset shows images before and after 10 min 
reaction. (f) Average time of cleavage product release (τrelease).  
 
 
Figure 4.16 | Time-lapse of cleavage byCpf1. 
Representative images of cleavage by Cpf1 at room temperature for different DNA targets as a function 
of time, from experiments utilizing 10% Polyacrylamide denaturing gel electrophoresis. Target strand in 
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DNA targets was radio-labeled. [Cpf1-RNA] =50 nM. [DNA] =0.5 nM. From 3 replicate experiments, 
uncleaved and cleaved DNA intensities were quantified and their decay fit to single exponential profile to 
obtain lifetime of cleavage (tcleavage) as shown and quantified in Figure 4.15b and Figure 4.15c Sequences 
of DNA targets and guide-RNA used for these experiments is in Table 4.2 and Table 4.5. Number of 





Figure 4.17 | Catalytic activity of Cpf1 increases stability of Cpf1-RNA-DNA. 
(a) Schematic of single-molecule FRET assay to investigate DNA binding by catalytically active FnCpf1 
(left) and catalytically dead FnCpf1 (right). DNA cleavage sites are indicated. 
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(b) E histograms of different DNA targets with 50 nM FnCpf1-RNA and n minutes post removal of free 
FnCpf1-RNA from the imaging chamber. (c) E histograms of different DNA targets with 50 nM 
dFnCpf1-RNA and n minutes (as indicated) post removal of free FnCpf1-RNA from the imaging 
chamber. Number of PAM-distal (nPD) in DNA targets are shown in cyan. (d) Internal DNA unwinding 
and rewinding dynamics in Cpf1-RNA-DNA likely causes eventual disassociation of Cpf1-RNA from 
DNA. Cleavage stalls the unwinding/rewinding dynamics thus preventing Cpf1-RNA dissociation leading 





Figure 4.18 | Design of DNA targets and guide-RNA for single-molecule cleavage product release 
assay to study Cpf1-RNA induced cleavage product release of DNA targets. 
(a) Description of single-stranded DNA oligonucleotides with appropriate modifications for constitution 
of a fully duplexed DNA target for use in the single-molecule cleavage product release assay. 
Oligonucleotides referred to as Biotin oligo provide anchor for surface immobilization of the fully 
144 
 
duplexed DNA target. These oligonucleotides were same for all the DNA targets.  The other two strands 
being, target strand that hybridizes with the guide-RNA (of Cpf1-RNA) and non-target strand, 
complementary to the target strand. The non-target strand was labeled with Cy3 at the indicated position. 
Base sequence of the target and non-target strands were changed to create DNA targets with mismatches 
against the fixed guide-RNA sequence. (b) Illustrated schematic of a complete Cpf1-RNA-DNA complex 
showing the base-pairing between different components. Sequence written in red denote the cognate 
sequence of the DNA target and the complementary sequence in the guide-RNA. Also shown are the 




The two-step mechanism of sampling for PAM followed by unidirectional RNA-DNA heteroduplex 
extension (Figure 4.19) is shared between Cas9 and Cpf1, suggesting this to be a general target 
identification mechanism of these CRISPR systems. Ultra-stable binding of Cpf1 requires the same extent 
of sequence match (17 bp PAM-proximal matches) as target cleavage. This contrasts with Cas9, which 
requires only 9 bp and 16 bp PAM-proximal matches for ultra-stable binding and cleavage 
respectively83,96,119. Therefore, Cpf1 can be more sequence specific in experiments involving the use of 
catalytically dead CRISPR for imaging, tracking and transcription regulation purposes18. The binding 
specificity of engineered Cas9s (eCas967 & Cas9-HF168) is still much lower than that of Cpf1119. 
Therefore, Cpf1 has the potential to be a better alternative to all current Cas9 variants.  
 
Cleavage rate is reduced with increasing PAM-distal mismatches (Figure 4.15c) even when the 
mismatches do not affect stable binding (Figure 4.7), suggesting that shorter RNA-DNA heteroduplexes 
result in slower conformational changes required for cleavage activation. Previous studies on Cas9 
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revealed that mismatches alter the kinetics of DNA unwinding, RNA-DNA heteroduplex extension, and 
nuclease and proof-reading domain movements88,96,112,119.  
 
For cognate DNA target, RNA-DNA heteroduplex extension would require unwinding of the parental 
DNA duplex. In the crystal structure of AsCpf1-RNA-DNA complex, four PAM-distal base pairs are 
unwound but not involved in RNA-DNA heteroduplex 114, hinting that DNA unwinding does not 
necessarily cause a concomitant annealing with the RNA.  We performed cleavage experiments using 
DNA with PAM-distal mismatched region pre-unwound in order to test the relative importance of 
parental DNA duplex unwinding and annealing with RNA in cleavage activation. Cpf1 needed much 
fewer PAM-proximal matches to cleave if the mismatched region is pre-unwound (Figure 4.20) indicating 
indeed DNA unwinding is likely more important than RNA-DNA heteroduplex in activating cleavage. 
Accordingly, ssDNA can also be cleaved by Cpf1 (Figure 4.20). Therefore, the role of RNA may 
primarily be in keeping the DNA unwound through annealing with the target strand.  
 
CRISPR enzymes bend DNA to cause a local kink near the PAM, which acts as a seed for unwinding and 
heteroduplex extension92,93,114. Perturbation of DNA bending by introducing a nick near the PAM slowed 
down cleavage, underscoring the importance of DNA bending for Cpf1 induced cleavage (Figure 4.21). 
Cas9 causes a larger DNA bend than Cpf193,114, possibly contributing to it higher tolerance of PAM-
proximal mismatches in binding and cleavage activity. 
 
Shorter and simpler guide-RNA11 for Cpf1 could potentially be deleterious for its engineering or 
extension, as is done for Cas9’s guide-RNA120. For e.g., an extra 5' guanine in the guide-RNA was 
extremely deleterious for LbCpf1 (Figure 4.22). This feature could affect applications where guide-RNAs 
are transcribed using U6/T7 RNA polymerase systems that require first nucleotide in transcribed RNA to 




Cas9 has provided a highly efficient and versatile platform for DNA targeting, but the efficiency of gene 
knock-in is low123. Amongst the possible reasons is the inability of Cas9 to release and expose cleaved 
DNA ends. In contrast, the ability of Cpf1 to release a cleavage product readily, combined with staggered 
cuts it generates, could in principle increase the knock-in efficiency. Although it remains to be seen how 
this property affects the downstream processing in vivo, we can also envision a scenario where product 
release by Cpf1 can be detrimental to genome engineering applications. Applying positive twist to the 
DNA in a Cas9-RNA-DNA complex can release Cas9-RNA from DNA by promoting rewinding of 
parental DNA duplex86. Positive supercoiling is generated ahead of a transcribing RNA polymerase124 and 
Cas9 holding onto the double strand break product may help build the torsional strain required to eject 
Cas9-RNA. If the PAM-distal cleavage product is released prematurely as in the case of Cpf1, 
transcription-induced positive supercoiling cannot build up and the Cpf1-RNA would remain bound 
stably to the PAM-proximal cleavage product, hiding the cleaved end and preventing efficient knock-in. 
 
High specificity of adaptive immunity by Cpf1 against hypervariable genetic invaders is a little 
paradoxical. But Cpf1 and Cas9 systems co-exist in many species and thus they likely provide immunity 
suited to their features, effectively broadening the scope of immunity. Overall, our results establish major 
different and common features between Cpf1 and Cas9 which can be useful for the broadening of genome 











Figure 4.20 | FnCpf1 activity for DNA targets in pre-unwound configuration and DNA targets with 
partially or completely single stranded target strand analyzed by 4% native gel electrophoresis and 
SYBR Gold II staining of nucleic acids. 
(a) Pre-unwound DNA targets with mismatches i.e. DNA targets with no base-pairing between target and 
non-target strands at the indicated bulged portion along with mismatches in the target strand. These were 
bound and cleaved by FnCpf1-RNA even with high extent of PAM-distal mismatches. This indicates that 
if DNA unwinding was facilitated by using pre-unwound DNA configuration, then the FnCpf1 was more 
likely to cause DNA cleavage. But even for pre-unwound DNA targets, PAM-proximal complementarity 
between guide-RNA and the target strand of the DNA targets was still a necessary condition for the 
FnCpf1 activity. x-ymm refers to a contiguous mismatch (between target strand and the guide-RNA) 
running from position x to y relative to PAM, whereas x-yuw refers to a contiguous stretch (relative to 
PAM) in the DNA target where the bases between the target and the non-target strands are not base-
paired. FnCpf1-RNA band was sometimes observed as a faint band right below the uncleaved DNA target 
band. Possibly, complexation of guide-RNA with FnCpf1 prevents efficient staining of RNA in the 
FnCpf1-RNA. As shown, if the gel-electrophoresis was run longer, then a clearer resolution between 
uncleaved DNA target and FnCpf1-RNA band could be observed. (b) Partially duplex DNA targets, i.e., 
DNA targets with a portion of target strand in single-stranded confirmation were also bound and cleaved 
by FnCpf1 even if the PAM was single-stranded. Sequences of DNA targets and guide-RNA used for all 





Figure 4.21 | Effect of ‘nick’ and reducing conditions on the Cpf1 induced DNA cleavage and 
release of cleavage products. 
(a) Presence of nick close to PAM can perturb DNA bending, which has been structurally characterized93 
to be important for Cas9 induced DNA unwinding or R-Loop formation, which in turn guides cleavage 
action as per our unpublished study. To probe its effect in cleavage action of Cpf1, the radio-labeled 
denaturing gel-electrophoresis experiments (Figure 4.15b) were performed to measure lifetime of 
cleavage with and without the nick. Values of which are shown in (b). Cleavage is 2-3-fold slower in 
presence of nick. Here, the values without nick are same as the ones shown in Figure 4.15c. (c) Schematic 
of single-molecule cleavage product release assay as described in Figure 4.15d. These experiments were 
done in reducing and non-reducing conditions i.e. with and without DTT. Lifetime of cleavage product 
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release with and without DTT is summarized in (d). Here, the values without nick are the same as the 
ones shown in Figure 4.15f. FnCpf1 and AsCpf1 activity were similar, as we have shown previously that 
their activity is not much affected by reducing conditions. But LbCpf1 which we have shown to be 




Figure 4.22 | Effect of an extra guanine (G) base in guide-RNA for LbCpf1-RNA activity. 
(a) Schematic of the single-molecule cleavage product release assay as described in Figure 4.15d and 
Figure 4.18. (b) Two different guide-RNA sequences tested for LbCpf1-RNA. Former is the canonical 
guide-RNA for LbCpf1 as has been described11. The latter is the guide-RNA we in-vitro transcribed for 
testing with LbCpf1, which has an extra guanine (G) at the 5’ end. (c) tcleavage by LbCpf1 with guide-RNA 
with the extra G at the 5’ end. (d) Extra G is quite deleterious for LbCpf1-RNA activity as shown by 




Figure 4.23 | FnCpf1 activity is not affected by the imaging buffer components. 
DNA cleavage & binding by FnCpf1 analyzed by 4% native gel electrophoresis and SYBR Gold II 
staining of nucleic acids. Lanes colored with black legends used the reaction buffer (50 mM Tris-HCl (pH 
8.0), 100 mM NaCl, 10 mM MgCl2, 5 mM Dithiothreitol (DTT)) while the lane colored with red legend 
used reaction buffer containing Trolox and BSA i.e. imaging buffer components (50 mM Tris-HCl (pH 
8.0), 100 mM NaCl, 10 mM MgCl2, 5 mM Dithiothreitol (DTT), 0.2 mg/ml BSA and saturated Trolox 
(>5 mM). Sequences of DNA targets and guide-RNA used for these experiments is in Table 4.3 and Table 
4.5. 
 
4.5 MATERIALS AND METHODS 
4.5.1 Preparation of DNA target and guide-RNA 
Single-stranded DNA (ssDNA) oligonucleotides were purchased from Integrated DNA Technologies. 
ssDNA target and non-target (labeled with Cy3) strands and a biotinylated adaptor strand were mixed. 
Excess target strand was used to ensure near complete hybridization of non-target strand with the target 
strand. Upon surface immobilization of the assembled DNA target, any free target strand can be washed 
away because it does not contain biotin. The non-target strand was created by ligating two component 
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strands, one with Cy3 and the other containing the protospacer region to avoid having to synthesize 
modified oligos for each mismatch construct. For schematics, see Figure 4.1a.  
Fully duplexed DNA targets but with a nick were also used.  The oligonucleotide containing Cy3 is 
referred to as “Cy3 oligo” and is in part, complementary to a “biotin oligo”. Hybridization of the two 
oligos results in a biotin-Cy3 adaptor, which has a 14 nt overhang complementary to the “target oligo” 
that contains the protospacer region. Finally, the non-target “oligo” complementary to the target oligo was 
used to complete the duplexed DNA target (Figure 4.1a). DNA targets were prepared by mixing all of the 
four component oligos in the buffer containing 50 mM NaCl, 20 mM Tris-HCl (pH 8.0), which was then 
heated to 90° C followed by slow-cooling to room temperature over 3 hr. The mixing ratio of component 
oligos was 1:1:2:3 for Cy3 oligo: biotin oligo: target oligo: non-target oligo. An excess of target and non–
target oligo was used to ensure that any Cy3 oligo detected on the surface is in complex with three other 
oligos. The Cy3 fluorophore is located 4 bp upstream of the protospacer adjacent motif (PAM: 5’-YTTN-
3’) and was conjugated via Cy3 N-hydroxysuccinimido (Cy3-NHS; GE Healthcare) to the Cy3 oligo at 
amino-group attached to a modified thymine through a C6 linker (amino-dT) using NHS ester linkage. 
smFRET experiments were done with both sets of DNA targets (with or without a nick) and no significant 
differences were found between them. Table 4.1 shows all DNA targets used. For single-molecule 
cleavage product release experiments, a non-target strand with the Cy3 relocated in a different position 
was used. Cy3 label was conjugated onto the amine modification (amino-dT) using Cy3-NHS, as 
described above.  Schematic of these DNA targets is in the Figure 4.18 and their sequences in Table 4.5. 
 
DNA targets for gel electrophoresis experiments were prepared and hybridized as described above. For 
radio-labeled gel electrophoresis experiments, the target strand was 5′ radiolabeled with T4 
polynucleotide kinase (New England BioLabs) and γ-32P ATP (Perkin Elmer). The target and non-target 
strands were annealed with the non-target strands in excess. For single molecule experiments, guide-RNA 
was purchased from IDT with modifications for Cy5 labeling as described in Table 4.5. Cy5 was 
conjugated via Cy3 N-hydroxysuccinimido (Cy5-NHS; GE Healthcare) to the RNA as described 
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previously83,125. For all other experiments, unmodified guide-RNA was used and they were either in vitro 
transcribed or purchased from IDT. Guide-RNA sequences used in this study is available in Table 4.5 
 
4.5.2 Preparation of Cpf1-RNA. 
The Cpf1-RNA was freshly prepared prior to each experiment by mixing the guide-RNA (50 nM) and 
Cpf1 in 1:3.5 ratio in the following reaction buffers and incubated for at least 10 min at room temperature. 
50 mM Tris-HCl (pH 8.0) 100 mM NaCl, 10 mM MgCl2, (FnCpf1 and LbCpf1) and 50 mM HEPES (pH 
7.0) 100 mM NaCl, 10 mM MgCl2, (AsCpf1). 5mM DTT was only used in the buffer when specified. 0.2 
mg/ml Bovine serum albumin (BSA), 1 mg/ml glucose oxidase, 0.04 mg/ml catalase, 0.8% dextrose and 
saturated Trolox (>5 mM)) were additional contents of the reaction buffers for single-molecule imaging 
experiments. Excess Cpf1 was used to achieve highest extent of complexation of all the available guide-
RNA and the concentration of guide-RNA was used as the concentration of Cpf1-RNA. Cpf1 activity 
using the similar guide-RNA and on DNA targets with same protospacer and PAM have been 
characterized previously11. Fluorophore labeling of either DNA targets or guide-RNA did not impair Cpf1 
activity (Figure 4.3). 
 
4.5.3 Single-molecule fluorescence imaging and data analysis. 
DNA targets were immobilized on the polyethylene glycol-passivated flow chamber surface (purchased 
from Johns Hopkins University Microscope Supplies Core or prepared following protocols reported 
previously 89 using neutrAvidin-biotin interaction and imaged in the presence of Cas9-RNA at the stated 
concentration using two-color total internal reflection fluorescence microscopy.  For DNA unwinding by 
surface-tethered Cas9-RNA smFRET assay, 20 nM of biotin-labeled Cas9-RNA was immobilized on 
surface before adding FRET pair labeled DNA targets. All the imaging experiments were done at room 
temperature in a Cas9-RNA activity buffer with oxygen scavenging for extending photostability (20 mM 
Tris-HCl, 100 mM KCl, 5 mM MgCl2, 5% (v/v) glycerol, 0.2 mg ml-1 BSA, 1 mg ml-1 glucose oxidase, 
0.04 mg ml-1 catalase, 0.8% dextrose and saturated Trolox (>5 mM)101. Time resolution was 100 ms 
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unless stated otherwise. Detailed methods of single-molecule FRET (smFRET) data acquisition and 
analysis have been described previously89. Video recordings obtained using EMCCD camera (Andor) 
were processed to extract single molecule fluorescence intensities at each frame and custom written 
scripts were used to calculate FRET efficiencies. Data acquisition and analysis software can be 
downloaded from https://cplc.illinois.edu/software/.  FRET efficiency (E) of the detected spot was 
approximated as E = IA/(ID+IA), where ID and IA are background and leakage corrected emission 
intensities of the donor and acceptor, respectively. 
 
4.5.4 Expression and purification of Cpf1. 
The methods of Cpf1 protein expression and purification were adapted from a protocol described 
previously9. Codon optimized Cpf1 gene sequence cloned into a bacterial expression vector (6-His-MBP-
TEV-FnCpf1, a pET based vector) was cloned in house or purchased from GenScript. The vector was 
transformed into Rosetta (DE3) pLyseS (EMD Millipore) cells and cells were plated onto LB-Kanamycin 
agar plates and grown at 37 °C overnight. Single colony from the agar plates was then cultured overnight 
in 10 ml of SOC medium (Thermo Fisher Scientific). The overnight miniculture of Rosetta (DE3) pLyseS 
cells containing the Cpf1 expression construct were inoculated (1:500 dilution) into 4 liters of Terrific 
Broth (Sigma Aldrich) growth media containing 50 μg/ml Kanamycin. Growth media with the inoculant 
was grown at 37 °C in a shaker at 100 revolution per minute (rpm) until the cell density reached 0.2 
OD600, at which point the temperature was lowered to 21 °C. Growth was continued and 6-His-MBP-
TEV-Cpf1 protein expression was induced when cells reached 0.6 OD600 by addition of IPTG (Sigma) to 
0.5 mM final concentration in the growth media. The induced culture was kept for 14–18 hr at 21 °C after 
which the cells were harvested by centrifugation at 5000 rpm for 30 min at 4 °C. The harvested cells were 
quickly stored at −80 °C until further purification. The harvested cells were then suspended in 200 ml of 
lysis buffer (50 mM HEPES [pH 7], 2M NaCl, 5 mM MgCl2, 20 mM imidazole) supplemented with 
protease inhibitors (Roche complete, EDTA-free) from Roche and lysozyme (Sigma Aldrich) and 
incubated at 4 °C for 30-45 minutes. After homogenization, cells were further lysed by sonication (Fisher 
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Model 500 Sonic Dismembrator; Thermo Fisher Scientific) at 30% amplitude in 3 cycles of 2 s sonicate-2 
s relax mode, each cycle lasting 1 min. Following lysis, cell solution was centrifuged at 15,000 ×g for 30-
45 minutes, the cellular debris was discarded and the supernatant of lysate was collected. The clear lysate 
was then incubated at 4 °C with Ni-NTA slurry (Qiagen) for 45 min in a shaker at 30 rpm. The lysate 
with the Ni-NTA slurry was then applied to a column and multiple cycles of lysis buffer were used to 
wash the Ni-NTA slurry through the column. The 6-His-MBP-TEV-Cpf1 was eluted in a single step with 
300 mM imidazole buffer (50 mM HEPES [pH 7], 2 M NaCl, 5 mM MgCl2, 300 mM imidazole). TEV 
protease (Sigma Aldrich) was then added, and the sample was dialyzed using Slide-A-Lyzer™ dialysis 
casettes (Thermo Fisher Scientific) overnight into the buffer suitable for TEV protease activity (500 mM 
NaCl, 50 mM HEPES [pH 7], 5 mM MgCl2, 2 mM DTT). TEV protease activity resulted in the 
deconstitution of 6-His-MBP-TEV-Cpf1 into 6-His-MBP and Cpf1, which was confirmed by SDS-
PAGE. The free 6-His-MBP was removed by another round of Ni-NTA chromatography resulting in the 
solution containing only Cpf1. Sample was then injected on to a HiLoad 26/600 S200 size exclusion 
column equilibrated with gel filtration buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM MgCl2, 
5mM DTT). Fractions containing Cpf1 were pooled, concentrated, and then flash frozen in liquid 
nitrogen. Final sample was stored at -80 °C until used in experiments. 
 
4.5.5 FRET histograms, Cas9-RNA bound DNA fraction and unwound fraction 
Neutravidin-biotin interaction was used to immobilize the biotinylated Cy3-labeled DNA targets on the 
polyethylene glycol (PEG) passivated flow chamber surface prepared following protocols reported 
previously89 or purchased from Johns Hopkins Microscope Supplies Core. Cy5-labeled Cpf1-RNA or 
unlabeled Cpf1-RNA (both referred to as Cpf1-RNA for brevity) was added to the flow chamber. The 
flow chamber was then illuminated with green laser and imaged with two color total internal reflection 
fluorescence microscopy. A buffer suitable for single-molecule imaging and Cpf1 activity was used and is 
referred to as the imaging-reaction buffer (50 mM Tris-HCl (pH 8.0) 100 mM NaCl, 10 mM MgCl2,0.2 
mg/ml Bovine serum albumin (BSA), 1 mg/ml glucose oxidase, 0.04 mg/ml catalase, 0.8% dextrose and 
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saturated Trolox (>5 mM)) (Figure 4.23). 50 mM HEPES (pH 7.0) was used in place of 50 mM Tris-HCl 
(pH 8.0) for AsCpf1 experiments only, unless stated otherwise. 5 mM DTT was only added to these 
buffers for experiments done and stated to be in reducing conditions (chiefly LbCpf1 only). Technical 
details of single-molecule imaging, data acquisition and analysis have been described previously89. Video 
recordings obtained using EMCCD camera (Andor) were processed to extract single molecule 
fluorescence intensities at each frame and custom written scripts were used to calculate FRET 
efficiencies. Data acquisition and analysis software can be downloaded from 
https://cplc.illinois.edu/software/.  FRET efficiency of the detected spot was approximated as FRET = 
IA/(ID+IA), where ID and IA are background and leakage corrected emission intensities of the donor and 
acceptor respectively.  For single-molecule cleavage experiments, series of snapshots of different imaging 
areas were taken at different time points, under same green laser illumination via total internal reflection. 
The snapshots were then analyzed to estimate the changing number of Cy3-labeled DNA targets on the 
surface. Time resolution for all the experiments was 100 ms unless stated otherwise. 
 
4.5.6 FRET efficiency histograms and Cpf1-RNA bound DNA fraction 
A smFRET time-trajectory is a series of E values every 100 ms. First five E values of each single-
molecule trace were pooled together to build single molecule E histograms. Cpf1-RNA bound DNA 
fraction (fbound) was calculated as a ratio between the number of molecules with E > 0.2 and the total 
number of molecules in the E histograms. E histograms shown in Figure 4.6 were constructed by 
combining data from two independent experiments (except for AsCpf1; PAM-less DNA). 
 
4.5.7 Determination of binding kinetics 
For DNA targets that showed real-time reversible binding/dissociation of Cpf1-RNA, idealization of 
smFRET traces via Hidden Markov Model90 analysis yielded two pre-dominant FRET states, of zero (E< 
0.2) and bound state (E> 0.2). Lifetime of the unbound state, τunbound, was calculated by fitting survival 
probability of dwell times of unwound state (E< 0.2) vs time to a single-exponential decay (exp[-
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t/τunbound]). The survival probability of the bound state required a double-exponential decay for adequate 
fitting (A*exp[-t/τ1]+ [1-A] *exp[-t/τ2], and the average lifetime was calculated as τavg = Aτ1 +(1-A)τ2.  
The bimolecular association rate constant kon, binding rate kbinding and dissociation rate koff were calculated 
as follows.  
kbinding =τunbound-1 
koff = τbound-1 
kon = kbinding  / [Cpf1-RNA] 
Due to under-sampled binding events, τavg of FnCpf1 for PAM-less DNA and DNA with 2 nPP were 
calculated as the algebraic average of E> 0.2 dwell-times.  
Cy5 labeling efficiency of guide-RNA was ~90% and thus fbound andτunbound were appropriately corrected. 
Due to high noise, the smFRET traces from experiments involving AsCpf1 could not be idealized with 
high accuracy thus preventing their koff and kon analysis. 
 
4.5.8 Estimation of dissociation constant (Kd) 
To estimate Kd, Cpf1-RNA bound DNA fraction (fbound) vs Cpf1-RNA concentration (c) was fit using  
fbound= M × c / (Kd + c) where M is the maximum observable fbound. M is typically less than 1 because 
inactive or missing acceptors or because not all of the DNA on the surface are capable of binding Cpf1-
RNA. 
 
4.5.9 Overall lifetime of release of cleavage products 
Single-molecule experiments were used to estimate the lifetime of the release of cleavage products by 
fitting the decreasing number of Cy3 spots (loss of spots due to Cpf1-RNA induced cleavage and release) 
to a single-exponential decay. The time of binding (kon×50 nM) and time of cleavage (τcleavage) were 
subtracted from the obtained lifetime to get the true lifetime of the release (τrelease) of cleavage products. 
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But since τcleavage was not measured for LbCpf1, its reported τrelease is without the τcleavage and time of 
binding subtraction. 
 
4.5.10 Gel electrophoresis experiments 
All the biochemical experiments were done in the following reaction buffers: 50 mM Tris-HCl (pH 8.0) 
100 mM NaCl, 10 mM MgCl2, 5 mM DTT (FnCpf1 and LbCpf1) and 50 mM HEPES (pH 7.0) 100 mM 
NaCl, 10 mM MgCl2, 5 mM DTT (AsCpf1). 
 
Gel electrophoresis experiments involving visualization of nucleic acid bands via SYBR Gold II staining. 
All experiments were conducted by mixing DNA targets and Cpf1-RNA in 1:5 ratio in the reaction 
buffer. The reaction was incubated for 4.5-5 hr (unless stated otherwise) before being resolved by 4% 
native/denaturing agarose gel electrophoresis and SYBR Gold II staining of nucleic acids using the 
precast gels containing SYBR Gold II, purchased from Thermo Fisher Scientific. For native gel 
electrophoresis, the reaction aliquots were directly loaded onto the gels. All the reactions were incubated 
at the room temperature, 37 °C or 4 °C and indicated in the presentation of their results. The gel 
electrophoresis was run at room temperature for experiments incubated at room temperature/37 °C and at 
4 °C for experiments incubated at 4 °C. The cleaved-uncleaved DNA target with/without the bound Cpf1-
RNA along with other nucleic acids were stained by SYBR Gold II and imaged by blue laser illumination 
(480 nm; GE Amersham Molecular Dynamics Typhoon 9410 Molecular Imager and 488 nm; Amersham 
Imager 600). For all of these experiments, the concentration of the DNA targets ranged from 20 nM to 60 
nM and consequently the effective concentration of Cpf1-RNA ranged from 100 nM to 300 nM 
respectively. Volume of aliquots used for gel loading ranged from 10 to 20 μL per lane. For the time-
lapse denaturing gel electrophoresis experiments, the acquired gel-images were quantified using 
ImageJ126. Entire panel of DNA targets used in these gel-electrophoresis experiments is available in  
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Table 4.3 and Table 4.4. Tris-HCl at pH 8.0 was used in the reaction buffers for all the experiments 
except for the ones reported in Figure 4.3 and Figure 4.12 where Tris-HCl at pH 8.5 was used. 
 
Gel electrophoresis experiments and autoradiography. Experiments containing radiolabeled DNA 
substrates were performed as above. However, samples were quenched, in buffer containing 95% 
formamide, 0.01% SDS 0.01% bromophenol blue, 0.01% xylene cyanol, and 1 mM EDTA and incubated 
at 95 °C for 5min then on ice for 2min. Volume ratio of quenching buffer to reaction was 5:1. Samples 
were loaded on to denaturing polyacrylamide gels (10% acrylamide, 50%(w/v) urea) and allowed to 
separate. Amount of sample loaded on to gel was normalized to 10,000 counts per sample. Gels were 
imaged via phosphor screens. Entire panel of DNA targets used in these gel-electrophoresis experiments 
is available in Table 4.1. 
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Table 4.3 | List of DNA targets used in gel electrophoresis experiments involving use of SYBR Gold 




Table 4.4 | Pre-unwound DNA targets used in gel electrophoresis experiments involving use of 








Table 4.5 | List of guide-RNA used in all experiments and DNA targets used in single-molecule 
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CONCLUSION AND OUTLOOK 
There are many outstanding questions about the CRISPR system which can be addressed using sm 
approaches. For example, it should be possible to employ 3-4 color smFRET127,128 for simultaneous 
observation of the DNA unwinding and nuclease and proofreading domain dynamics, helping us 
understand the molecular details of allosteric communication between RNA-DNA heteroduplex, DNA 
unwinding and cleavage action. While the majority of single molecule investigations have focused on 
CRISPR’s DNA binding and its conformational changes upon DNA binding, a largely unexplored 
territory has been the assembly of CRISPR-RNA complex. smFRET is a powerful technique to probe the 
folding pathways of RNA129 and thus could be used to probe structural rearrangements within guide-RNA 
and also within CRISPR enzymes that ensures efficient complexation of guide-RNA with CRISPR 
enzyme. The information from such experiments will aid in the rational design of efficient guide-RNAs 
and explain the variations in activity of different guide-RNA sequences31.  
 
Another unexplored territory is the use of high resolution force (optical traps130 & nanopore sequencer131) 
or correlative force-fluorescence spectroscopy. A suitable geometry of force application, with and without 
fluorescence visualization, can be used to extract additional information about transitions states between 
different dominant intermediates and also probe mechanical stability of CRISPR-RNA-DNA complex132. 
CRISPR-RNA-DNA is an ultrastable complex that persists even post DNA cleavage, thus masking the 
cleaved DNA sites from genome editing machinery. The chromatin in vivo is likely to be under tension 
and torsional stress which would be altered during the process of transcription and replication133,134. DNA 
stretching and twisting may help in quick dissociation of CRISPR-RNA-DNA complex and help expose 
cleaved DNA sites for genome editing machinery. Therefore, probing mechanical stability of CRISPR-




Dead CRISPR enzymes fused with transcriptional effectors are being increasingly used to achieve in vivo 
site-specific transcriptional control as the fused transcriptional effectors recruit additional effectors at 
CRISPR targeted sites97, but the molecular details of their recruitment are unknown. This recruitment 
assembly can be studied using another sm technique called Co-localization Single Molecule Spectroscopy 
(COSMOS)135, wherein entry and exit of fluorescently labeled biomolecules of interest (additional 
effectors in this case) can be studied at a particular site or a molecule (CRISPR targeted site in a DNA 
molecule).  
 
Identification of critical steps in various stages of DNA targeting by CRISPR will not only help in 
designing strategies to improve its efficiency and reduce off-target effects but will be useful for 
evaluating the rational design of new CRISPR enzyme and their chemical and enzymatic regulators, 
which are being increasingly pursued for additional control over CRISPR enzymes136-138.  For example, a 
chemical regulator may be rationally designed to target an important intermediate of CRISPR enzyme. sm 
approaches allow for precise characterization of differences between different CRISPR enzymes. This 
characterization of differences can be used to explain the variation in activity of different CRISPR 
enzymes in different conditions and organisms.  CRISPR enzymes with different biophysical and 
biochemical parameters may be employed for different applications, expanding the functionalities of 
























The goal of this chapter is to provide a detailed protocol for the key fundamental experiments that 
underlie this dissertation. While the previous chapters provide the methods for all the reported 
experiments, it is important to have protocols with detailed step by step procedures. The writing of the 
protocols in this chapter has been deliberately kept conversational to aid the reader in visualizing these 
experiments. Particular emphasis has been given to common mistakes and scenarios that result in the 
failure of these experiments. These protocols are based on previously described methods4,83,89,125,139,140. 
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5.2 EXPRESSION and PURIFICATION of CRISPR proteins 
This protocol will describe the steps for the over-expression of CRISPR proteins and their purification. It 
will also describe the vector (plasmids) that will be used for these over-expression. Specific warnings 
have been added at many steps to emphasize the important points of that particular step. While this 
protocol is specific for Cas9 protein, it is broadly applicable to other Cas9 and Cpf1 variants and 
orthologs with necessary changes to some important buffers etc.  
 
5.2.1 Materials 
• A vector for over-expression of Cas9 or Cas9 mutant protein in E. coli cells. 
• One Shot® BL21(DE3) Chemically Competent E. coli. 
• Ampicillin for Anti-biotic resistance. 
• LB-Agar Plates with Ampicillin as Anti-biotic resistance. 
• 37 °C incubator and shaker. 
• Lysogeny broth (LB) powder or LB media. 
• Terrific Broth (TB) powder or media. 
• Nalgene flasks for harvesting the cells. 
• Ultra-centrifuge. 
• Nalgene tubes, capable of handling ultra-centrifugation steps for collecting the cell-lysate. 
• Ni-NTA resin (or IMAC resin). The protein being over-expressed has a histidine tag so Ni-NTA 
resin will be used to purify the protein. 
• Basic salts needed for making various buffers. Double check that you have all of them. 
• A column for Ni-NTA resin assisted protein purification. 
• A gentle shaker. 
• Cold room. 
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• Dialysis cassettes (for e.g. Slide-A-Lyzer™ Dialysis Cassettes) for the dialysis of the final 
retrieved protein. 
• All the components involved in the expression, purification and final preparation of the protein 
must be certified RNAse/DNAse free components. 
• Lysis Buffer – 500 mL: 
o 25 mL of 1 M Tris-HCl, pH 7.5 (50 mM Tris-HCl, pH 7.5 final concentration) 
o 14.66 g of NaCl (500mM NaCl) 
o 1 mL of 0.5M TCEP solution (1mM TCEP). Add it right before the lysis, do not keep it added 
in the lysis solution 
o 25 mL of 100% Glycerol (5% glycerol) 
o 500 µL of 200mM of Phenylmethanesulfonyl fluoride (PMSF) in its isopraponal solution 
(0.5mM PMSF). Add it right before the lysis, do not keep it added in the lysis buffer solution 
o Protease inhibitors (Roche). 2 tablets per 100mL of the lysis solution. Generally, 100 mL of 
lysis solution is used for 1-2 liters of bacterial solution used for over-expressing the protein. 
Add it right before the lysis, do not keep it added in the lysis buffer solution 
• Wash Buffer – 2000mL: 
o 100mL of 1M Tris-HCl, pH 7.5 (50mM Tris-HCl, pH 7.5) 
o 58.44g of NaCl (500mM NaCl) 
o 4mL of 0.5M TCEP solution (1mM TCEP). Add it right before the wash, do not keep it 
added in the wash buffer solution 
o 1.36g of Imidazole powder (10mM imidazole) 
o 100mL of 100% Glycerol (5% glycerol) 
• Elution Buffer – 20mL: 
o 1mL of 1M Tris-HCl, pH 7.5 (50mM Tris-HCl, pH 7.5) 
o 2.5mL of 4M NaCl (500mM NaCl) 
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o 0.4mL of 0.5 M TCEP (1mM TCEP) 
o 2mL of 3M imidazole (300mM imidazole) 
o 1mL of 100% glycerol (5% glycerol) 
o Check the pH of this solution. With the presence of Tris-HCl, the pH should be regulated but 
high concentration of imidazole will cause pH increase. The pH should not be higher than 
8.0. 
• TEV buffer-1.5 liters. This is the buffer in which the Ni-NTA eluted protein will be dialyzed to, 
with TEV protease added to it which will cleave the TEV site tag.  
o 30mL of 1M Tris-HCl, pH 7.5 (20mM Tris-HCl, pH 7.5) 
o 13.97 g of KCl powder (125mM KCl) 
o 3mL of 0.5 M TCEP (1mM TCEP) 
o 75mL of 100% glycerol (5% glycerol) 
• All the components involved in the expression, purification and final preparation of the protein 
must be certified RNAse/DNAse free components. 
 
5.2.2 Basic introduction about the pET based vector for Cas9 protein production 
pET (Plasmid for Expression by T7 RNA polymerase) 28a vector generally has the gene of interest 
inserted under the T7 promoter as shown below. The T7 RNA polymerase can only transcribe the gene of 
interest since our gene of interest is present under the T7 promoter. The cell line (BL21 cell lines) which 
we are using does not have any endogenous levels of T7 RNA polymerase i.e. does not produce T7 RNA 
polymerase in normal conditions, but will produce them when we switch the production on. The cell line 
(BL21 cell lines) has been artificially engineered and has the T7 RNA polymerase gene inserted within 
the bacterial genome under the lac operator. Please note that this T7 RNA polymerase gene and the lac 
operator is in the bacterial chromosome and is most likely not present in your plasmid of interest (which 
has your gene of interest). But if they are present in the plasmid, they have the similar job i.e. the Lac 
operator would be present 5' to your gene of interest. When Lac repressor is bound to the Lac operator, it 
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will prevent any transcription from that region i.e. Lac operator genes and the gene of interest present 
downstream of it, hence no protein production. In a normal condition, the lac repressor protein (present 
endogenously) is bound to the lac operator and thus preventing the transcription of T7 RNA polymerase 
gene in bacteria. This prevents the production of any T7 Polymerase in the cell which obviously prevents 
the transcription of our genes of interest (in the plasmid we transformed) in the pET 28a vector. When the 
IPTG is added, it arrests all the Lac repressor from its bound site at the lac operator. The T7 RNA 
polymerase is translated in bulk from the bacterial genome which then starts binds the T7 promoter in the 
pET28 vector and starts transcribing the gene of interest. Our gene of interest is the one that codes for 
Cas9 or mutants. It has a maltose binding sequence (to improve the solubility of the protein) conjugated 
right next to a TEV protease site. The TEV protease will be added to cleave out the maltose binding site 
from the protein of interest after majority of purification steps. 
 
5.2.3 Transformation of the cells with the vector containing your gene of interest 
1) Prepare Ice. 
 
2) Get the competent cells (One Shot® BL21(DE3) Chemically Competent E. coli) from -80 °C 
freezer.  
 
3) Never vortex the competent cells. These are the cells we discussed briefly above that have the 
artificially engineered gene in them that will produce the T7 RNA polymerase which will then 
transcribe the gene of interest in our vector. 
 
4) Thaw the competent cells on ice, store the competent cells on ice at all times while aliquoting. 
5) Bring a clean Eppendorf tube or something similar and keep it in the ice for pre-chilling. It is 





6) Gently mix the competent cells. Aliquot 50µL of the competent cells into the appropriate number 
of tubes, generally only 1 will be required. 
 
7) Dilute XL 10-Gold Beta mercaptoethanol mix (BME) provided with the appropriate kit 1:10 with 
nuclease free water. The cells suffer from a tremendous oxidative stress and hence the BME is 
added which is a strong reducing agent for relieving the oxidative stress.  
 
8) Each aliquot of cells (50µL) requires 1µL of diluted Beta mercaptoethanol. Add 1µL of BME 
into each of the aliquots.  
 
9) Add a very small amount of the plasmid from the plasmid stock to the cells, so that the its final 
amount in the solution ranges from 1-50 ng.  
 
10) Incubate the reactions on ice for 30 minutes. 
 
11) Heat pulse each transformation reaction in a bath preset at 42 °C for 20-30 seconds. The duration 
of the heat pulse is critical. The heat pulses will porate the cell membrane and few of the plasmid 
molecules will be able to get inside the cells. 
 
12) Put the tube back onto the ice and let it incubate for 5 minutes.  
 
13) Add 950µL of a freshly prepared SOC (Super Optimal broth with Catabolite repression) media to 
each transformation and incubate the reactions at 37 °C for 1 hour in the shaker shaking at 225-
250 revolutions per minute (rpm). Please make sure that the 1000µL sample is properly aerated 
and that it is in a big enough flask. Please do not use small tubes for growing this culture. Cells 
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growing in a small tube tend to have problems wherein many cells are cramped into the bottom of 
the solution where they are forced to grow without proper oxygen levels. And these cells are 
extremely bad for protein production. The amount of bacterial culture in a flask with respect to its 
maximum volume should be a very low fraction. Please also make sure that the cap to the flask is 
very lightly placed, so that it does not fall off during the shaking but should be able provide 
enough aeration. I personally putting aluminum foil to cover the flask. The aluminum foils do not 
fall off and yet provide good aeration, if they are lightly placed. 
 
14) Meanwhile, take out two LB-Agar plates with appropriate anti-biotic resistance and put them in 
the 37 °C incubator for ~5-10 minutes. 
 
15) After 1 hr of bacterial growth in the shaker. Create the following dilutions of the culture you 
grew: 
 
16) 5 times dilution: 20µL culture + 80-100µL of SOC media. 
 
17) 2 times dilution: 75µL culture + 75µL of SOC media. 
 
18) Take our the LB-Agar plates (from 37 °C incubator) and pour the above two diluted culture 
solutions into the two plates, right at the center. 
 
19) Meanwhile, light up the Bunsen burner and use a glass spreader or something similar (kept in 
ethanol) and burn it for few seconds under a propane flame. Then let it cool down. Now the 
spreader has been sterilized and you can use the spreader to spread the suspended culture onto the 
agar plates. Make sure you spread it evenly. Please make sure the spreader has been cooled down 




20) Keep the agar plates upside down in incubator at 37 °C. Please make sure to keep the plates away 
from each other and away from other plates. You do not want any contamination. Keep changing 
gloves while you are doing all of this to avoid any possible chance of cross-contamination. 
 
21) Tranformants will appear as colonies following overnight incubation at 37 °C. All the cells that 
took up the pET28 vector (that produced the antibiotic resistance) will be the only ones surviving. 
So this is a very easy selection for cells that took up the plasmid. 
 
5.2.4 Preparing the media for large-scale culture 
1) Take 2 four liter flasks and add ~36 grams of Terrific Broth to each one of them and add 750mL 
of extremely clean nuclease free water to it. Please remember the point, I wrote earlier about 
giving the cells enough room for good aeration. Hence do not grow the 1-liter or similar culture in 
a 2-liter flask. That is too small a flask for a 2-liter culture. Please also make sure that the cap to 
the flask is very lightly placed, so that it does not fall off during the shaking but should provide 
enough aeration. I personally putting aluminum foil to cover the flask. The aluminum foil does 
not fall off easily and yet provide good aeration, if they are lightly placed. 
 
2) Add 6mL of 100% glycerol to each of the flasks and mix well to dissolve everything. 
 
3) Using commercial Terrific Broth powder is highly recommended. Or you can make your own 
Terrific Broth powder. 
 
4) It is also recommended to use granulated terrific broth powder .These are dust-free and dissolve 
much easily. Some of the commercial available ones are packed in gelatin capsules. I would 
avoid using those. There is no point adding gelatin in your culture media. Hence granulated 
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gelatin free Terrific Broth powder are the best. 
 
5) Put the aluminum foil on the flask and then the autoclave tapes on them and autoclave the flasks 
containing the media. 
 
6) Take them out of the autoclave machine and let them cool down to the room temperature, at 
which point add 75mg of Ampicillin to them. This is for the selection via anti-biotic resistance. 
The desired concentration of the Ampicillin the media is 100µg/mL. Hence 75mg to each 0.75 
liter of the media achieves that. Mix everything well. 
 
7) Please do not add Ampicillin powder while the media is still hot from the auto-clave step, high 
temperature may degrade the Ampicillin compound. 
 
8) Store a small amount from this formulation, to be used a base-line correcting solution(media) 
when measuring the optical density at 600 nanometers wavelength (OD600) for the culture growth. 
Please note that OD600 is a decent estimate for the density of cells in the solution, but far from 
accurate. The best way would be to calibrate your spectrophotometer so that you can derive an 
empirical relationship between the OD600 obtained from your spectrophotometer and the density 
of the cells (for e.g. cells/ml). 
 
5.2.5 Preparing the inoculant for large-scale culture 
1) Take 4mL of the LB medium in a 50mL Falcon tube. Please remember the point, I wrote earlier 
about giving the cells enough room for good aeration. Hence do not grow the 4mL culture in 
a 10mL tube. That is too small a tube for a 4mL culture. Please also make sure that the cap to the 
flask is very lightly placed, so that it does not fall off during the shaking but should provide 
enough aeration. I personally putting aluminum foil to cover the flask. The aluminum foil does 
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not fall off and yet provide good aeration, if they are lightly placed. 
 
2) Take a single colony from the LB agar plates from the step number 28. Choose a colony which is 
well separated from other colonies, yet be in the middle of the plate. The middle of the plates 
tends to have more nutrition and grow better and hence such colonies are better than the colonies 
at the edges. But please make sure that you pick a single colony. All the cells in your culture that 
you will be growing need to be from a single progeny. And a single colony always starts off with 
a single cell hence ensuring that all the bacterial cells would be coming from a single parent. 
 
3) Take the single colony using a 10-200µL pipette tip. This tip works the best to pick the colony. 
Put the tip on a pipette and aspirate the colony onto the 4mL small inoculant culture. Mix 
everything well and discard the pipette tip into bacterial cell culture trash. 
 
4) Put the 4mL culture into a shaker at 37 °C, rotating at 250 rpm. Make sure that the cap/or foil for 
the flask is just lightly placed for the proper aeration. 
 
5) The steps of preparing the inoculant for large-scale culture and preparing the media for large-
scale culture can be done largely side by side. 
 
5.2.6 Transferring the inoculant from 4mL culture to the large-scale culture 
1) First of all, put the 4-liter flask, each containing 0.75 liter of the media supplemented 
with 75mg of Ampicillin into the shaker at 37 °C. The large media has to be brought to the same 





2) Let the inoculate grow to a point where the expected 0D600 is ~1.0. i.e. the solution will turn 
milky. Do not go beyond that. The cells may just enter a toxic phase of growth if the cells in the 
inoculant culture are grown too much without transferring them to the large-scale culture. From 
the addition of a small single colony to the desired inoculant culture, the inoculant culture is 
grown for ~4-6 hrs before transferring them to the big culture. In 4 hrs, the solution will turn quite 
milky. 
 
3) In my experience, please do not transfer a prematurely grown inoculant into the large-scale 
culture. Bacterial cells employ quorum sensing. And my armchair hypothesis is that a dilute 
inoculant will dilute further in the large scale culture. And it will take even longer for the cells to 
grow to expected ODs. Let the inoculant turn milky before transferring it to the large scale 
culture. 
 
4) Once the temperature of the 4 liter flasks media has reached 37 °C. Equally distribute 
the 4mL culture between the two flasks. The 'equally' here is very important because then the 
amount of cells (OD600) in both the 1-liter culture will always be the same and their temperature 
changes/induction/harvesting etc. can all be carried out concurrently without any delay between 
them. The cells divide and multiply and hence even a small change in the amount of inoculant 
that is distributed between them will lead to a big subsequent changes in their OD600. 
 
5) After the transfer is over, discard the inoculant flask in bacterial trash. And let the large scale 
(0.75 liter) culture (s) grow at 37 °C till the temperature changes/induction are required. 
 
5.2.7 Setting up the OD600 measurement 
1) A small amount from the large scale 0.75 liter (after adding Ampicillin) media was stored for 
using as a blank for the OD measurements. It is best to use a dedicated spectrophotometer for the 
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0D600 measurements i.e. the labs usually have a small machine set for measuring OD at precisely 
600 nm wavelength point. 
 
2) Baseline with the blank solution that had been stored from the large-scale media. Now the 
machine is ready for measuring the OD of actual large scale culture. 
 
5.2.8 OD600 check 
1) Keep checking the 0D600 of the large-scale culture. 
 
2) Check the OD600 of all the flasks separately, there may be significant changes of OD600 between 
and thus you do not want to rely on the OD600 from one flask and assume it for the other flasks as 
well. 
 
3) As mentioned before, do not set up a culture of more than 0.75- 1L in a 4Lflask. The bacteria do 
not grow well and goes into an anaerobic condition, if they are grown in a very large culture i.e. 3 
liters in a 4-liter flask, it prevents proper aeration of the cells. A good check of whether cells are 
growing well or not is to check the doubling time, at 37 °C the doubling time should be about 20 
minutes and at 21 °C, it should be about 40 minutes. 
 
5.2.9 Induction with (Isopropyl β-D-1-thiogalactopyranoside) IPTG 
1) Keep checking the 0D600 of the large-scale culture. The temperature should now be 37 °C. 
 
2) When the OD600 reaches 0.5, induce the production of the protein by supplementing both the 
culture with 0.5mM IPTG. i.e. to each 1-liter culture, add 1mL of 1000X IPTG (0.5M solution). 
 




4) It is important to understand why the temperature was decreased to 18 °C, sometimes some big 
proteins cannot take the excess temperature well. They will fold and be expressed properly when 
they are at low enough temperature. Same goes for this protein, it is important for the protein to 
be actively formed that the temperature is not too high. 18 °C is the most optimum temperature 
for this protein to be stably over expressed. 
 
5) Let the cells/culture grow at 18 °C for 16-18 hrs and then harvest the cells. I have noticed that the 
culture left for longer than 16-18 hrs, tended to have lesser over-expression. Perhaps the protein 
of interest was degrading. Anyways 16-18 hrs is sufficient for massive expression of your for 
Cas9 proteins as I have observed. 
 
5.2.10 Harvesting the cells 
1) After 16-18 hours, depending on the type of centrifuge, pour the bacterial culture into appropriate 
Nalgene flasks and centrifuge the culture at 5000-7000 rpm for 20-30 minutes at 4 degrees.  
 
2) The cells would have collected at the bottom of each flasks as bacterial pellets. Discard the 
supernatant media. Quickly store the pellets at -80 0C for later purification. Or proceed directly 
for the purification.  
 
3) Keep a very small amount of the pellet for the SDS-Page to confirm the protein overexpression. 
The protocol for the SDS-Page with the pellets is attached at the end of this protocol. 
 
4) You now need 100mL of lysis solution per 1 liter of culture from which the cells were harvested. 
You would have only the ions/salts in the lysis solution. Please add the following to 100mLof 
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lysis solution in the given order strictly. 
 
o Two protease inhibitor tables (Ones from Roche work well). These are chemicals that inhibit 
the protease from acting. 
o Add 100µL 200mM of isopraponal solution of PMSF (0.5mM PMSF final concentration). 
PMSF is extremely toxic. So please be very careful. 
o 200 µL 0.5M TCEP solution (1mM TCEP final concentration in lysis buffer solution). 
o Add appropriate amount of lysozyme (Sigma Aldrich) so that its final concentration is 
1mg/mL.Add the lysozyme powder and not lysozyme chloride or any other salt of it. 
 
5) Mix the lysis solution well to make sure that everything dissolves. You cannot vortex it or give it 
harsh mechanical shakeup. Mix and dissolve all things gently. Let it take time. Do not rush. 
 
6) Re-suspend the harvested cells in the above lysis buffer solution and mix them well but gently. 
Do not give mechanical shakeups to the solution at any subsequent solution at any stage because 
that will denature your protein and lysozyme etc. 
 
7) Mix the cells thoroughly and gently in the lysis buffer solution. You would have to break up the 
chunks of the cells in the DNA. Doing this will significantly increase the yield of your protein. 
Take a spatula and gently break up the cellular chunks manually one by one. This can be a boring 
process but it is important and well worth it. 
 
5.2.11 Lysing the cells 




2) Set the amplitude of the sonicator to 30%. Please follow the settings appropriate for your 
sonicator. 
 
3) Break the cells by sonication in cycles of 2s sonicate-2s rest. Each cycle is to last 1 minute and 
you have to do 3 cycles. The sonication heats up the sample that is why the cells have to be 
surrounded by ice throughout this process. 
 
4) Put the lysate now into Polyallomer tubes. These tubes are very strong and can withstand 
the rigors of the ultra-centrifugation which would be the next step. Do not use tubes which are not 
certified for use in ultra-centrifugation, as they will break during the process. 
 
5) Centrifuge the lysate now at 15,000g -17,000g for 30 minutes to remove the cell lysate away from 
the other hard cellular junks which will settle down. And the desired cell lysate, containing 
protein, will be in the supernatant. 
 
5.2.12 Ni-NTA Chromatography for protein purification 
A small note about Ni-NTA Chromatography. Since your protein of interest has a polyhistidine-tag. Ni-
NTA can be used to selectively retrieve your protein of interest leaving behind the other proteins present 
in the cell-lysate. It uses the ability of Histidine to bind nickel. A polyhistidine-tag is an amino acid motif 
in proteins that consists of at least five histidine (His) residues, often at the N- or C-terminus of the 
protein. It is also known as polyhistidine-tag, and by the trademarked name His-tag. Nickel is bound to an 
agarose bead by chelation using Nitroloacetic acid (NTA) beads. Several companies produce these beads 
as His-tagged proteins are some of the most commonly used. The general method is to batch absorb the 
His-tagged protein onto the column packed with the Ni-NTA agarose beads where solutions of low 
concentrations of phosphate and imidazole are used to remove low affinity bound proteins (i.e. the ones 
which do not have the His-tag) at a time when the His-tagged protein is strongly bound to the Ni-NTA 
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beads. And finally a high concentration of the Imidazole is passed through the column to elute out the 
protein of interest which is as we discussed remains firmly bound to the beads at low concentrations of 
imidazole but disassociates and gives away in the higher concentration of Imidazole. 
 
1) To the clean cell-lysate, add 3-5mL of Ni-NTA resin. Shake the resin well before adding it to the 
cell-lysate. 3-5mL of this resin is appropriate for 100mL of the cell-lysate. Incubate in the cold 
room (in the gentle-shaker) for 30-45 minutes. Put it for a slow and gentle shake. 
 
2) Do not add copious amount of this Ni-NTA resin, otherwise it will be very slow for the column. 
Like mentioned, 3-5mL is just fine. 
 
3) The solution can be directly added to a column and the resin can be washed with the wash buffer 
in the column, but letting the cell-lysate drip through the column and then letting the wash buffer 
drip through the column is a painfully slow process largely because the cell-lysate solutions are 
quite viscous. It is at this step that the user can lose patience and try to hurry things, which may 
mean less wash of the Ni-NTA resin/slurry and less wash could mean that the protein prep could 
end up with some non-specific protein components. And it would be extremely deleterious, if 
those non-specific proteins are nucleases.  
Here's describing a much more effective way of washing the Ni-NTA resin. 
 
4) After adding the 3-5mL of Ni-NTA resin/slurry to the cell -lysate and 30-45 minutes incubation. 
All the purification steps are to be done at 4 0C, so cold room is the ideal place to carry out the 
purification and required incubations.   
 




6) Centrifuge at 2400 rpm (no higher!) for 3 minutes, and gently pour off supernatant into the sink 
immediately after spin is over. Please do not remove all the cell-lysate solution. You let a full 
portion of Ni-NTA immersed in the solution. The Ni-NTA resin/slurry must never get dry and be 
exposed to air. 
 
7) These pellets are quite fragile, and will begin to dissipate in the supernatant rather quickly so 
remove the supernatant quickly. Avoid accidentally pouring off your Ni-NTA resin. 
 
8) Now add wash buffer solution to these falcon tubes (fill to ~50 mL mark) containing the Ni-NTA 
resin, which would be at the bottom of the tube. Put them in the gentle shaker for 10-15 minutes. 
This will wash the Ni-NTA resin more. Centrifuge again at 2400 rpm for 3 minutes, and gently 
pour off some supernatant into the sink immediately after spin is over, leaving behind substantial 
wash buffer solution so that the Ni-NTA resin is completely submerged. Repeat this step 3 more 
times for complete wash of the Ni-NTA resin. 
 
9) Now pour the Ni-NTA resin along with the wash buffer solution (do not remove all the 
supernatant as discussed before) into a column. Please make sure that the prior to the use, column 
has been properly cleaned. 
 
10) Now pass about 50mL- 100mL of the wash buffer through the column and collect the dripping 
solution in the falcon tubes. The protein of interest is still bound to the Ni-NTA resin/slurry. 
 
11) Do this till the most of the wash buffer solution has almost run through the column. Please do not 
let the Ni-NTA resin/slurry ever run dry. You let the entire portion of Ni-NTA resin immersed in 




12) All the above processes with the wash buffer solution is to get rid of all the proteins that bound 
Ni-NTA resin/slurry non-specifically. This wash step is extremely critical, because if the non-
specific proteins are not washed out from the Ni-NTA resin, they may elute with your protein of 
interest and create all sorts of problems. Chiefly, these non-specific proteins maybe nucleases and 
will remain as a nuclease contaminant in your CRISPR protein samples. Hence, it is very critical 
that the resin/slurry be washed extensively. 
 
13) The protein of interest is still bound to the Ni-NTA resin/slurry. 
 
5.2.13 Elution of the protein of interest 
When the wash buffer level just reaches the very top of the Ni-NTA resin/slurry level i.e. when the wash 
buffer is about to get over. That is the time to elute. Adding elution buffer while lot of wash buffer is still 
in the column makes no sense, because the wash buffer present in the column will not only significantly 
dilute the high concentration imidazole necessary to elute the protein of interest but it will also carry some 
unwanted protein which was non-specifically stuck in the Ni-NTA resin and is now part of the wash 
buffer. So just when the column is about to run dry, that is when you add the elution buffer. Typically, do 
not add more than 10-15mL of elution. 10-15mL is enough to retrieve all the protein of interested bound 
to the Ni-NTA resin. 10-15mL is enough for the pellets collected from 0.75-liter culture, for more amount 
of pellets, you may need more elution buffer. Never let the Ni-NTA resin/slurry run dry. 
 
1) Blank the spectrophotometer using the elution buffer. 
 
2) Elute your protein of interest in a single step by adding 10-15mL of elution buffer 




3) After adding 10-15mL elute buffer, close the cap of the column, this will stop the column follow 
and give enough time to the elute buffer to retrieve all possible Hist-tagged protein of interest 
from the Ni-NTA resin. Collect all the elutant in a brand new and ultra-clean nuclease free tube. 
 
4) Measure the absorbance at 280 nm and record this, along with the volume, to give us the overall 
yield. Also, print out the absorbance spectrum for your notebook, since this has information on 
the purity of protein (or, if it is co-purifying with any nucleic acid). 
 
5) Absorbance at 280 nm is important to measure the purity of the protein (against nucleic acids) as 
well as to figure out the amount of TEV protease that will be needed. 
 
5.2.14 Dialysis and obtaining Apo-Cas9 by utilizing TEV protease to remove Hist-Tag and MBP-
Tag 
As we discussed above that the protein was designed along with a maltose binding site (MBP Tag) which 
increases the solubility of the protein so that lot of it can retrieved from the cell pellet and be brought into 
the cell-lysate solution. After the purification of the protein, we must get rid of this maltose binding site in 
the protein. The way we had designed the original protein construct was that it had His-Tag-MBP-Tag-
TEV-Cas9. His-Tag for purification using Ni-NTA chromatography as performed above. MBP-Tag is for 
higher protein solubility. TEV is the protease site for the TEV protease, which will make the cut at the 
TEV protease site thus removing both the Hist-Tag and MBP-Tag from the rest of the protein i.e. Cas9 
sequence. 
 
1) Add the appropriate amount of TEV protease directly to the elutant containing protein of 
interest. Figure out the appropriate amount by using the absorbance 280 nm and thus the amount 




2) Prepare the TEV buffer as described in the materials section above. This is the buffer to which the 
elutant/elute obtained will be dialyzed to. 
 
3) After adding the TEV protease to the elutant, now transfer it to a dialysis cassette that can hold 
atleast 10mL of the solution. Be very careful in adding the solution/sample to the cassette, the 
cassette membranes are very gentle. Any damage/leak you introduce will lead to complete loss of 
your protein of interest. After adding the solution/sample to the cassette, double-triple check to 
make sure that there is no leak at all before adding it to the vast dialysis buffer. 
 
4) Make sure to suck out the air from the cassette, too much air reduces the surface area and will 
slow the dialysis process. 
 
5) Now drop the cassette into the TEV buffer. Make sure to use a floater so that casette can be 
floated and it does not drop down to the bottom of the giant dialysis solution. Then, it will be 
difficult to retrieve the cassette afterwards. 
 
6) A reminder again that all of these steps must be taking place in the cold room at 4 0C. 
 
7) Do the dialysis of the protein sample in TEV buffer for at least 6 hours in cold room at 40C to 
remove excess NaCl, Imidazole and everything other than protein of protein of interest i.e. Cas9. 
During the dialysis, the TEV protease will cut out the MBP site from your protein of interest 
leaving Apo-Cas9. 
 
8) It is critical that this dialysis not proceed longer, as Cas9 is not very soluble at low salt and can 
precipitate with prolonged incubation. The disadvantage of raising the salt concentration is that 
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Cas9 will no longer bind the SP column efficiently (i.e. FPLC steps). 
 
9) Retrieve the dialysis cassette and slowly aspirate out the sample/solution inside the cassette. This 
solution now has the following cleaved Apo-Cas9 without His-Tag and MBP tag, fusion of His-
Tag-MBP-Tag, and TEV protease. Commonly used TEV protease have a His-tag in it as well. So, 
all the components (except our desired Apo-Cas9) has the Hist-Tag. Therefore, this can be used 
to separate Apo-Cas9 from other unwanted components. Add a small amount of Ni-NTA resin 
again to this sample and run it through another fresh and ultra-clean column. This time, collect 
the wash/flow through, because the wash/flow through contains desired Apo-Cas9. All other 
unwanted components will be stuck in the column in the Ni-NTA resin. 
 
10) The retrieved flow through is now ready for further FPLC purification steps. Please carry them 




5.3 IN VITRO TRANSCRIPTION AND PURIFICATION OF RNA 
5.3.1 Introduction 
Chemically synthesized RNAs are extremely expensive to buy. If you are not looking for any special 
modification, you should almost always in vitro transcribe the RNA instead. You can make any amount 
of RNA from a much cheaper DNA template and you can keep making more should you need more. 
 
5.3.2 Materials 
• DNA template oligo which depends on the RNA sequence you want to transcribe. 
• T7 oligo which is the same for all RNA that you want to transcribe.  
T7 oligo =5'-TAATACGACTCACTATA-3'. Hybridization of DNA template oligo and T7 oligo 
produces the DNA template. 
• HiScribe™ T7 Quick High Yield RNA Synthesis Kit  
• Zymos RNA Clean & Concentrator™-25  
• T50 buffer (20mM Tris- HCl, pH 8.0 and 50mM NaCl). 
• Ultra-Centrifuge. 
• DNase I (RNase-free) from New England Biolabs (NEB). 
• E-Gel™ EX Agarose Gels, 4% 
• E-Gel machine  
• Do not use any component which is not certified nuclease free. 
 
5.3.3 Procedure 
Schematic of the DNA template and the RNA it transcribes. Please take a look at this carefully. We already 





Figure 5.1 | Schematic of DNA template for invitro transcription 
 
 






Figure 5.2 | Importance of C/CC at +1 and +2 sites for high efficiency invitro transcription 
 
5.3.4 Preparation of partial dsDNA template for invitro transcription 
1) Mix the DNA template oligo and T7 oligo in 1:1 ratio at 10µM concentration in a T50 buffer 
(20mM Tris- HCl, pH 8 and 50mM NaCl). 
 
2) Heat the mixture at 95 0C for 2 minutes and let it cool down slowly to the room temperature over 




3) 10 uM of the partial dsDNA template is now ready for use in the invitro transcription reaction.  
 
5.3.5 Setting up the invitro transcription reaction 
1) Add the required components in exactly the following order: 
Nuclease-free water                               x µl 
rNTP Buffer Mix                                  10 µl  
Template DNA                                      y µl (1 µg) 
T7 RNA Polymerase Mix                     2 µl 
 
Use only the components/samples from the same HiScribe Kit. Do not use rNTP from other kit. 
Different manufactures keep their components in different buffer and different concentration. 
You never want to mix stuff from different kits for any experiments. 
 
2) Choose x such that the total reaction volume is 30µL if the RNA transcript < 0.3kb. If the RNA 
transcript >0.3kb, then the total reaction volume needs to be 20µL. 
 
3) Mix thoroughly and Incubate at 37 °C. Incubate at 37°C for 4 hrs if the length of the RNA 
transcript < 0.3kb. Incubate at 37 °C for 2 hrs if the length of the RNA transcript > 0.3kb. The 
timing is especially critical if the RNA > 0.3 kB. 
 
4) After the incubation, the RNA is ready. It now needs to be purified. We also need to use DNAse 
to chop off the DNA template. Please note that the concentration/amount of DNA template << 
RNA transcribed, so for many applications, it may not be overtly important to get rid of the DNA 




5.3.6 DNAse treatment to degrade the partial dsDNA template  
The reaction is quite viscous from all the RNA that has been transcribed. We need to dilute it first by 
adding 30 μl nuclease-free water to the 20 μl reaction. Then add 2 μl of DNase I (RNase-free, supplied by 
NEB), mix and incubate for 15 minutes at 37°C. Use only the DNAse I from NEB if you are following 
this protocol. 
 
5.3.7 Purification of the RNA 
1) The total volume of the solution containing the transcribed RNA along with tons of rNTP is 50 
µL. 
 
2) Now we will proceed to use Zymos RNA Clean & Concentrator™-25 for purifying the RNA. 
 
3) Add 2 volumes (2 × 50µL in this case) RNA Binding Buffer to the sample and mix. Total volume 
is now 150µL. 
 
4) Add an equal volume,150 µL in this case, of pure ethanol and mix. 
 
5) Transfer the sample to the Zymo-Spin™ IIC Column in a Collection Tube and centrifuge for 30 
seconds. Discard the flow-through. 
 
6) Add 400µL RNA Prep Buffer to the column and centrifuge for 30 seconds. Discard the flow-
through. 
 





8) Add 400µL RNA Wash Buffer to the column and centrifuge for 2 minutes to ensure complete 
removal of the wash buffer. 
 
9) Transfer the column carefully into an RNase free tube. 
 
10) Elution. Add 50 µL T50 buffer directly to the center of the column matrix and centrifuge for 30 
seconds. The desired transcribed RNA will be eluted in this T50 buffer. The efficiency of this 
column in removing small molecules like rNTP is pretty high. 99% of the rNTP must have been 
removed and you would have a very pure RNA in the T50 buffer which can be stored in -80C for 
long term storage.  
 
11) To further remove small amounts of possible residual rNTP and obtain even ultra-pure RNA. I 
generally do the same Zymos column purification again using new columns and tubes. So repeat 
the section 6.6.7 again and that should give you an ultra-pure RNA sample stock. 
 
Measure the concentration of the RNA in the Nanodrop using the absorbance at 260nm. You can 
measure the extinction coefficient of the RNA using any of the online tools available like IDT 
OligoAnalyzer. 
 
Do not add Magnesium ions to any RNA stock for long term storage. Nuclease contaminants 
need Magnesium ions to function and by denying them that you are protecting your RNA from 
possible nuclease contamination activity. But the only source of nuclease contamination is you 
and your mistakes. Do not use any component which is not certified nuclease free. 
 
You can also use PAGE to purify the RNA. PAGE involves working with more buffers and other 
components and involves heating. It could be deleterious to subject RNA to such conditions. I 
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personally prefer using the Zymos RNA concentrator kit for RNA purification. Please note that 
RNA degradation can not only be caused by the nuclease contaminants but also chemical 
contaminants.  
 
5.3.8 Checking the integrity of the RNA  
1) The easiest way to check if you have the right size and fully integral RNA, just use a pre-cast 4% 
Agarose gel (E-Gel™ EX) (or 2% depending on the length of the RNA).  
 
2) Load 4µL of the purified RNA into one of the lanes. Put RNA ladder into the other lanes or any 
other reference RNA you might have. 
 
3) Run the Gel in the E-Gel™ machine. The Gel is pre-mixed with the SYBR Gold for the staining 
of the nucleic acids, so you will be able to visualize the RNA. 
 
4) Visualize the RNA bands post electrophoresis. How does it compare to the ladder? Most RNA 
will atleast show two bands because this is the native gel and RNA generally exists in a folding 
equilibrium between two states. Do not be worried about 2 states, they are likely the two states of 
the same RNA. You can run a denaturing gel to confirm this. But the main point of the native gel 
was to make sure that your RNA is there and has not been degraded. If the RNA is degraded, then 







5.4 NHS ESTER LABELING OF NUCLEIC ACIDS WITH FLUORESCENT LABELS 
N-Hydroxysuccinimide (NHS) is an organic compound with the formula C4H5NO3. NHS reacts with 
carboxylic acids to form NHS-Ester linkage which provide for an excellent and easy chemical linkage 
platform that are widely used in Biochemistry and Molecular biology for labeling purposes. Please see the 
reaction-schematic diagram below. 
 
5.4.1 Materials 
• Anhydrous Dimethyl sulfoxide (DMSO) 
• DNA (or RNA) sample with reactive amine group at the desired labeling location. 
• Dyes (monofunctional NHS ester form i.e. Dyes with NHS ester linkage as described in the 
diagram below. R in the diagram below is the Dye. 
o Alexa and other dyes (Invitrogen) 
o Cy3 (GE Healthcare PA13101) 
o Cy5 (GE Healthcare PA15101) 
o Cy5.5 (GE Healthcare PA15601) 
o or can be anything that you want conjugate onto the RNA/DNA. 
• Ethanol (cold). 
• Labeling Buffer (pH 8.5). Dissolve 384mg of sodium tetraborate (Borax) in 10mL of nuclease 
free dH2O (for a final concentration of 0.1M). Add 65µL of 12.1M HCl or equivalent to bring the 
pH to 8.5. Prepare fresh before use. Please see below about the exact formula and specs of the 
chemical required. pH is extremely important. So please double check the pH. We will see below 
why it is so important. 
• 3M Sodium Chloride Solution. 
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• Nuclease free dH2O. Nuclease acids are very sensitive to any nuclease contamination. Please be 
sure to use ultra-pure chemicals (NaCl, DMSO, dyes) for use. The dH20 being used should also 
be a certified nuclease free dH20. 
• Equipments: 
o Centrifuge 




Reaction-schematic. R here is any dye that you want to conjugate on your DNA/RNA. P is any 
DNA/RNA that you want to label with the dye of choice (R). P i.e. DNA/RNA needs to have a reactive 
amine group at the desired labeling location. pH is very important for the efficiency of this reaction, 
which we will look at more details later.  
 
Figure 5.3 | Schematic describing the reaction between NHS ester reagent (conjugated to 
fluorophore R) with the –NH2 group in the nucleic acid or other target of interest. 
For nucleic acids, we typically use an internally modified thymine for labeling. As seen below, you will 
see that the thymine base is modified to have a reaction amine (NH2) group. So the molecule P-NH2 in the 
reaction schematic above is the nucleic acid molecule below. More details and references at: 
http://www.valuegene.com/site/Catalog/Modifications/Product/1388 
For Integrated DNA technology (IDT) orders: For 3' and 5' ends of the nucleic acids, a different thymine 




Figure 5.4 | -NH2 (amine) group present in the modified thymine. 
Reference for the figure: https://www.idtdna.com/site/Catalog/Modifications/Product/1388 
 
The commercial dyes typically come in tubes containing 1mg of dye in solid form. Add 56µL of DMSO 
(∼20 mM) to the entire tube containing 1mg of dye. You would not need the whole 1mg dye (now in 
DMSO solution for a single experiment). But it is extremely difficult to take out <1mg of dye out from 
this tube and weigh it accurately. Hence the best solution is to add 56µL of DMSO to 1mg of dye and 
then use small aliquots of DMSO dissolved dye for your labeling reaction. As soon as you add DMSO to 
the dye, take out the required amount for your labeling reaction and store the rest of DMSO dissolved dye 
solution at -80 °C, you can make aliquots if you like. The dye is not super stable in the solution at the 
room temperature, so you should quickly put it in -80°C and never keep the dyes dissolved in the DMSO 
solution at room temperature for too long. Some people take the dye aliquots (dye dissolved in DMSO) 
and dry them for long term storage. If you dry it out for too long at room temperature, in my opinion this 
could do more harm than good. The reason is that over-exposue to the atmospheric humidity will lead to 
the hydrolysis of the ester (dye is conjugated to an ester) and reduce the quality. So you have to take the 




1) In an Eppendorf tube, add 5µL of dye in DMSO. 
 
2) To the above tube, add 27.5µL of freshly prepared labeling buffer (pH 8.5). 
pH of this labeling buffer is extremely important, hence double check the pH before adding this to the 
tube containing dye dissolved in DMSO. A high pH enhances the acylation rate; however, it also 
increases the hydrolysis of the esters. The addition of acyl group (shown below in green) is called 
acylation. Our labeling reaction is an acylation reaction i.e. the addition of the acyl group where the R 
is the dye or any molecule of interest. So high pH enhances the rate of this reaction but it comes at a 
pretty bad cost i.e. the ester themselves get hydrolyzed quicker at higher pH conditions. NHS esters 
half-life is few minutes at pH>8.6. See below. So a right balance of pH is an absolute must for the 
success of this experiment and pH 8.5 is the most optimum pH for the high efficiency of the labeling. 
 
Figure 5.5 | Hydrolysis of the ester. 
 
3) Add 2.5/2µL of 1mM DNA or equivalent (~2.5/2nmol total). 
 
4) This composition results in about 40/50 dye molecules for each reactive amine group 





5) Some protocols suggest to use 20:1 ratio for the dye to DNA/RNA. I have found that, for such 
compositions, the labeling efficiency is ~80%. So if you want a near 100% labeling efficiency, I 
would use the 40:1 or 50 :1 dye to DNA ratio. For single molecule experiments, the amount of 
DNA/RNA that we require is fairly little. So the better way to achieve a higher Dye to DNA ratio 
is to reduce the amount of DNA/RNA in the labeling reaction instead of using more dyes. Dyes 
are pretty expensive and one successful labeling reaction should be enough for many replicates of 
single molecule experiments. 
 
6) Cover the tube with aluminum foil to restrict any stray light exposure for the dye molecules. 
 
7) Incubate the mixture for 6 hours at room temperature with gentle mixing. Some protocols would 
also suggest overnight at 4°C with gentle mixing in the dark. Room temperature is the 
best, 4°C incubation may result in lower labeling efficiency, even if done for longer hours. 
 
 
5.4.3 Purifying the labeled nucleic acids from the labeling reaction 
1) Add 87.5µL of ethanol and 3.5µL of 3 M NaCl to the mixture and keep it at −80 °C for 30 min. 
Salt is added to help with the ethanol precipitation of the nucleic acids. Read more here at : 
http://physiology.med.cornell.edu/faculty/mason/lab/zumbo/files/ETHANOL_PRECIPITATION.
pdf. Some people put the labeling reaction (after addition of ethanol and salt) at 4 degrees for 
slow precipitation. In my opinion, this could be a bad step and may influence the quality of the 
dyes for experiments. 30 minutes at -80C is more than enough. Infact, you will see the nucleic 
acid being precipitated out as soon as you add ethanol, when you spin the reaction in a centrifuge. 




2) Centrifuge at 14,000g for 30 min at 4 °C. The DNA or RNA will have pelleted at the bottom of 
the tube. The pellet will be colored. 
 
3) Remove the supernatant carefully and rinse the pellet with cold ethanol several times very gently. 
Make sure to not disturb the pellet. Multiple such steps will lead to the wash of all the free dyes 
from the solution. Some people prefer to use spin columns like P6 or P30 to remove the free dyes. 
In my opinion, those are not needed. The disadvantage of using spin columns to remove free dyes 
is that they will also lead to a considerable loss of your labeled nucleic acids as well. The 
procedure described above will guarantee a very high efficiency of the removal of free dyes. 
 
4) Dry the labeled nucleic acid pellet to evaporate the ethanol. 
 
5) Dissolve the pellet in an appropriate buffer solution. 20mM Tris HCl (pH 8.0) and 50mM NaCl 
buffer is perfect for this. Be sure to use nuclease free buffers for all the purposes. 
 
6) Check the labeling efficiency by comparing the absorption spectra of the nucleic acid (260 nm) 
and the conjugated dye. Typically, it is close to 100%. If not, run an additional purification such 













5.5 CYSTEINE MALEIMIDE LABELING OF PROTEINS WITH FLUORESCENT LABELS 
This protocol is valid for any protein with cysteine in it that needs to be labeled with a molecule of 
interest containing the Maleimide linkage. The thiols or sulfhydryl present in the Cysteine amino acid 
residues of the proteins can be used for site-specific labeling. The labeling reaction schematic is described 
below. 
5.5.1 Materials 
• Protein of interest (at < 10µM concentration) to be labeled in buffer containing (20mMTris-Cl pH 
7.5, 200mM KCl, 5% glycerol, 1mM TCEP). This is a fairly regular buffer, most proteins that we 
use for biophysical experiments should be stable and well behaved in this condition. When you 
are HPLC/FPLC purifying the protein, it would be best to purify it out in this buffer so that 
protein can be directly used for labeling. Any component like DTT or BME should be totally 
avoided in the protein buffer. Because they contain -SH group which will compete away all the 
available Maleimide reagent. TCEP does not have any -thiol (-SH) group so it is fine. 
• Anhydrous DMSO. 
• Molecule of interest with Maleimide functional group that needs to be conjugated to the protein. 
R in the schematic below. 
 
Figure 5.6 | Schematic describing the reaction between Maleimide reagent (conjugated to 






1) The molecule of interest with Maleimide functional group (R /the dye) would mostly likely be 
supplied as a dried anhydrous powder. Please keep it away from moisture and humidity as much 
as possible, as the humidity can hydrolyze the Maleimide functional group. 
 
2) Mix the molecule of interest with Maleimide functional group in Anhydrous DMSO so that its 
concentration is 10mM. 
 
3) Typically, the amount of supplied R will be very less i.e. 1 -2mg. It is hard to scoop out 
and accurately measure small amount of R from such a stock. The best way is to add n µL of 
anhydrous DMSO to it so that its final concentration = 10mM. And store this stock in -80 °C for 
long term storage. 
 
4) After adding the n µL of the anhydrous DMSO, mix very well. DMSO is an excellent dissolving 
agent and will dissolve all the R. Be sure that all the R has completely dissolved. 
 
5) Now you can use x µL of the R dissolved in anhydrous DMSO for any number of future labeling 
reactions. 
 
6) In an Eppendorf tube (1.5mL), take 24.5 µL of the protein of interest (<10µM; preferably 4 
µM concentration) in the buffer with 20mM Tris-Cl pH 7.5, 200mM KCl, 5% glycerol, 1mM 
TCEP. 
 




8) This will produce a labeling reaction of the following conditions: 
o [Protein of interest to be labeled] = 4µM 
o [R]= 200µM. 
o Buffer conditions = 20mM Tris-Cl pH 7.5, 200mM KCl, 5% glycerol, 1mM TCEP 
o % Anhydrous DMSO in labeling reaction solution = 2% 
 
Anhydrous DMSO in labeling reaction solution should not exceed 5% at any cost, for it can affect the 
protein. Moreover, it can be deleterious for the downstream applications because if you directly use the 
protein from this labeling reaction, your downstream experiments will end up having a small amount of 
DMSO in the reaction solutions. 
 
The Maleimide reaction is most effective at the pH 6.5-7.5. This is on the lower side; most proteins may 
not be at their 'happiest' in this pH range. The best solution is to do the reaction at the pH 7.5. That is why 
it was recommended to keep the protein in the buffer which has 20mM Tris-Cl pH 7.5, 200mM KCl, 5% 
glycerol, 1mMTCEP. 
 
9) Incubate the reaction in the dark for 2 hours at the room temperature (~23-25 °C). Following this, 
incubate the reaction at 4 °C  (like cold room) in dark for another 8-10 hrs. 
 
10) Optional. Reactions can be quenched adding x µL of 0.5M DTT so that its final concentration in 
the reaction solution = 10mM. DTT also has -SH group so such a high concentration of DTT will 
compete away all the Maleimide reagent away from the -SH site in the protein of interest. 
 
I would not add DTT for quenching. Infact, I don't think quenching is particularly required. You can let 
the reaction solution as it is and directly use for your experiments. DTT causes severe problems for single 
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molecule fluorescence experiments, hence I will totally avoid it. 
 
Any component like DTT or BME should be totally avoided in the reaction mixture. Because they contain 
-SH group and will compete away all the available Maleimide reagent. TCEP does not have any -thiol (-
SH) group so it is fine. 
 
5.5.3 Purifying the labeled protein from free R or dyes 
The purification depends on the experiments you want to do. In majority of experiments, the protein will 
be immobilized on the surface and the free protein (along with excess dyes) will be washed out. So I do 
not need to worry about free dyes interfering as a background etc. But if you must purify out the labeled 
protein from the free R (or dyes). You can do HPLC/FPLC and even easier solution would be to use a 
dialysis membrane. The protein of interest will remain inside the membrane while the free dyes/R will 
diffuse out the membrane into the large reservoir. This can also be a good way, should you need to 
exchange your protein into a different buffer. But all these purification procedures require that you have 
atleast 1mL of the reaction solution for small amounts are hard to run through these procedures. So you 
can prepare labeling reaction at a much higher volume or dilute the sample for purification. 
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5.6 PEGYLATION PROTOCOL 
5.6.1 Introduction 
For TIR or any microscopy, clean and a fully passivated surface i.e. passive to any non-specific binding 
so that only specifically bound molecules (labeled with fluorophores) can be visualized. Polyethylene 
Glycol (PEG) is a polymer that has been well studied and established to be a powerful repellent for any 
non-specific binding (especially of proteins) and nucleic acids to some extent. The two most commonly 
attributed reasons are:  
Physical: PEG polymer create a globular mesh around itself thus masking the surface it is attached to it 
and preventing any non-specific binding. It itself is a hydrophobic polymer and the biomolecules in the 
aqueous solution largely have hydrophilic surfaces exposed (for better interaction with the water). This 
hydrophilic-hydrophobic anti-match is one of the reasons why proteins do not interact with PEG directly 
that well. Chemical, which have been previously described in details141-144. 
 
But achieving a high quality and clean PEG surface is not trivial. In this protocol, I will go over the 
detailed protocol and go over some key points which are critical for achieving a high quality PEG and 




• mPEG SVA : This is the PEG polymer that will be grafted onto the slides and coverslips. 
• Biotin PEG SVA : The PEG polymer above will be doped with this PEG which has a Biotin on 
its end. The Biotin-Neutravidin interaction is used for the specific immobilization of desired 
molecules on the surface. 
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• Coverslips: Preferably 24*40 mm size. 24*50mm will be good as well. Longer ones may have 
trouble fitting well into the holder in the microscope. Coverslips cannot be reused. Always take 
out new ones for new batch of PEGylation. 
• Quartz slides: Quartz slides are better than glass. Because they have less 'impurities' and thus 
cause slightly lower background levels in images. But Quartz is more expensive that glass. 22$ 
per piece. You should reuse the Quartz slides. 
• Acetone. Purer the better. 
• Methanol. Purer the better. 
• Sodium Bicarbonate. 
• dH20. 
• Amino silane. 
• 4M KOH solution. Purer the better. 
• Propane flame for burning the slides and the coverslips. 
 
5.6.3 Procedure 
The schematic shown below is the full chemical schematic of the PEG protocol. It is broadly classified 
into 4 steps which are Cleaning, Introduction of -OH group and etching via KOH, Amino-silanization, 





Figure 5.7 | Complete chemical schematic of the PEGylation protocol 
 
5.6.3.1 Cleaning 
Please do not make more than 5 slides at once. We are tempted to make >5 slides in one go, thinking that 
they will be used for many long term experiments. But managing >5 slides can be difficult and takes time 
and bring the quality of slides down. You must be wearing and regularly changing the gloves all the time 
during this entire process. 
1) Cleaning with Acetone dipped lens tissue paper. Take the fresh lens paper wipes and put acetone 
in it. Clean each of the slides with this acetone dipped lens tissue wipes thoroughly by rubbing the 
slides with these wipes. Use the razor to scrap out any unwanted dirt or epoxy or any other in the 
slide. Folling which, cleane them with acetone dipped lens tissue paper once again. You can use 
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KimWipes instead of lens tissue paper, but they will introduce scratches in the slide. 
 
2) Place the slides in a glass staining jar. 
 
3) Now take out 6 cover slips. Preferred size 24 x 40 mm or 24 x 50 mm. If you use longer 
coverslips, it may prevent the slide-coverslip chimera to fit into the microscope holders. So 
double check. Put these cover slips into the glass staining jar. 
 
4) Cleaning with dH20: Rinse the slides and coverslips with MilliQ H2O. Repeat it 3 times. 
 
5) Now sonicate the slides and coverslips with MilliQ H2O for 20 min to remove the remaining dirt. 
Dispose the water and rinse the slides and coverslips 3 times again with MilliQ H2O. 
 
6) Optional. At this stage, sometime I prefer to let the slides and coverslips soak in water overnight 
and begin the subsequent steps the next day. 
 
7) Cleaning with acetone. Replace the MilliQ dH2O with acetone in the jar containing slides and 
coverslips. Sonicate them with acetone for 20-30 min. 
 
8) Cleaning with methanol. Replace the acetone with methanol in the jar containing slides and 
coverslips. Sonicate them with methanol for 20-30 min. 
 
9) Rinsing with dH2O. Discard the methanol and rinse the slides with MilliQ dH2O. Repeat it for 2 
times in order to remove any methanol residue. The acetone and methanol must not be discarded 
into the sink. In every lab, there must be separate waste bottles for the acetone and methanol 




Why does sonication help in cleaning? Sonication causes lot of agitation. This agitation forces the 
contaminants to break free from the surface it is attached to. This agitation also forces the water 
molecules through narrow openings and holes thus efficiently cleaning them. 
Why methanol and acetone are used? These solvents help in dissolving out the contaminants and 
impurities from the slides and coverslips which might not have dissolved well with the water. 
 
10) Burning. Start the propane flame and use tweezers etc. to burn both slides of the slides. Burn each 
surface completely for about 1-2 minutes. Burn well near the holes in the slides. The burning will 
further get rid of contaminants. 
Burning coverslips will be far more difficult, they are extremely thin and brittle. Over burning 
will quickly break them. So be very careful in limiting the duration of the flame over the 
coverslips. Please do not exceed 1-2 seconds and burn the coverslips in 3 repeats, each lasting 1-2 
seconds. Burn both the sides of the coverslips. 
 
5.6.3.2 Introduction of –OH group and etching via KOH 
1) Put the slides and the coverslips in a glass staining jar and add 4M KOH to it. 
 
2) Sonicate for 20-30 minutes. KOH etches the surface of the slides and coverslips. This etching 
process produces large number of hydroxyl (-OH) group on the slides and coverslips as shown in 
Figure 5.7. It is extremely important that the slides and coverslips be not subjected to any more 
burning or cleaning process after KOH etching. The –OH groups can be destroyed by such 
processes.  
 
3) Rinse the slides and coverslips with dH2O for 2 times to remove traces of KOH. Any trace of 




4) Rinse the slides and coverslips with methanol for 2 times to remove traces of dH2O. Any trace of 
dH2O will interfere with downstream PEGylation steps, for e.g. Aminosilanization. 
 
5) Let the slides and coverslips be immersed in methanol. 
 
5.6.3.3 Aminosilanization 
The process of covalent addition of a silane with an amine (-NH2) is called Aminosilanization. This 
reaction for slides and coverslips is shown in Figure 5.7. 
 
1) Take out an ultra-clean and dry 500 mL flask. It must be devoid of any traces of dH2O.  
 
2) Add methanol solution to it and just sonicate the flask with methanol in it for 20 minutes. Discard 
the methanol 
 
3) Add 200 mL of 100% anhydrous methanol to it. 200 mL is the right amount for 5 slides. For 
more or less number of slides, you have to scale accordingly. 
 
4) Add 10 ml of Glacial Acetic acid. Please do not use plastic pipette tips for transferring Glacial 
Acetic acid as it reacts with plastic creating unwanted products. Use a glass pipette (for e.g. 
Pasteur pipettes) for this. 
 




6) Mix the above solutions well. Avoid any water in the solution. The Aminosilanization reaction 
solution is now ready. 
 
7) Remove methanol from the glass jar containing the slides and coverslips.  
 
8) Now add Aminosilanization reaction solution into the glass staining jar containing slides and the 
coverslips. 
 
9) Incubate the jar with Aminosilanization reaction solution for 30-35 minutes. No sonication or 
ultra-mixing is recommended at this stage.  
1) Wash the slides and coverslips with copious amounts of MilliQ dH20.A common mistake people 
at this stage is that they do not clean the slides/coverslips well enough at this step. Any amount of 
residual Aminosilane left in the solution or on the slides/coverslips will be a chemical target for 
the PEG polymer you are trying to conjugate. But you want them conjugated only on the silane 
groups on the slides/coverslips and not on the free flowing ones. So please clean the 
slides/coverslips with copious amounts of water. 
5.6.3.4 Final PEGylation 
1) Take 84 mg of Sodium Bicarbonate and mix it in 10 mL MilliQ dH20 to get 0.1 M Sodium 
Bicarbonate solution. 
 
2) Take 5 (slides) × 70 µL = 350 µL of the above solution for making the final PEG reaction 
solution. 
 
3) Add ~160-200 mg of mPEG-SVA to 350 µL of the solution above. Please note that different 
versions of mPEG are commercially available and do not use the incorrect mPEG and use mPEG-
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SVA. The incorrect mPEG may not have the functional group necessary for the required reaction 
so everything will be a waste. Please double check to make sure it is mPEG-SVA. 
 
4) Dope the above solution with ~2-5 mg of Biotin-PEG-SVA. Please double check to make sure 
that this is the right Biotin-PEG polymer.  
 
5) Mix the above very well and centrifuge them in 4,000g for 2 minutes. 
 
6) Put the slides in chamber with tons of water beneath/around it to make sure that things stay 
hydrated. PEGylation efficiency is poor in dry and non-humid environment. An easy way of 
making a hydrated chamber is to use the old pipette tip boxes. Fill the tip box with MilliQ dH20 
and add tips to it. And position the slides onto the tips.  
 
7) Now add 70 µL of the PEG reaction solution to each quartz slide and put a single coverslip on 
each one of them. 
Close the lid of chamber and place them in the dark for incubation. Please check from time to 
time to make sure that the slides and coverslips are perfectly horizontal. Even if they are slightly 
titled, the PEG reaction solution will slowly drip out, rendering the entire region dry without any 
PEG for PEGylation of the surface. This is a very common mistake, please avoid it. The PEG 
slides may also get stuck in the top/roof of the tip box so please keep a check to make sure that 
the slides and coverslips are oriented in the right away in the tip boxes for the PEGylation 
reaction. 
 
8) The PEG reaction is almost over in 4 hrs. So please do incubate the slides for more than 4-4.5 
hours. Beyond this time, the PEG coating on your surface is largely degrading. In some ways, 
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over-incubation is equivalent to putting PEGylated slides on the room temperature for n hrs, n 
being the number of hours after 4-4.5 hours incubation.  
 
9) Clean the slides with copious amount of water. Under cleaning the slides is another common 
mistake. Please think of it this way, this is the last chance you will get to clean the slides before 
your experiments so clean the slides with copious amount of MilliQ dH20, otherwise your surface 
may substantial auto fluorescent junk which will interfere with your experiments. 
 
10) Dry the slides and coverslips with Nitrogen and Mark the Un-PEGylated sides of the coverslips 
and slides with ‘N’.  
 
11) Put each pair of coverslip and slide into a falcon tube with their PEGylated sides facing outward.  
 
12) Put each falcon tube, with partially closed caps, into a food saver bag and vacuum seal them. 
 





5.7 A VERSATILE PROTOCOL FOR SINGLE MOLECULE FRET EXPERIMENT USING 
CRISPR ENZYMES 
 
5.7.1 Introduction  
The protocol presented below has been written for smFRET experiments to investigate DNA 
interrogation by Cas9-RNA. But the protocol is broadly applicable for other CRISPR enzymes, DNA 
targets and experiments that investigate DNA unwinding etc. The goal of the protocol is to inform critical 
aspects of performing single molecule fluorescent experiments to investigate CRISPR toolbox. We use an 
in-house built software called smCamera for movie acquisition and data analysis. The software is 
available for download at https://cplc.illinois.edu/software/ 
 
5.7.2 Materials 
• PEGylated quartz slides and coverslips. Please make sure they have been made to the highest 
possible quality.  
• All the components involved in these experiments must be certified RNAse/DNAse free 
components.  
• Basic salts needed for making various buffers. Double check that you have all of them. Prior to 
starting any CRISPR experiments, remake all your buffers using certified RNAse/DNAse free 
components. Store them in an ultra-clean space to avoid contamination. These experiments use 
RNA, which are very sensitive to degradation, therefore experiments can suffer a lot if you do not 
keep everything super clean and free of nuclease contamination. 
• DNA or CRISPR enzyme or RNA substrates labeled with fluorophores for smfluorescence or 
smFRET and biotin for surface immobilization. 
• CRISPR protein. These must be the highest quality and should be in the aliquots stored at -80 0C. 
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• Guide-RNA. This will be a chimera of tracrRNA and crRNA (Cy5; acceptor labeled) pre-mixed 
in aliquots stored at -80 0C. 
• Cas9-RNA imaging buffer recipe. Please note that this buffer is without gloxy, we will add gloxy 
right before the imaging. 
o 2 × 20µL of 1M Tris-HCl, pH 8.0 (20mM Tris-HCl, final concentration) 
o 2 × 33.3µL of 3M KCl (100mM KCl) 
o 2 × 10µL of 0.5M MgCl2 (5mM MgCl2) 
o 2 × 50µL 100% Glycerol (5% v/v glycerol) 
o 2 × 10µL NEB Bovine Serum Albumin (BSA) stock (0.2mg/mL BSA) 
o 2 × 875µL of Saturated Trolox+ glucose solution (recipe below) 
o Total = 2 tubes of 1000µL each. 1-2 tubes will be required per set of experiment. 
 
I like to use a single buffer for all of the steps of the experiments including Neutravidin 
immobilization, DNA immobilization, adding Cas9-RNA etc. I do all of this in a single buffer 
i.e. this Cas9-RNA imaging buffer. Hence we have made 2mL of it, which should be enough 
for a single set of experiments (i.e. 5-6 channels). I do not like to juggle around between 
different kinds of buffers while doing experiments. Moreover, it is best to treat everything i.e. 
the surface, DNA only etc. with a single buffer to avoid any artifact of other buffers. 
 
• Saturated Trolox+ glucose solution recipe. To 10mL of dH20 add the following: 
o 15mg of Trolox powder. 
o 80mg of Glucose powder 
o 10µL of 5M NaOH 
o Mix at room temperature in a gentle shaker. DO NOT cover it in aluminum foil, this is a 
common mistake people make. The Trolox requires initial light activation when it is being 
mixed in the water. After ~8-10hrs of mixing, then be sure to cover it in the aluminum foil 
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and keep it in 4 0C or -20 0C. Lasts about 7 days in 4 0C and much longer in -20 0C. 
 
5.7.3 Procedure 
Glove Policy. It is also important to keep changing gloves. While working, gloves will accrue all sorts of 
bad contaminants which can then end up in your samples. So keep changing glove every few minutes 
while working. Extra gloves are worth nothing as compared to the quality of good experiments, your time 
and efforts, so please do not mind using extra gloves. 
5.7.4 Preparing the chambers for smFRET experiments 
1) Assemble the PEG slides as per the conventional protocol described previously89. No touching 
the slides with bare hands i.e. without gloves. Hands have tons of nucleases (commonly referred 
to as fingerases) and they can degrade your sample so please avoid that. None of what you do 
should be without gloves. Please check out the glove policy. 
 
2) Do 5-6 chamber worth of experiments in a single microscope use. 5-6 is the most optimum 
number, trying to do more is bad because the latter experiments can lose quality. Doing only 1-2 
chamber is not worth the effort of setting up the whole experiment. Moreover, I do not want to 
refreeze the slides after taking them out to room temperature. A single slide has 5-6 
channels/chamber so the idea is to use a single slide for 5-6 set of experiments (1 experiment per 
channel). 
 
3) After the slide has been assembled, add 30µL of Cas9-RNA imaging buffer to each channel. The 
BSA in this buffer will further passivate the surface against any residual non-specific binding 
possibilities. Incubate for ~3-5 minutes. This is an extremely important step. BSA must be 




4) Prepare a Neutravidin solution by mixing 1µL of Neutravidin stock (200 nM stock will suffice) 
with 100µL of Cas9-RNA imaging buffer. Keep the Neutravidin back to the public stock box. 
 
5) Now add 20µL of this diluted Neutravidin solution to each channel/chamber and incubate for 2 
minutes. 
 
6) Wash out the unbound Neutravidin with 40µL of Cas9-RNA imaging buffer for each channel. 
 
7) The slides are now ready for immobilization of biomolecules of interest. 
 
8) Put the slide in the microscope and arrange all the required optical components to achieve TIR 
condition. 
 
5.7.5 TIR Condition and TIR Spot 
Applicable if you are using PRISM based TIR microscope.  
1) Adjust the TIR (Total internal reflection) spot. The TIR spot must be a clean, regular, elliptical 
shaped blob in the middle. The TIR spot must be just the right size i.e. not too small and not too 
big. Too small would mean that the illuminating area will not fill the imaging area. Too big 
would mean that the intensity of the single molecule spots will be very low and would require 
high laser power and your TIR illumination will not be sharp. The TIR spots must be right size 
and right shape. Take your time in setting up the TIR spot, please do not rush.  
 
2) Once the right TIR spot has been achieved, move the slide around to make sure that the entire 





5.7.6 Immobilizing DNA target molecules on the surface 
Before putting the DNA molecules on the surface, decide on the identity of DNA target that you will be 
testing. As a good practice, it is important to put some DNA targets that we know will show high extent 
of Cas9-RNA binding (i.e. Cognate DNA target) and no stable binding (ones without PAM) The success 
of experiment, seen via stable high FRET for cognate DNA and no stable FRET for PAMless DNA, will 
be a good confirmation that the Cas9-RNA complex you have prepared is a high quality and active 
complex and that smFRET signal is due to specific binding. So for 5-6 channels, I would use the 
following set of DNA targets. Please refer to the chapter 2 for the naming of the DNA targets as shown 
below. 
o Channel 1: Cognate DNA target (0-0mm) 
o Channel 2: 13-20mm DNA target. 
o Channel 3: 8-20mm DNA target. 
o Channel 4: 5-20mm DNA target. 
o Channel 5: 1-20mm DNA target. 
o Channel 6: 1-20mmNOPAM DNA target. 
 
1) To a 100µL Cas9-RNA imaging buffer solution. Add 1 µL of the Gloxy and then add 0.2µL of 
the DNA from the 5nM stock. Add 20µL of this on a particular channel and immediately 
visualize the density on the surface. The density has to be just right, too less is bad and too much 
is even worse as it can result in multiple molecules for many fluorescent spots.  
 
2) The number of spots will continue to increase for up to 10 minutes, so if you have achieved 
optimal density per imaging area kind of density then, immediately flow out the remaining 




3) The above two steps are extremely critical, so please do them very well. Here's how you single 
molecule spots for a given imaging area should look like in our setup. The optimal density will be 
different for different setups, please determine this accordingly. 
 
Figure 5.8| Representative image of Cognate DNA target in Cas9-RNA imaging buffer.  
The spots on the donor channel (left channel) indicate Cy3 labeled DNA target molecules. Since there is 
no acceptor Cas9-RNA in solution, there are no ‘FRETing’ molecules on the acceptor channel (on the 
right). 
 
4) You can now immobilize DNA targets of different sequence on al1 or 2 more channels. In my 
opinion, it is best to get ready with DNA targets in 2-3 channels before adding Cas9-RNA and 
measuring binding. It also helps with the fact that you can now put all the DNA stocks back in the 
-80 0C and clean up your workspace/bench and focus totally on the next part. The idea is to do 
things step by step. i.e. whenever you are immobilizing DNA targets, do not even bring out Cas9 





5) Now when all the DNA targets are immobilized properly on the channels. Take a very small 
break, drink some water, catch some air and regain your focus. Now is the time to dwell into the 
main part. 
 
5.7.7 Preparation of Guide-RNA 
The guide-RNA can be stored as aliquots of hybridized-chimera consisting of crRNA and TracrRNA in 
T50 buffer (50 mM NaCl, 10mM Tris-HCl pH 8). Please do not store any RNA in a buffer that has 
Magnesium ions. Magnesium ions are required for nuclease activity, keeping the RNA storage buffer 
devoid of magnesium provides an extra insurance against the possible nuclease contamination activity. 
The crRNA is labeled with Cy5 for smFRET imaging. TracrRNA is unlabeled. The aliquot may contain 
2.5µL of 4µM guide RNA (i.e. 4µM of Cy5 labeled crRNA+ 5µM TracrRNA) in T50 buffer (10mM Tris-
HCl, pH 8.0 and 50mM NaCl). The guide-RNA is already annealed, so you can use it directly. This 
chimera of TracrRNA and crRNA is known as guide-RNA. RNA in Cas9-RNA refers to this guide-RNA. 
The crRNA;TracrRNA hybridized chimera is shown below. Also shown is the base pairing region 
between guide-RNA (crRNA;TracrRNA is referred to as guide-RNA, which then is referred to as RNA 




Figure 5.9 | FRET probe labeling locations in the Cas9-RNA-DNA complex. 
(a) Cy3 and Cy5 labeling locations shown in the crystal structure of Cas9-RNA bound to a cognate DNA 
target (PDB ID: 4UN3)65. The strand hybridized with the guide RNA to form the RNA-DNA 
heteroduplex is referred to as the target strand while the other strand, containing the PAM (5’-NGG-3’), is 
the non-target strand. (b) Schematic of a bound Cas9-RNA-DNA complex showing the base pairing 
between different components. The sequences shown in red denote the cognate sequence of the DNA 
target and the complementary guide sequence of the crRNA. The DNA sequence highlighted in light gray 
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5.7.8 Preparation of Cas9-RNA 
2) The Cas9 protein must be stored in aliquots at -80 0C. Preferably 2-3 µL of 4 uM concentration in 
Cas9 storage buffer (20mM Tris-HCl, 100mM KCl, 5mM MgCl2, 5 % v/v glycerol). 
 
3) Mix the 1µL of the annealed guide-RNA (4 uM stock) from with 2-3µL of Cas9 (4 uM stock) 
Total volume 4µL. 
 
4) Incubate them on ice for atleast 10-15 minutes. Cas9-RNA complex is made with 2:1 or 3:1 ratio 
between Cas9 and guide-RNA. KD of Cas9 and guide-RNA is extremely low at about 10 pM145. 
But excess of Cas9 is added to ensure near 100% complexation of acceptor labeled guide-RNA 
with Cas9. 
 
5) After incubation, Cas9-RNA complex labeled with Cy5 is now ready for use in the smFRET 
experiment. 
 
6) As reminder note of caution, I must warn that all the tubes, pipette tips, pipette and almost 
anything you are using to do this experiment must be certified RNAse/DNAse free. I thoroughly 
clean my pipettes with 70% Ethanol from time to time to make sure that they are not a breeding 
ground for contamination. 
 
7) The total volume of Cas9-RNA complex at this point is 4µL. Add 196µL of Cas9-RNA imaging 
buffer to this Cas9-RNA complex, this will bring the total volume of Cas9-RNA complex to 
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be 100µL with the concentration of Cas9-RNA at 20nMwhich is what we will use in the 
experiment. This Cas9-RNA is now ready to be added to the channels with DNA targets 
immobilized on them, but do not yet add Gloxy on them. Gloxy leads to drop in the drop in the 
pH problem, so Gloxy is to be added right before the actual imaging. 
 
8) Take 25µL of 20nM Cas9-RNA complex (from the 200µL stock prepared above) and 
add 0.3µL of relatively fresh stock of Gloxy. This is now ready to be added to a given channel. 
The remaining Cas9-RNA of the initial 200µL stock should still be sitting in the ice. 
 
9) Add the above ~25µL of 50nM of Cas9-RNA (labeled with Cy5) to a particular channel. Wait for 
~5-10 minutes for the reaction to reach equilibrium. Now you can begin single molecule imaging. 
Each channel must be imaged separately i.e. you add 25µL of 20nM of Cas9-RNA (supplemented 
with Gloxy, right before imaging) to a channel. Wait 10 minutes and then acquire all the movies 
for that channel and then proceed to the next channel, which till now should be sitting with just 
the DNA without any Cas9-RNA. 
 
10) As a reminder, Gloxy should be added to the mini 25µL sample as it is just about to be added to 
the channel for imaging. Do not add any Gloxy to original 200µL 50nM Cas9-RNA stock which 
should now be sitting in the ice. 
 
5.7.9 Single Molecule Imaging/Data Acquisition 
1) After waiting for about 10 minutes as mentioned before, begin the image acquisition. This is what 




Figure 5.10 | Representative image of Cognate DNA target (Cy3) incubated with 20nM Cas9-RNA 
complex (Cy5). The Spots on the right indicate FRETing molecules which indicate the interaction 
between DNA (with Cy3) and Cas9-RNA (with Cy5) bound to the DNA target. 
 
2) Please check the following: 
o Density of the spots. 
o Intensity of the spots. Intensity is about 10% less than what I think would be ideal, so you 
might want to use slightly higher laser power. But these parameters are highly dependent on 
your instrument, the gain (I always work at near maximum gain) of your camera. So you 
should use laser power that gives good signal to noise ratio and enables fairly long duration 
of detection prior to photobleaching. 
o Constant and uniform illumination of the entire imaging area, if the TIRF spot is not ideal, 
you will not get this and such experiment will be a waste. So please make sure that you have 
the right TIRF spot. 
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o Check the Gain value. I like to max it so that I get the highest possible signal for a given laser 
power. Allows you to get good intensity while still not having to use very high laser power. 
 
3) Make 15-20 movies each imaging channel (i.e. each DNA target) each lasting about 20-30 
frames. This is for making the FRET histograms i.e. a distribution of FRET value of the first few 
frames of each of the detected single molecule. 
 
4) Get an absolute tight focus for each movie, people tend to make multiple movies by just moving 
different areas without re-adjusting the focus. But whenever you move, you lose the focus a 
slightest bit and the data will then be bad with single molecule spots being slightly de-focused. So 
for each of the 15-20 movies, move to a new imaging area re-adjust the focus till you are 
convinced that is the tightest possible focus and then image. It may look cumbersome but you 
have done so much effort to get to this point, it would be a terrible waste of efforts, if you 
acquired sub-standard images, just because you do not want to re-focus. 
 
5) Now, another important part is the long duration movies. You have to make about 3 movies each 
lasting atleast 3000-4000 frames (4000 frames, 100 ms/frame == 400 seconds). Longer than 4000 
frames would be even better, but it is quite likely that the fluorophores would photobleach before 
it.  
 
6) Before you start acquiring the long-duration movies. Readjust the focus, get the tightest possible 
focus and now start the recording. Do not move the optical table or anything in the room while 
you are recording the long -duration movies. Now when you are making movies that long, the 
biggest problem you will face is the de-focusing problem. Over the course of the movie 
acquisition for the long -duration movie, the focus will shift and your spots will not be sharp 
anymore. If you keep moving things around the room or in the optical table, your movies will 
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lose the focus and that movie will be totally useless. 
 
7) It is important to understand why even slight defocusing in the movies is totally useless. The 
biggest power of single molecule experiment is to detect transient and minute things. If you are 
interested in broader interaction, you might as well run a gel. To capture the minutest/transient 
interaction/event, your movies have to be extremely sharp, otherwise the real minute/transient 
event will be buried deep within the noise of the single molecule trajectories. So be very careful 
while making long duration movies. 
 
8) The more obvious reason why you need good quality long -duration movies is that these movies 
will be used for different kinds of kinetic analysis for Cas9-RNA binding/disassociation etc. So 
those movies are really the backbone/end-goal of these experiments. 
 
5.7.10 Double checking the consistency of the focus in the long-duration movies 
I have emphasized the importance of the long duration movies a lot. While you are doing the experiment, 
it is important to know whether a long movie you are acquiring is good or not. A simple check is the 
check of the eye, you will see that the spots will lose their sharpness and shape if the focus is being 
gradually lost. But this is not always obvious, infact it is quite difficult to see just by the naked eye. To 
resolve this problem, just quickly analyze the movie using smCamera software (in-house software, 
described in the introduction) and check the smFRET time trajectory in the smCamera software itself. If 
the traces look like this i.e. slight gradual delay of the signal, then it is a movie with defocusing problem 




Figure 5.11 | A representative smFRET time-trajectory from a long duration movie 
(Top Panel) Representative single molecule fluorescent spot in donor (left) and acceptor (right) channel. 
(Middle Panel) The green and red curve as a function of time denotes the donor and acceptor channel 
intensity of the spot respectively. (Bottom Panel) The blue curve as a function of time is the FRET 
efficiency curve for the single molecule spot. The gradual decay of the signal indicates that the focus was 
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being lost gradually as the movie was acquired. So this movie cannot be used for any kinetic or any 
lifetime analysis and you would have to acquire another long duration movie. 
15-20 short movies for FRET histograms and 3 long -duration movies with no defocusing issues is 
enough for a single DNA target. 
 
5.7.11 Analysis of the single molecule movies 
1) After you are done taking movies for all the DNA targets. You can analyze the movie using the 
smCamera software. 
 
2) Here's a snapshot of the Analysis parameters that you need to use while analysing these movies. 
Please check the following important parameters. 
 





3) You should do the mapping for each set of experiments and use it for the analysis.  
Things move in any microscope, for smFRET experiments analysis, where there has to be a one 
to one correlation between the spots in two different channels. A bad mapping is the worst 
possible ‘sin’ for these experiments. You have done all the hard work, your reagents and 
substrates worked, you saw good smFRET signal, but if you had the bad mapping file, all that 
information is essentially lost. Think about it. 
 
4) Mapping file, the one relating the coordinate in the donor channel to the acceptor channel, being 
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